"ID"	"Pathway"	"zscore"	"obs"	"mean"	"std"
"R-HSA-199977"	"ER to Golgi Anterograde Transport"	"67.211"	"296"	"18.499"	"4.129"
"R-HSA-948021"	"Transport to the Golgi and subsequent modification"	"66.726"	"296"	"18.89"	"4.153"
"R-HSA-6807878"	"COPI-mediated anterograde transport"	"58.94"	"217"	"13.184"	"3.458"
"R-HSA-446203"	"Asparagine N-linked glycosylation"	"50.201"	"309"	"33.366"	"5.491"
"R-HSA-199991"	"Membrane Trafficking"	"42.223"	"418"	"74.694"	"8.131"
"R-HSA-6811442"	"Intra-Golgi and retrograde Golgi-to-ER traffic"	"41.929"	"194"	"18.067"	"4.196"
"R-HSA-5653656"	"Vesicle-mediated transport"	"41.646"	"420"	"78.644"	"8.197"
"R-HSA-204005"	"COPII-mediated vesicle transport"	"39.752"	"121"	"8.192"	"2.838"
"R-HSA-6811434"	"COPI-dependent Golgi-to-ER retrograde traffic"	"37.637"	"128"	"9.82"	"3.14"
"R-HSA-8856688"	"Golgi-to-ER retrograde transport"	"37.304"	"155"	"14.212"	"3.774"
"R-HSA-445095"	"Interaction between L1 and Ankyrins"	"33.711"	"41"	"1.427"	"1.174"
"R-HSA-5694530"	"Cargo concentration in the ER"	"31.464"	"63"	"3.526"	"1.89"
"R-HSA-597592"	"Post-translational protein modification"	"22.327"	"411"	"158.336"	"11.317"
"R-HSA-6811438"	"Intra-Golgi traffic"	"19.964"	"38"	"3.172"	"1.745"
"R-HSA-9007101"	"Rab regulation of trafficking"	"18.814"	"63"	"8.829"	"2.879"
"R-HSA-8876198"	"RAB GEFs exchange GTP for GDP on RABs"	"17.559"	"50"	"6.337"	"2.487"
"R-HSA-392499"	"Metabolism of proteins"	"14.894"	"447"	"241.083"	"13.826"
"R-HSA-8873719"	"RAB geranylgeranylation"	"13.381"	"31"	"4.103"	"2.01"
"R-HSA-373760"	"L1CAM interactions"	"11.819"	"58"	"14.83"	"3.652"
"R-HSA-6811436"	"COPI-independent Golgi-to-ER retrograde traffic"	"10.984"	"27"	"4.392"	"2.058"
"R-HSA-6811440"	"Retrograde transport at the Trans-Golgi-Network"	"10.745"	"23"	"3.369"	"1.827"
"R-HSA-983189"	"Kinesins"	"9.535"	"20"	"3.056"	"1.777"
"R-HSA-8854214"	"TBC/RABGAPs"	"9.413"	"24"	"4.581"	"2.063"
"R-HSA-375165"	"NCAM signaling for neurite out-growth"	"9.386"	"29"	"6.341"	"2.414"
"R-HSA-5620924"	"Intraflagellar transport"	"8.106"	"15"	"2.699"	"1.517"
"R-HSA-162658"	"Golgi Cisternae Pericentriolar Stack Reorganization"	"7.852"	"20"	"4.281"	"2.002"
"R-HSA-2132295"	"MHC class II antigen presentation"	"7.202"	"27"	"7.581"	"2.696"
"R-HSA-421837"	"Clathrin derived vesicle budding"	"5.625"	"28"	"10.717"	"3.073"
"R-HSA-199992"	"trans-Golgi Network Vesicle Budding"	"5.625"	"28"	"10.717"	"3.073"
"R-HSA-5617833"	"Cilium Assembly"	"5.543"	"66"	"34.812"	"5.626"
"R-HSA-983170"	"Antigen Presentation: Folding, assembly and peptide loading of class I MHC"	"5.324"	"15"	"4.373"	"1.996"
"R-HSA-5620916"	"VxPx cargo-targeting to cilium"	"5.281"	"9"	"1.86"	"1.352"
"WP4129"	"Plasma lipoprotein assembly, remodeling, and clearance"	"5.245"	"18"	"5.851"	"2.316"
"R-HSA-8963898"	"Plasma lipoprotein assembly"	"4.942"	"10"	"2.361"	"1.546"
"R-HSA-1852241"	"Organelle biogenesis and maintenance"	"4.743"	"67"	"38.78"	"5.949"
"R-HSA-264876"	"Insulin processing"	"4.74"	"5"	"0.26"	"0.509"
"R-HSA-8963896"	"HDL assembly"	"4.555"	"7"	"1.505"	"1.206"
"R-HSA-977606"	"Regulation of Complement cascade"	"4.554"	"10"	"2.677"	"1.608"
"R-HSA-447041"	"CHL1 interactions"	"4.508"	"8"	"2.117"	"1.305"
"R-HSA-392517"	"Rap1 signalling"	"4.429"	"11"	"3.3"	"1.739"
"R-HSA-166658"	"Complement cascade"	"4.424"	"10"	"2.75"	"1.639"
"R-HSA-163358"	"PKA-mediated phosphorylation of key metabolic factors"	"4.409"	"6"	"1.236"	"1.08"
"R-HSA-1660514"	"Synthesis of PIPs at the Golgi membrane"	"4.388"	"7"	"1.562"	"1.239"
"hsa04360"	"Axon guidance"	"4.379"	"79"	"49.666"	"6.699"
"R-HSA-1445148"	"Translocation of GLUT4 to the plasma membrane"	"4.378"	"19"	"7.595"	"2.605"
"R-HSA-432722"	"Golgi Associated Vesicle Biogenesis"	"4.175"	"19"	"8.007"	"2.633"
"R-HSA-983231"	"Factors involved in megakaryocyte development and platelet production"	"4.017"	"30"	"15.01"	"3.732"
"R-HSA-442720"	"CREB phosphorylation through the activation of Adenylate Cyclase"	"3.962"	"6"	"1.406"	"1.16"
"R-HSA-167590"	"Nef Mediated CD4 Down-regulation"	"3.922"	"8"	"2.155"	"1.49"
"R-HSA-1236974"	"ER-Phagosome pathway"	"3.906"	"8"	"2.229"	"1.477"
"R-HSA-8854518"	"AURKA Activation by TPX2"	"3.866"	"40"	"22.344"	"4.567"
"R-HSA-380259"	"Loss of Nlp from mitotic centrosomes"	"3.802"	"39"	"21.761"	"4.535"
"R-HSA-380284"	"Loss of proteins required for interphase microtubule organization from the centrosome"	"3.802"	"39"	"21.761"	"4.535"
"R-HSA-1236975"	"Antigen processing-Cross presentation"	"3.707"	"10"	"3.378"	"1.786"
"R-HSA-447043"	"Neurofascin interactions"	"3.649"	"4"	"0.351"	"0.58"
"R-HSA-180897"	"Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization"	"3.619"	"6"	"1.551"	"1.229"
"R-HSA-8964043"	"Plasma lipoprotein clearance"	"3.616"	"10"	"3.494"	"1.799"
"R-HSA-432720"	"Lysosome Vesicle Biogenesis"	"3.6"	"17"	"7.715"	"2.579"
"R-HSA-1632852"	"Macroautophagy"	"3.59"	"16"	"6.899"	"2.535"
"R-HSA-74713"	"IRS activation"	"3.571"	"4"	"0.429"	"0.682"
"R-HSA-9010642"	"ROBO receptors bind AKAP5"	"3.567"	"7"	"2.061"	"1.385"
"R-HSA-8964038"	"LDL clearance"	"3.561"	"9"	"2.991"	"1.688"
"R-HSA-2565942"	"Regulation of PLK1 Activity at G2/M Transition"	"3.549"	"53"	"32.975"	"5.643"
"R-HSA-6798695"	"Neutrophil degranulation"	"3.545"	"74"	"49.849"	"6.812"
"R-HSA-164378"	"PKA activation in glucagon signalling"	"3.53"	"8"	"2.646"	"1.517"
"R-HSA-380287"	"Centrosome maturation"	"3.484"	"39"	"22.75"	"4.664"
"R-HSA-380270"	"Recruitment of mitotic centrosome proteins and complexes"	"3.484"	"39"	"22.75"	"4.664"
"R-HSA-380320"	"Recruitment of NuMA to mitotic centrosomes"	"3.48"	"39"	"22.788"	"4.658"
"R-HSA-264870"	"Caspase-mediated cleavage of cytoskeletal proteins"	"3.428"	"5"	"1.298"	"1.08"
"R-HSA-75035"	"Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex"	"3.395"	"14"	"5.971"	"2.365"
"R-HSA-8866427"	"VLDLR internalisation and degradation"	"3.343"	"8"	"2.606"	"1.613"
"R-HSA-5620912"	"Anchoring of the basal body to the plasma membrane"	"3.256"	"44"	"27.273"	"5.137"
"R-HSA-140875"	"Common Pathway of Fibrin Clot Formation"	"3.247"	"4"	"0.753"	"0.824"
"R-HSA-1660661"	"Sphingolipid de novo biosynthesis"	"3.242"	"5"	"1.305"	"1.14"
"R-HSA-8955332"	"Carboxyterminal post-translational modifications of tubulin"	"3.165"	"18"	"9.088"	"2.816"
"R-HSA-389977"	"Post-chaperonin tubulin folding pathway"	"3.093"	"20"	"10.57"	"3.049"
"R-HSA-447038"	"NrCAM interactions"	"3.072"	"4"	"0.928"	"0.939"
"R-HSA-426117"	"Cation-coupled Chloride cotransporters"	"2.951"	"3"	"0.049"	"0.216"
"R-HSA-182218"	"Nef Mediated CD8 Down-regulation"	"2.921"	"5"	"1.433"	"1.221"
"R-HSA-164938"	"Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters"	"2.85"	"8"	"3.08"	"1.726"
"R-HSA-163615"	"PKA activation"	"2.823"	"8"	"3.192"	"1.703"
"R-HSA-2214320"	"Anchoring fibril formation"	"2.817"	"3"	"0.183"	"0.438"
"R-HSA-2980736"	"Peptide hormone metabolism"	"2.816"	"7"	"2.403"	"1.633"
"R-HSA-416993"	"Trafficking of GluR2-containing AMPA receptors"	"2.699"	"7"	"2.582"	"1.637"
"hsa00600"	"Sphingolipid metabolism"	"2.648"	"5"	"1.637"	"1.27"
"R-HSA-75105"	"Fatty acyl-CoA biosynthesis"	"2.642"	"6"	"2.241"	"1.423"
"R-HSA-111931"	"PKA-mediated phosphorylation of CREB"	"2.63"	"8"	"3.369"	"1.761"
"R-HSA-114452"	"Activation of BH3-only proteins"	"2.623"	"16"	"8.644"	"2.804"
"R-HSA-3371497"	"HSP90 chaperone cycle for steroid hormone receptors (SHR)"	"2.621"	"24"	"14.519"	"3.618"
"R-HSA-373753"	"Nephrin family interactions"	"2.613"	"9"	"3.946"	"1.934"
"R-HSA-437239"	"Recycling pathway of L1"	"2.612"	"11"	"5.168"	"2.233"
"R-HSA-177504"	"Retrograde neurotrophin signalling"	"2.605"	"10"	"4.622"	"2.064"
"R-HSA-5099900"	"WNT5A-dependent internalization of FZD4"	"2.594"	"9"	"3.964"	"1.941"
"R-HSA-68877"	"Mitotic Prometaphase"	"2.552"	"60"	"43.316"	"6.538"
"R-HSA-8963901"	"Chylomicron remodeling"	"2.549"	"3"	"0.451"	"0.659"
"R-HSA-111447"	"Activation of BAD and translocation to mitochondria "	"2.508"	"11"	"5.516"	"2.187"
"R-HSA-69275"	"G2/M Transition"	"2.454"	"60"	"44.102"	"6.479"
"WP1841"	"Intrinsic Pathway for Apoptosis"	"2.434"	"17"	"9.702"	"2.998"
"R-HSA-1660517"	"Synthesis of PIPs at the late endosome membrane"	"2.359"	"3"	"0.641"	"0.794"
"R-HSA-418359"	"Reduction of cytosolic Ca++ levels"	"2.351"	"4"	"1.336"	"1.133"
"R-HSA-453274"	"Mitotic G2-G2/M phases"	"2.341"	"60"	"44.736"	"6.519"
"R-HSA-1660516"	"Synthesis of PIPs at the early endosome membrane"	"2.339"	"3"	"0.661"	"0.813"
"R-HSA-5673001"	"RAF/MAP kinase cascade"	"2.337"	"42"	"30.109"	"5.089"
"R-HSA-425393"	"Transport of inorganic cations/anions and amino acids/oligopeptides"	"2.331"	"4"	"1.342"	"1.14"
"R-HSA-5684996"	"MAPK1/MAPK3 signaling"	"2.294"	"43"	"31.046"	"5.211"
"R-HSA-1483255"	"PI Metabolism"	"2.289"	"9"	"4.274"	"2.064"
"R-HSA-1912399"	"Pre-NOTCH Processing in the Endoplasmic Reticulum"	"2.284"	"3"	"0.716"	"0.799"
"WP3472"	"XBP1(S) activates chaperone genes"	"2.239"	"3"	"0.761"	"0.911"
"R-HSA-8963899"	"Plasma lipoprotein remodeling"	"2.193"	"3"	"0.807"	"0.888"
"R-HSA-1912420"	"Pre-NOTCH Processing in Golgi"	"2.187"	"3"	"0.813"	"0.856"
"R-HSA-140877"	"Formation of Fibrin Clot (Clotting Cascade)"	"2.185"	"4"	"1.502"	"1.143"
"R-HSA-8957275"	"Post-translational protein phosphorylation"	"2.161"	"12"	"6.773"	"2.419"
"R-HSA-5683057"	"MAPK family signaling cascades"	"2.149"	"51"	"38.571"	"5.783"
"R-HSA-8856828"	"Clathrin-mediated endocytosis"	"2.128"	"43"	"31.785"	"5.271"
"R-HSA-111933"	"Calmodulin induced events"	"2.065"	"8"	"4.042"	"1.917"
"R-HSA-111997"	"CaM pathway"	"2.065"	"8"	"4.042"	"1.917"
"R-HSA-1660499"	"Synthesis of PIPs at the plasma membrane"	"2.029"	"7"	"3.287"	"1.83"
"R-HSA-418360"	"Platelet calcium homeostasis"	"2.026"	"4"	"1.519"	"1.224"
"R-HSA-168275"	"Entry of Influenza Virion into Host Cell via Endocytosis"	"2.018"	"3"	"0.982"	"0.959"
"R-HSA-8963888"	"Chylomicron assembly"	"2.016"	"3"	"0.984"	"0.976"
"R-HSA-382551"	"Transport of small molecules"	"2.005"	"50"	"38.19"	"5.89"
"R-HSA-196025"	"Formation of annular gap junctions"	"1.978"	"6"	"2.825"	"1.605"
"R-HSA-1266738"	"Developmental Biology"	"1.977"	"82"	"66.896"	"7.641"
"R-HSA-163359"	"Glucagon signaling in metabolic regulation"	"1.963"	"9"	"4.864"	"2.107"
"R-HSA-381426"	"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"	"1.935"	"12"	"7.171"	"2.496"
"R-HSA-435368"	"Zinc efflux and compartmentalization by the SLC30 family"	"1.935"	"2"	"0.065"	"0.255"
"R-HSA-5620920"	"Cargo trafficking to the periciliary membrane"	"1.892"	"10"	"5.743"	"2.25"
"R-HSA-6806664"	"Metabolism of vitamin K"	"1.885"	"2"	"0.115"	"0.328"
"R-HSA-190873"	"Gap junction degradation"	"1.867"	"6"	"2.919"	"1.65"
"R-HSA-190828"	"Gap junction trafficking"	"1.855"	"6"	"2.933"	"1.653"
"R-HSA-936837"	"Ion transport by P-type ATPases"	"1.849"	"6"	"2.921"	"1.665"
"WP3810"	"Cardiac conduction"	"1.837"	"8"	"4.267"	"2.032"
"R-HSA-6803205"	"TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain"	"1.812"	"4"	"1.744"	"1.245"
"R-HSA-1650814"	"Collagen biosynthesis and modifying enzymes"	"1.809"	"4"	"1.665"	"1.291"
"R-HSA-435354"	"Zinc transporters"	"1.798"	"2"	"0.202"	"0.451"
"R-HSA-3371568"	"Attenuation phase"	"1.793"	"23"	"16.231"	"3.775"
"R-HSA-6806667"	"Metabolism of fat-soluble vitamins"	"1.787"	"5"	"2.309"	"1.506"
"R-HSA-2022090"	"Assembly of collagen fibrils and other multimeric structures"	"1.762"	"3"	"1.147"	"1.052"
"R-HSA-425410"	"Metal ion SLC transporters"	"1.762"	"2"	"0.238"	"0.492"
"R-HSA-164952"	"The role of Nef in HIV-1 replication and disease pathogenesis"	"1.753"	"8"	"4.436"	"2.033"
"R-HSA-3371571"	"HSF1-dependent transactivation"	"1.744"	"24"	"17.236"	"3.878"
"R-HSA-399710"	"Activation of AMPA receptors"	"1.722"	"2"	"0.278"	"0.519"
"R-HSA-205025"	"NADE modulates death signalling"	"1.71"	"3"	"1.267"	"1.013"
"R-HSA-432040"	"Vasopressin regulates renal water homeostasis via Aquaporins"	"1.659"	"9"	"5.393"	"2.175"
"R-HSA-445717"	"Aquaporin-mediated transport"	"1.656"	"9"	"5.397"	"2.176"
"R-HSA-163560"	"Triglyceride catabolism"	"1.655"	"6"	"3.206"	"1.688"
"R-HSA-422356"	"Regulation of insulin secretion"	"1.615"	"15"	"10.035"	"3.075"
"R-HSA-111996"	"Ca-dependent events"	"1.59"	"8"	"4.725"	"2.06"
"R-HSA-139910"	"Activation of BMF and translocation to mitochondria"	"1.582"	"2"	"0.418"	"0.64"
"R-HSA-69478"	"G2/M DNA replication checkpoint"	"1.574"	"3"	"1.233"	"1.122"
"R-HSA-8964026"	"Chylomicron clearance"	"1.551"	"2"	"0.449"	"0.665"
"R-HSA-1489509"	"DAG and IP3 signaling"	"1.547"	"8"	"4.738"	"2.109"
"R-HSA-389958"	"Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding"	"1.532"	"23"	"16.868"	"4.002"
"R-HSA-8964058"	"HDL remodeling"	"1.51"	"2"	"0.49"	"0.683"
"R-HSA-399721"	"Glutamate binding, activation of AMPA receptors and synaptic plasticity"	"1.498"	"8"	"4.759"	"2.164"
"R-HSA-399719"	"Trafficking of AMPA receptors"	"1.498"	"8"	"4.759"	"2.164"
"R-HSA-174577"	"Activation of C3 and C5"	"1.495"	"2"	"0.505"	"0.712"
"R-HSA-77387"	"Insulin receptor recycling"	"1.48"	"8"	"4.837"	"2.137"
"R-HSA-425407"	"SLC-mediated transmembrane transport"	"1.48"	"6"	"3.335"	"1.801"
"R-HSA-5578775"	"Ion homeostasis"	"1.467"	"6"	"3.337"	"1.815"
"R-HSA-381676"	"Glucagon-like Peptide-1 (GLP1) regulates insulin secretion"	"1.455"	"9"	"5.721"	"2.254"
"R-HSA-888590"	"GABA synthesis, release, reuptake and degradation"	"1.453"	"5"	"2.742"	"1.554"
"R-HSA-8979227"	"Triglyceride metabolism"	"1.435"	"6"	"3.471"	"1.762"
"R-HSA-141424"	"Amplification of signal from the kinetochores"	"1.425"	"25"	"19.036"	"4.184"
"R-HSA-141444"	"Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal"	"1.425"	"25"	"19.036"	"4.184"
"R-HSA-389960"	"Formation of tubulin folding intermediates by CCT/TriC"	"1.396"	"20"	"14.829"	"3.703"
"R-HSA-425366"	"Transport of bile salts and organic acids, metal ions and amine compounds"	"1.386"	"2"	"0.614"	"0.788"
"R-HSA-170984"	"ARMS-mediated activation"	"1.374"	"5"	"2.832"	"1.578"
"R-HSA-157858"	"Gap junction trafficking and regulation"	"1.356"	"6"	"3.536"	"1.818"
"R-HSA-168277"	"Influenza Virus Induced Apoptosis"	"1.356"	"2"	"0.644"	"0.79"
"R-HSA-8948216"	"Collagen chain trimerization"	"1.341"	"2"	"0.659"	"0.821"
"R-HSA-389957"	"Prefoldin mediated transfer of substrate  to CCT/TriC"	"1.339"	"19"	"14.117"	"3.647"
"R-HSA-2022377"	"Metabolism of Angiotensinogen to Angiotensins"	"1.334"	"2"	"0.666"	"0.807"
"R-HSA-75876"	"Synthesis of very long-chain fatty acyl-CoAs"	"1.288"	"3"	"1.458"	"1.197"
"R-HSA-500753"	"Pyrimidine biosynthesis"	"1.287"	"2"	"0.713"	"0.811"
"R-HSA-2500257"	"Resolution of Sister Chromatid Cohesion"	"1.285"	"28"	"22.119"	"4.576"
"R-HSA-381119"	"Unfolded Protein Response (UPR)"	"1.273"	"4"	"2.177"	"1.432"
"R-HSA-170968"	"Frs2-mediated activation"	"1.261"	"5"	"2.953"	"1.623"
"R-HSA-163125"	"Post-translational modification: synthesis of GPI-anchored proteins"	"1.249"	"2"	"0.751"	"0.869"
"R-HSA-397014"	"Muscle contraction"	"1.245"	"16"	"11.759"	"3.406"
"R-HSA-111446"	"Activation of BIM and translocation to mitochondria "	"1.228"	"2"	"0.772"	"0.851"
"R-HSA-5610785"	"GLI3 is processed to GLI3R by the proteasome"	"1.224"	"15"	"11.147"	"3.148"
"R-HSA-5610783"	"Degradation of GLI2 by the proteasome"	"1.215"	"15"	"11.167"	"3.154"
"R-HSA-2562597"	"Optineurin and Myosin Phosphatase Negatively Regulate PLK1"	"1.207"	"2"	"0.793"	"0.865"
"R-HSA-442755"	"Activation of NMDA receptor and postsynaptic events"	"1.185"	"9"	"6.195"	"2.367"
"R-HSA-5668599"	"RHO GTPases Activate NADPH Oxidases"	"1.182"	"2"	"0.818"	"0.826"
"R-HSA-8949664"	"Processing of SMDT1"	"1.158"	"2"	"0.842"	"0.899"
"R-HSA-450531"	"Regulation of mRNA stability by proteins that bind AU-rich elements"	"1.133"	"16"	"12.258"	"3.302"
"R-HSA-157212"	"A third proteolytic cleavage releases NICD"	"1.112"	"2"	"0.888"	"0.928"
"R-HSA-446210"	"Synthesis of UDP-N-acetyl-glucosamine"	"1.11"	"2"	"0.89"	"0.936"
"R-HSA-74749"	"Signal attenuation"	"1.106"	"5"	"3.147"	"1.676"
"R-HSA-156590"	"Glutathione conjugation"	"1.101"	"2"	"0.899"	"0.951"
"R-HSA-381070"	"IRE1alpha activates chaperones"	"1.062"	"3"	"1.683"	"1.24"
"R-HSA-1236977"	"Endosomal/Vacuolar pathway"	"1.061"	"2"	"0.939"	"0.925"
"WP3316"	"Hedgehog ,off, state"	"1.054"	"17"	"13.377"	"3.437"
"R-HSA-5610780"	"Degradation of GLI1 by the proteasome"	"1.043"	"14"	"10.773"	"3.095"
"R-HSA-2028269"	"Signaling by Hippo"	"1.037"	"6"	"3.982"	"1.947"
"R-HSA-8978868"	"Fatty acid metabolism"	"1.036"	"8"	"5.712"	"2.208"
"R-HSA-556833"	"Metabolism of lipids"	"1.031"	"35"	"29.712"	"5.128"
"R-HSA-140837"	"Intrinsic Pathway of Fibrin Clot Formation"	"1.006"	"2"	"0.994"	"0.933"
"R-HSA-1483257"	"Phospholipid metabolism"	"0.985"	"11"	"8.209"	"2.833"
"R-HSA-6788656"	"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism"	"0.984"	"3"	"1.75"	"1.27"
"R-HSA-1474290"	"Collagen formation"	"0.979"	"4"	"2.459"	"1.574"
"R-HSA-1482883"	"Acyl chain remodeling of DAG and TAG"	"0.976"	"1"	"0.024"	"0.153"
"R-HSA-68886"	"M Phase"	"0.969"	"85"	"76.505"	"8.766"
"R-HSA-69618"	"Mitotic Spindle Checkpoint"	"0.957"	"25"	"20.79"	"4.397"
"R-HSA-169893"	"Prolonged ERK activation events"	"0.957"	"5"	"3.33"	"1.744"
"R-HSA-425986"	"Sodium/Proton exchangers"	"0.948"	"1"	"0.052"	"0.227"
"R-HSA-450408"	"AUF1 (hnRNP D0) binds and destabilizes mRNA"	"0.936"	"7"	"5.022"	"2.112"
"R-HSA-6782861"	"Synthesis of wybutosine at G37 of tRNA(Phe)"	"0.927"	"1"	"0.073"	"0.272"
"R-HSA-450513"	"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA"	"0.921"	"4"	"2.555"	"1.568"
"WP3379"	"RHO GTPases Activate Formins"	"0.918"	"29"	"24.74"	"4.643"
"R-HSA-5624138"	"Trafficking of myristoylated proteins to the cilium"	"0.913"	"1"	"0.087"	"0.289"
"R-HSA-1483226"	"Synthesis of PI"	"0.912"	"1"	"0.088"	"0.297"
"R-HSA-983169"	"Class I MHC mediated antigen processing & presentation"	"0.896"	"45"	"39.865"	"5.732"
"R-HSA-2243919"	"Crosslinking of collagen fibrils"	"0.863"	"1"	"0.137"	"0.361"
"R-HSA-162699"	"Synthesis of dolichyl-phosphate mannose"	"0.859"	"1"	"0.141"	"0.368"
"R-HSA-71182"	"Phenylalanine and tyrosine catabolism"	"0.838"	"1"	"0.162"	"0.405"
"R-HSA-8964041"	"LDL remodeling"	"0.834"	"1"	"0.166"	"0.406"
"R-HSA-176417"	"Phosphorylation of Emi1"	"0.825"	"3"	"1.865"	"1.376"
"R-HSA-3371511"	"HSF1 activation"	"0.82"	"19"	"15.915"	"3.761"
"R-HSA-3000480"	"Scavenging by Class A Receptors"	"0.82"	"2"	"1.133"	"1.058"
"R-HSA-9018681"	"Biosynthesis of protectins"	"0.816"	"1"	"0.184"	"0.429"
"R-HSA-112310"	"Neurotransmitter release cycle"	"0.809"	"5"	"3.551"	"1.79"
"R-HSA-913709"	"O-linked glycosylation of mucins"	"0.806"	"2"	"1.146"	"1.059"
"R-HSA-450520"	"HuR (ELAVL1) binds and stabilizes mRNA"	"0.802"	"5"	"3.623"	"1.717"
"R-HSA-5250982"	"Toxicity of tetanus toxin (TeNT)"	"0.802"	"1"	"0.198"	"0.439"
"R-HSA-3000497"	"Scavenging by Class H Receptors"	"0.799"	"1"	"0.201"	"0.453"
"hsa04210"	"Apoptosis"	"0.79"	"21"	"17.65"	"4.243"
"R-HSA-5576890"	"Phase 3 - rapid repolarisation"	"0.787"	"1"	"0.213"	"0.465"
"R-HSA-2453902"	"The canonical retinoid cycle in rods (twilight vision)"	"0.787"	"1"	"0.213"	"0.475"
"R-HSA-8964046"	"VLDL clearance"	"0.786"	"1"	"0.214"	"0.461"
"R-HSA-73614"	"Pyrimidine salvage"	"0.775"	"1"	"0.225"	"0.47"
"R-HSA-3371453"	"Regulation of HSF1-mediated heat shock response"	"0.774"	"31"	"27.31"	"4.767"
"R-HSA-165181"	"Inhibition of TSC complex formation by PKB"	"0.772"	"1"	"0.228"	"0.463"
"R-HSA-5250955"	"Toxicity of botulinum toxin type D (BoNT/D)"	"0.75"	"1"	"0.25"	"0.488"
"R-HSA-5250981"	"Toxicity of botulinum toxin type F (BoNT/F)"	"0.75"	"1"	"0.25"	"0.488"
"R-HSA-8874211"	"CREB3 factors activate genes"	"0.749"	"1"	"0.251"	"0.49"
"R-HSA-6782315"	"tRNA modification in the nucleus and cytosol"	"0.748"	"2"	"1.214"	"1.05"
"R-HSA-2160916"	"Hyaluronan uptake and degradation"	"0.744"	"1"	"0.256"	"0.505"
"R-HSA-2142845"	"Hyaluronan metabolism"	"0.738"	"1"	"0.262"	"0.51"
"R-HSA-2980767"	"Activation of NIMA Kinases NEK9, NEK6, NEK7"	"0.723"	"3"	"1.965"	"1.432"
"R-HSA-5357801"	"Programmed Cell Death"	"0.706"	"21"	"17.98"	"4.277"
"R-HSA-5625970"	"RHO GTPases activate KTN1"	"0.678"	"3"	"2.049"	"1.403"
"R-HSA-5635838"	"Activation of SMO"	"0.667"	"2"	"1.265"	"1.103"
"R-HSA-2660826"	"Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	"0.656"	"1"	"0.344"	"0.578"
"R-HSA-2660825"	"Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"	"0.656"	"1"	"0.344"	"0.578"
"R-HSA-8876725"	"Protein methylation"	"0.653"	"7"	"5.599"	"2.144"
"R-HSA-2142670"	"Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)"	"0.648"	"1"	"0.352"	"0.607"
"R-HSA-111459"	"Activation of caspases through apoptosome-mediated cleavage"	"0.647"	"1"	"0.353"	"0.589"
"R-HSA-111461"	"Cytochrome c-mediated apoptotic response"	"0.647"	"1"	"0.353"	"0.589"
"R-HSA-112315"	"Transmission across Chemical Synapses"	"0.644"	"22"	"19.253"	"4.264"
"R-HSA-164939"	"Nef mediated downregulation of CD28 cell surface expression"	"0.642"	"1"	"0.358"	"0.582"
"R-HSA-8854521"	"Interaction between PHLDA1 and AURKA"	"0.641"	"1"	"0.359"	"0.6"
"R-HSA-112043"	"PLC beta mediated events"	"0.625"	"8"	"6.47"	"2.447"
"R-HSA-77346"	"Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA"	"0.618"	"1"	"0.382"	"0.612"
"R-HSA-71240"	"Tryptophan catabolism"	"0.615"	"1"	"0.385"	"0.589"
"R-HSA-2142816"	"Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)"	"0.606"	"1"	"0.394"	"0.629"
"R-HSA-1296072"	"Voltage gated Potassium channels"	"0.6"	"1"	"0.4"	"0.641"
"R-HSA-111463"	"SMAC binds to IAPs "	"0.596"	"1"	"0.404"	"0.635"
"R-HSA-111469"	"SMAC-mediated apoptotic response"	"0.596"	"1"	"0.404"	"0.635"
"R-HSA-111464"	"SMAC-mediated dissociation of IAP:caspase complexes "	"0.596"	"1"	"0.404"	"0.635"
"R-HSA-5250989"	"Toxicity of botulinum toxin type G (BoNT/G)"	"0.59"	"1"	"0.41"	"0.63"
"R-HSA-211736"	"Stimulation of the cell death response by PAK-2p34"	"0.587"	"1"	"0.413"	"0.62"
"R-HSA-983712"	"Ion channel transport"	"0.582"	"19"	"16.81"	"3.763"
"R-HSA-390466"	"Chaperonin-mediated protein folding"	"0.569"	"30"	"27.117"	"5.071"
"R-HSA-77286"	"mitochondrial fatty acid beta-oxidation of saturated fatty acids"	"0.559"	"1"	"0.441"	"0.649"
"R-HSA-196836"	"Vitamin C (ascorbate) metabolism"	"0.559"	"1"	"0.441"	"0.661"
"WP383"	"Striated Muscle Contraction"	"0.55"	"4"	"3.05"	"1.726"
"R-HSA-975634"	"Retinoid metabolism and transport"	"0.547"	"3"	"2.194"	"1.473"
"R-HSA-391251"	"Protein folding"	"0.545"	"30"	"27.237"	"5.07"
"R-HSA-1614558"	"Degradation of cysteine and homocysteine"	"0.543"	"1"	"0.457"	"0.665"
"R-HSA-5250958"	"Toxicity of botulinum toxin type B (BoNT/B)"	"0.543"	"1"	"0.457"	"0.68"
"R-HSA-5621575"	"CD209 (DC-SIGN) signaling"	"0.507"	"6"	"4.884"	"2.2"
"R-HSA-168330"	"Viral RNP Complexes in the Host Cell Nucleus"	"0.506"	"2"	"1.443"	"1.101"
"R-HSA-438066"	"Unblocking of NMDA receptor, glutamate binding and activation"	"0.491"	"3"	"2.275"	"1.477"
"R-HSA-9018677"	"Biosynthesis of DHA-derived SPMs"	"0.486"	"1"	"0.514"	"0.706"
"R-HSA-9018678"	"Biosynthesis of specialized proresolving mediators (SPMs)"	"0.481"	"1"	"0.519"	"0.709"
"R-HSA-1442490"	"Collagen degradation"	"0.477"	"1"	"0.523"	"0.701"
"R-HSA-180024"	"DARPP-32 events"	"0.474"	"8"	"6.824"	"2.482"
"R-HSA-438064"	"Post NMDA receptor activation events"	"0.468"	"7"	"5.917"	"2.312"
"R-HSA-111471"	"Apoptotic factor-mediated response"	"0.466"	"1"	"0.534"	"0.707"
"R-HSA-380612"	"Metabolism of serotonin"	"0.465"	"1"	"0.535"	"0.698"
"R-HSA-166663"	"Initial triggering of complement"	"0.464"	"2"	"1.437"	"1.212"
"R-HSA-166208"	"mTORC1-mediated signalling"	"0.464"	"4"	"3.195"	"1.735"
"R-HSA-380615"	"Serotonin clearance from the synaptic cleft"	"0.463"	"1"	"0.537"	"0.699"
"R-HSA-113507"	"E2F-enabled inhibition of pre-replication complex formation"	"0.46"	"2"	"1.456"	"1.182"
"R-HSA-112040"	"G-protein mediated events"	"0.459"	"8"	"6.833"	"2.544"
"WP3395"	"Cellular response to heat stress"	"0.457"	"37"	"34.552"	"5.355"
"R-HSA-5173105"	"O-linked glycosylation"	"0.455"	"2"	"1.453"	"1.203"
"R-HSA-8866423"	"VLDL assembly"	"0.453"	"1"	"0.547"	"0.71"
"R-HSA-191273"	"Cholesterol biosynthesis"	"0.448"	"2"	"1.471"	"1.18"
"R-HSA-3000471"	"Scavenging by Class B Receptors"	"0.448"	"1"	"0.552"	"0.724"
"R-HSA-5576893"	"Phase 2 - plateau phase"	"0.445"	"1"	"0.555"	"0.751"
"R-HSA-112311"	"Neurotransmitter clearance"	"0.429"	"1"	"0.571"	"0.726"
"R-HSA-1855183"	"Synthesis of IP2, IP, and Ins in the cytosol"	"0.422"	"1"	"0.578"	"0.742"
"R-HSA-8856825"	"Cargo recognition for clathrin-mediated endocytosis"	"0.42"	"26"	"24.091"	"4.547"
"R-HSA-418889"	"Ligand-independent caspase activation via DCC"	"0.409"	"1"	"0.591"	"0.776"
"R-HSA-5669034"	"TNFs bind their physiological receptors"	"0.404"	"1"	"0.596"	"0.775"
"WP3802"	"TP53 Regulates Transcription of Cell Death Genes"	"0.399"	"4"	"3.31"	"1.731"
"R-HSA-114608"	"Platelet degranulation "	"0.395"	"13"	"11.775"	"3.098"
"R-HSA-8853659"	"RET signaling"	"0.385"	"6"	"5.147"	"2.215"
"R-HSA-4086400"	"PCP/CE pathway"	"0.38"	"15"	"13.689"	"3.449"
"R-HSA-449836"	"Other interleukin signaling"	"0.377"	"2"	"1.542"	"1.216"
"R-HSA-163685"	"Integration of energy metabolism"	"0.375"	"15"	"13.69"	"3.493"
"R-HSA-187042"	"TRKA activation by NGF"	"0.362"	"2"	"1.593"	"1.124"
"R-HSA-879415"	"Advanced glycosylation endproduct receptor signaling"	"0.361"	"5"	"4.301"	"1.938"
"R-HSA-8857538"	"PTK6 promotes HIF1A stabilization"	"0.343"	"2"	"1.586"	"1.208"
"WP4079"	"RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)"	"0.332"	"1"	"0.668"	"0.783"
"R-HSA-5686938"	"Regulation of TLR by endogenous ligand"	"0.329"	"1"	"0.671"	"0.827"
"R-HSA-112314"	"Neurotransmitter receptors and postsynaptic signal transmission"	"0.322"	"16"	"14.782"	"3.783"
"R-HSA-111465"	"Apoptotic cleavage of cellular proteins"	"0.32"	"5"	"4.344"	"2.05"
"R-HSA-8956321"	"Nucleotide salvage"	"0.318"	"1"	"0.682"	"0.815"
"R-HSA-6804115"	"TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain"	"0.312"	"4"	"3.458"	"1.74"
"R-HSA-9017802"	"Noncanonical activation of NOTCH3"	"0.306"	"1"	"0.694"	"0.812"
"R-HSA-1474228"	"Degradation of the extracellular matrix"	"0.305"	"3"	"2.522"	"1.567"
"R-HSA-8866910"	"TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"	"0.302"	"3"	"2.536"	"1.537"
"R-HSA-450385"	"Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA"	"0.294"	"3"	"2.533"	"1.59"
"R-HSA-196780"	"Biotin transport and metabolism"	"0.292"	"1"	"0.708"	"0.828"
"R-HSA-5358351"	"Signaling by Hedgehog"	"0.285"	"19"	"17.881"	"3.927"
"R-HSA-3000170"	"Syndecan interactions"	"0.266"	"2"	"1.665"	"1.26"
"R-HSA-187706"	"Signalling to p38 via RIT and RIN"	"0.259"	"2"	"1.7"	"1.158"
"R-HSA-77289"	"Mitochondrial Fatty Acid Beta-Oxidation"	"0.254"	"1"	"0.746"	"0.86"
"R-HSA-446219"	"Synthesis of substrates in N-glycan biosythesis"	"0.254"	"3"	"2.598"	"1.584"
"R-HSA-159418"	"Recycling of bile acids and salts"	"0.248"	"1"	"0.752"	"0.855"
"R-HSA-168256"	"Immune System"	"0.239"	"165"	"162.383"	"10.963"
"R-HSA-162909"	"Host Interactions of HIV factors"	"0.238"	"27"	"25.861"	"4.788"
"R-HSA-76005"	"Response to elevated platelet cytosolic Ca2+"	"0.22"	"13"	"12.293"	"3.207"
"R-HSA-168249"	"Innate Immune System"	"0.212"	"111"	"108.986"	"9.481"
"R-HSA-170145"	"Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes"	"0.212"	"1"	"0.788"	"0.85"
"R-HSA-157052"	"NICD traffics to nucleus"	"0.207"	"3"	"2.691"	"1.493"
"R-HSA-350054"	"Notch-HLH transcription pathway"	"0.207"	"3"	"2.691"	"1.493"
"R-HSA-112316"	"Neuronal System"	"0.191"	"23"	"22.095"	"4.731"
"R-HSA-6809371"	"Formation of the cornified envelope"	"0.181"	"1"	"0.819"	"0.894"
"R-HSA-2467813"	"Separation of Sister Chromatids"	"0.178"	"31"	"30.048"	"5.356"
"WP3349"	"TP53 Regulates Metabolic Genes"	"0.165"	"14"	"13.415"	"3.543"
"R-HSA-4419969"	"Depolymerisation of the Nuclear Lamina"	"0.152"	"2"	"1.797"	"1.339"
"R-HSA-176033"	"Interactions of Vpr with host cellular proteins"	"0.147"	"8"	"7.615"	"2.626"
"R-HSA-168799"	"Neurotoxicity of clostridium toxins"	"0.146"	"1"	"0.854"	"0.943"
"R-HSA-445355"	"Smooth Muscle Contraction"	"0.142"	"6"	"5.67"	"2.329"
"R-HSA-5696394"	"DNA Damage Recognition in GG-NER"	"0.136"	"15"	"14.526"	"3.493"
"R-HSA-187024"	"NGF-independant TRKA activation"	"0.134"	"2"	"1.832"	"1.254"
"R-HSA-203641"	"NOSTRIN mediated eNOS trafficking"	"0.129"	"1"	"0.871"	"0.946"
"R-HSA-156580"	"Phase II - Conjugation of compounds"	"0.129"	"4"	"3.761"	"1.848"
"R-HSA-1500931"	"Cell-Cell communication"	"0.123"	"10"	"9.632"	"2.983"
"R-HSA-211859"	"Biological oxidations"	"0.118"	"11"	"10.625"	"3.171"
"R-HSA-8849932"	"Synaptic adhesion-like molecules"	"0.115"	"2"	"1.845"	"1.344"
"R-HSA-74751"	"Insulin receptor signalling cascade"	"0.113"	"7"	"6.722"	"2.461"
"R-HSA-446193"	"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein"	"0.112"	"3"	"2.817"	"1.641"
"R-HSA-171319"	"Telomere Extension By Telomerase"	"0.109"	"2"	"1.861"	"1.272"
"R-HSA-167021"	"PLC-gamma1 signalling"	"0.102"	"2"	"1.876"	"1.222"
"R-HSA-198745"	"Signalling to STAT3"	"0.094"	"2"	"1.88"	"1.277"
"R-HSA-156988"	"Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor"	"0.083"	"8"	"7.784"	"2.603"
"R-HSA-187015"	"Activation of TRKA receptors"	"0.078"	"2"	"1.901"	"1.275"
"R-HSA-6804754"	"Regulation of TP53 Expression"	"0.074"	"1"	"0.926"	"0.846"
"R-HSA-211945"	"Phase I - Functionalization of compounds"	"0.073"	"7"	"6.814"	"2.562"
"R-HSA-9013973"	"TICAM1-dependent activation of IRF3/IRF7"	"0.071"	"1"	"0.929"	"0.978"
"R-HSA-8866911"	"TFAP2 (AP-2) family regulates transcription of cell cycle factors"	"0.062"	"2"	"1.919"	"1.305"
"R-HSA-2691232"	"Constitutive Signaling by NOTCH1 HD Domain Mutants"	"0.056"	"8"	"7.854"	"2.596"
"R-HSA-2691230"	"Signaling by NOTCH1 HD Domain Mutants in Cancer"	"0.056"	"8"	"7.854"	"2.596"
"R-HSA-2468052"	"Establishment of Sister Chromatid Cohesion"	"0.053"	"2"	"1.928"	"1.352"
"R-HSA-156581"	"Methylation"	"0.046"	"2"	"1.942"	"1.273"
"R-HSA-4641265"	"Repression of WNT target genes"	"0.034"	"3"	"2.948"	"1.538"
"WP2706"	"Activation of gene expression by SREBF (SREBP)"	"0.025"	"2"	"1.965"	"1.423"
"R-HSA-917977"	"Transferrin endocytosis and recycling"	"0.015"	"5"	"4.968"	"2.172"
"R-HSA-71384"	"Ethanol oxidation"	"0.006"	"2"	"1.992"	"1.316"
"R-HSA-2466712"	"Biosynthesis of A2E, implicated in retinal degradation"	"0"	"0"	"0"	"0"
"R-HSA-9026766"	"Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)"	"0"	"0"	"0"	"0"
"R-HSA-177162"	"Conjugation of phenylacetate with glutamine"	"0"	"0"	"0"	"0"
"R-HSA-2474795"	"Diseases associated with visual transduction"	"0"	"0"	"0"	"0"
"R-HSA-1483152"	"Hydrolysis of LPE"	"0"	"0"	"0"	"0"
"R-HSA-2534343"	"Interaction With Cumulus Cells"	"0"	"0"	"0"	"0"
"R-HSA-9007892"	"Interleukin-38 signaling"	"0"	"0"	"0"	"0"
"R-HSA-5662702"	"Melanin biosynthesis"	"0"	"0"	"0"	"0"
"R-HSA-141334"	"PAOs oxidise polyamines to amines"	"0"	"0"	"0"	"0"
"R-HSA-975574"	"Reactions specific to the hybrid N-glycan synthesis pathway"	"0"	"0"	"0"	"0"
"R-HSA-2453864"	"Retinoid cycle disease events"	"0"	"0"	"0"	"0"
"R-HSA-444411"	"Rhesus glycoproteins mediate ammonium transport."	"0"	"0"	"0"	"0"
"R-HSA-433137"	"Sodium-coupled sulphate, di- and tri-carboxylate transporters"	"0"	"0"	"0"	"0"
"R-HSA-1299287"	"Tandem pore domain halothane-inhibited K+ channel (THIK)"	"0"	"0"	"0"	"0"
"R-HSA-432030"	"Transport of glycerol from adipocytes to the liver by Aquaporins"	"0"	"0"	"0"	"0"
"R-HSA-6785470"	"tRNA processing in the mitochondrion"	"0"	"0"	"0"	"0"
"R-HSA-1299344"	"TWIK-related spinal cord K+ channel (TRESK)"	"0"	"0"	"0"	"0"
"R-HSA-8877627"	"Vitamin E"	"0"	"0"	"0"	"0"
"R-HSA-140179"	"Amine Oxidase reactions"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-141333"	"Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-9025106"	"Biosynthesis of DPAn-6 SPMs"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-8981373"	"Intestinal hexose absorption"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-8942233"	"Intestinal infectious diseases"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-561048"	"Organic anion transport"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-2142696"	"Synthesis of Hepoxilins (HX) and Trioxilins (TrX)"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-1855231"	"Synthesis of IPs in the ER lumen"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-5340573"	"WNT ligand secretion is abrogated by the PORCN inhibitor LGK974"	"-0.001"	"0"	"0.001"	"0.032"
"R-HSA-1300645"	"Acrosome Reaction"	"-0.002"	"0"	"0.002"	"0.045"
"R-HSA-351143"	"Agmatine biosynthesis"	"-0.002"	"0"	"0.002"	"0.045"
"R-HSA-426048"	"Arachidonate production from DAG"	"-0.002"	"0"	"0.002"	"0.045"
"R-HSA-5683177"	"Defective ABCC8 can cause hypoglycemias and hyperglycemias"	"-0.002"	"0"	"0.002"	"0.045"
"R-HSA-1299316"	"TWIK-releated acid-sensitive K+ channel (TASK)"	"-0.002"	"0"	"0.002"	"0.045"
"R-HSA-140180"	"COX reactions"	"-0.003"	"0"	"0.003"	"0.055"
"R-HSA-9012546"	"Interleukin-18 signaling"	"-0.003"	"0"	"0.003"	"0.055"
"R-HSA-8963678"	"Intestinal lipid absorption"	"-0.003"	"0"	"0.003"	"0.055"
"R-HSA-427975"	"Proton/oligopeptide cotransporters"	"-0.003"	"0"	"0.003"	"0.055"
"R-HSA-350864"	"Regulation of thyroid hormone activity"	"-0.003"	"0"	"0.003"	"0.055"
"R-HSA-83936"	"Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane"	"-0.003"	"0"	"0.003"	"0.055"
"R-HSA-112122"	"ALKBH2 mediated reversal of alkylation damage"	"-0.004"	"0"	"0.004"	"0.063"
"R-HSA-217271"	"FMO oxidises nucleophiles"	"-0.004"	"0"	"0.004"	"0.063"
"R-HSA-977442"	"GABA A (rho) receptor activation"	"-0.004"	"0"	"0.004"	"0.063"
"R-HSA-8963676"	"Intestinal absorption"	"-0.004"	"0"	"0.004"	"0.063"
"R-HSA-8981607"	"Intracellular oxygen transport"	"-0.004"	"0"	"0.004"	"0.063"
"R-HSA-156587"	"Amino Acid conjugation"	"-0.005"	"0"	"0.005"	"0.071"
"R-HSA-177135"	"Conjugation of benzoate with glycine"	"-0.005"	"0"	"0.005"	"0.071"
"R-HSA-159424"	"Conjugation of carboxylic acids"	"-0.005"	"0"	"0.005"	"0.071"
"R-HSA-177128"	"Conjugation of salicylate with glycine"	"-0.005"	"0"	"0.005"	"0.071"
"R-HSA-888593"	"Reuptake of GABA"	"-0.005"	"0"	"0.005"	"0.071"
"R-HSA-209931"	"Serotonin and melatonin biosynthesis"	"-0.005"	"0"	"0.005"	"0.071"
"R-HSA-2142850"	"Hyaluronan biosynthesis and export"	"-0.006"	"0"	"0.006"	"0.077"
"R-HSA-110056"	"MAPK3 (ERK1) activation"	"-0.006"	"2"	"2.008"	"1.425"
"R-HSA-2408552"	"Methylation of MeSeH for excretion"	"-0.006"	"0"	"0.006"	"0.077"
"R-HSA-427589"	"Type II Na+/Pi cotransporters"	"-0.006"	"0"	"0.006"	"0.077"
"R-HSA-1483196"	"PI and PC transport between ER and Golgi membranes"	"-0.007"	"0"	"0.007"	"0.083"
"R-HSA-3248023"	"Regulation by TREX1"	"-0.007"	"0"	"0.007"	"0.083"
"R-HSA-1299503"	"TWIK related potassium channel (TREK)"	"-0.007"	"0"	"0.007"	"0.083"
"R-HSA-964827"	"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2"	"-0.008"	"0"	"0.008"	"0.089"
"R-HSA-9026403"	"Biosynthesis of DPAn-3-derived 13-series resolvins"	"-0.009"	"0"	"0.009"	"0.094"
"R-HSA-9026286"	"Biosynthesis of DPAn-3-derived protectins and resolvins"	"-0.009"	"0"	"0.009"	"0.094"
"R-HSA-2564830"	"Cytosolic iron-sulfur cluster assembly"	"-0.009"	"0"	"0.009"	"0.094"
"R-HSA-192456"	"Digestion of dietary lipid"	"-0.009"	"0"	"0.009"	"0.094"
"R-HSA-9026290"	"Biosynthesis of DPAn-3-derived maresins"	"-0.01"	"0"	"0.01"	"0.1"
"R-HSA-8964572"	"Lipid particle organization"	"-0.01"	"0"	"0.01"	"0.1"
"R-HSA-1855191"	"Synthesis of IPs in the nucleus"	"-0.01"	"0"	"0.01"	"0.1"
"R-HSA-1483101"	"Synthesis of PS"	"-0.01"	"0"	"0.01"	"0.1"
"R-HSA-1299361"	"TWIK-related alkaline pH activated K+ channel (TALK)"	"-0.01"	"0"	"0.01"	"0.1"
"R-HSA-209905"	"Catecholamine biosynthesis"	"-0.011"	"0"	"0.011"	"0.104"
"R-HSA-5263617"	"Metabolism of ingested MeSeO2H into MeSeH"	"-0.011"	"0"	"0.011"	"0.104"
"R-HSA-2187335"	"The retinoid cycle in cones (daylight vision)"	"-0.011"	"0"	"0.011"	"0.114"
"R-HSA-964739"	"N-glycan trimming and elongation in the cis-Golgi"	"-0.012"	"0"	"0.012"	"0.109"
"R-HSA-1296061"	"HCN channels"	"-0.013"	"0"	"0.013"	"0.113"
"R-HSA-429593"	"Inositol transporters"	"-0.013"	"0"	"0.013"	"0.113"
"R-HSA-163316"	"Mitochondrial transcription termination"	"-0.013"	"0"	"0.013"	"0.113"
"R-HSA-5578768"	"Physiological factors"	"-0.013"	"0"	"0.013"	"0.113"
"R-HSA-1296025"	"ATP sensitive Potassium channels"	"-0.014"	"0"	"0.014"	"0.118"
"R-HSA-112303"	"Electric Transmission Across Gap Junctions"	"-0.015"	"0"	"0.015"	"0.122"
"R-HSA-75094"	"Formation of the Editosome"	"-0.015"	"0"	"0.015"	"0.122"
"R-HSA-1222352"	"Latent infection of Homo sapiens with Mycobacterium tuberculosis"	"-0.015"	"0"	"0.015"	"0.13"
"R-HSA-72200"	"mRNA Editing: C to U Conversion"	"-0.015"	"0"	"0.015"	"0.122"
"R-HSA-1222449"	"Mtb iron assimilation by chelation"	"-0.015"	"0"	"0.015"	"0.13"
"R-HSA-1222499"	"Response of Mtb to phagocytosis"	"-0.015"	"0"	"0.015"	"0.13"
"R-HSA-427652"	"Sodium-coupled phosphate cotransporters"	"-0.015"	"0"	"0.015"	"0.122"
"R-HSA-2142700"	"Synthesis of Lipoxins (LX)"	"-0.015"	"0"	"0.015"	"0.122"
"R-HSA-112307"	"Transmission across Electrical Synapses "	"-0.015"	"0"	"0.015"	"0.122"
"R-HSA-2395516"	"Electron transport from NADPH to Ferredoxin"	"-0.016"	"0"	"0.016"	"0.126"
"R-HSA-379397"	"Enzymatic degradation of dopamine by COMT"	"-0.016"	"0"	"0.016"	"0.126"
"R-HSA-379398"	"Enzymatic degradation of Dopamine by monoamine oxidase"	"-0.016"	"0"	"0.016"	"0.126"
"R-HSA-2473224"	"Antagonism of Activin by Follistatin"	"-0.017"	"0"	"0.017"	"0.129"
"R-HSA-163765"	"ChREBP activates metabolic gene expression"	"-0.017"	"0"	"0.017"	"0.137"
"R-HSA-629587"	"Highly sodium permeable acetylcholine nicotinic receptors"	"-0.017"	"0"	"0.017"	"0.137"
"R-HSA-916853"	"Degradation of GABA"	"-0.018"	"0"	"0.018"	"0.14"
"R-HSA-6787639"	"GDP-fucose biosynthesis"	"-0.018"	"0"	"0.018"	"0.133"
"R-HSA-451307"	"Activation of Na-permeable kainate receptors"	"-0.019"	"0"	"0.019"	"0.137"
"R-HSA-629597"	"Highly calcium permeable nicotinic acetylcholine receptors"	"-0.019"	"0"	"0.019"	"0.137"
"R-HSA-166187"	"Mitochondrial Uncoupling Proteins"	"-0.019"	"0"	"0.019"	"0.137"
"R-HSA-167826"	"The fatty acid cycling model"	"-0.019"	"0"	"0.019"	"0.137"
"R-HSA-167827"	"The proton buffering model"	"-0.019"	"0"	"0.019"	"0.137"
"R-HSA-888568"	"GABA synthesis"	"-0.02"	"0"	"0.02"	"0.14"
"R-HSA-427601"	"Multifunctional anion exchangers"	"-0.021"	"0"	"0.021"	"0.143"
"R-HSA-75896"	"Plasmalogen biosynthesis"	"-0.022"	"0"	"0.022"	"0.147"
"R-HSA-70688"	"Proline catabolism"	"-0.022"	"0"	"0.022"	"0.147"
"R-HSA-9014826"	"Interleukin-36 pathway"	"-0.023"	"0"	"0.023"	"0.15"
"R-HSA-8848584"	"Wax biosynthesis"	"-0.023"	"0"	"0.023"	"0.15"
"R-HSA-156582"	"Acetylation"	"-0.024"	"0"	"0.024"	"0.153"
"R-HSA-6798163"	"Choline catabolism"	"-0.024"	"0"	"0.024"	"0.153"
"R-HSA-140834"	"Extrinsic Pathway of Fibrin Clot Formation"	"-0.024"	"0"	"0.024"	"0.153"
"R-HSA-622323"	"Presynaptic nicotinic acetylcholine receptors"	"-0.024"	"0"	"0.024"	"0.16"
"R-HSA-373756"	"SDK interactions"	"-0.024"	"0"	"0.024"	"0.16"
"R-HSA-1300652"	"Sperm:Oocyte Membrane Binding"	"-0.025"	"0"	"0.025"	"0.156"
"R-HSA-480985"	"Synthesis of dolichyl-phosphate-glucose"	"-0.025"	"0"	"0.025"	"0.156"
"R-HSA-727802"	"Transport of nucleotide sugars"	"-0.025"	"0"	"0.025"	"0.156"
"R-HSA-8850843"	"Phosphate bond hydrolysis by NTPDase proteins"	"-0.026"	"0"	"0.026"	"0.159"
"R-HSA-196819"	"Vitamin B1 (thiamin) metabolism"	"-0.026"	"0"	"0.026"	"0.159"
"R-HSA-9026395"	"Biosynthesis of DHA-derived sulfido conjugates"	"-0.027"	"0"	"0.027"	"0.162"
"R-HSA-9026762"	"Biosynthesis of maresin conjugates in tissue regeneration (MCTR)"	"-0.027"	"0"	"0.027"	"0.162"
"WP4036"	"MTF1 activates gene expression"	"-0.027"	"0"	"0.027"	"0.162"
"R-HSA-9014843"	"Interleukin-33 signaling"	"-0.029"	"0"	"0.029"	"0.168"
"R-HSA-165159"	"mTOR signalling"	"-0.029"	"5"	"5.064"	"2.192"
"R-HSA-71032"	"Propionyl-CoA catabolism"	"-0.029"	"0"	"0.029"	"0.174"
"R-HSA-171286"	"Synthesis and processing of ENV and VPU"	"-0.03"	"0"	"0.03"	"0.176"
"R-HSA-1483076"	"Synthesis of CL"	"-0.031"	"0"	"0.031"	"0.179"
"R-HSA-9027604"	"Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives"	"-0.032"	"0"	"0.032"	"0.176"
"R-HSA-1236978"	"Cross-presentation of soluble exogenous antigens (endosomes)"	"-0.032"	"0"	"0.032"	"0.182"
"WP4115"	"Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models"	"-0.032"	"4"	"4.06"	"1.857"
"R-HSA-8863678"	"Neurodegenerative Diseases"	"-0.032"	"4"	"4.06"	"1.857"
"R-HSA-9018683"	"Biosynthesis of DPA-derived SPMs"	"-0.033"	"0"	"0.033"	"0.179"
"R-HSA-9025094"	"Biosynthesis of DPAn-3 SPMs"	"-0.033"	"0"	"0.033"	"0.179"
"R-HSA-379401"	"Dopamine clearance from the synaptic cleft"	"-0.033"	"0"	"0.033"	"0.179"
"R-HSA-432047"	"Passive transport by Aquaporins"	"-0.033"	"0"	"0.033"	"0.179"
"R-HSA-8852276"	"The role of GTSE1 in G2/M progression after G2 checkpoint"	"-0.034"	"6"	"6.081"	"2.38"
"R-HSA-73621"	"Pyrimidine catabolism"	"-0.035"	"0"	"0.035"	"0.184"
"R-HSA-1300642"	"Sperm Motility And Taxes"	"-0.035"	"0"	"0.035"	"0.184"
"R-HSA-2022857"	"Keratan sulfate degradation"	"-0.036"	"0"	"0.036"	"0.186"
"R-HSA-8949613"	"Cristae formation"	"-0.037"	"0"	"0.037"	"0.189"
"R-HSA-2855086"	"Ficolins bind to repetitive carbohydrate structures on the target cell surface"	"-0.037"	"0"	"0.037"	"0.189"
"R-HSA-163210"	"Formation of ATP by chemiosmotic coupling"	"-0.037"	"0"	"0.037"	"0.189"
"R-HSA-5661231"	"Metallothioneins bind metals"	"-0.037"	"0"	"0.037"	"0.194"
"R-HSA-1296067"	"Potassium transport channels"	"-0.037"	"0"	"0.037"	"0.189"
"R-HSA-1483115"	"Hydrolysis of LPC"	"-0.039"	"0"	"0.039"	"0.199"
"R-HSA-1369007"	"Mitochondrial ABC transporters"	"-0.04"	"0"	"0.04"	"0.201"
"R-HSA-9026357"	"NTF4 activates NTRK2 (TRKB) signaling"	"-0.04"	"0"	"0.04"	"0.201"
"R-HSA-9025046"	"NTF3 activates NTRK2 (TRKB) signaling"	"-0.042"	"0"	"0.042"	"0.206"
"R-HSA-211981"	"Xenobiotics"	"-0.042"	"1"	"1.042"	"1.008"
"R-HSA-9024909"	"BDNF activates NTRK2 (TRKB) signaling"	"-0.043"	"0"	"0.043"	"0.208"
"R-HSA-1839128"	"FGFR4 mutant receptor activation"	"-0.043"	"0"	"0.043"	"0.203"
"R-HSA-844623"	"The IPAF inflammasome"	"-0.043"	"0"	"0.043"	"0.203"
"Vitamin B2 (riboflavin) metabolism"	"Vitamin B2 (riboflavin) metabolism"	"-0.044"	"0"	"0.044"	"0.205"
"R-HSA-68882"	"Mitotic Anaphase"	"-0.045"	"31"	"31.244"	"5.452"
"R-HSA-6807047"	"Cholesterol biosynthesis via desmosterol"	"-0.047"	"0"	"0.047"	"0.216"
"R-HSA-6807062"	"Cholesterol biosynthesis via lathosterol"	"-0.047"	"0"	"0.047"	"0.216"
"R-HSA-2142712"	"Synthesis of 12-eicosatetraenoic acid derivatives"	"-0.048"	"0"	"0.048"	"0.219"
"R-HSA-211957"	"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"	"-0.049"	"0"	"0.049"	"0.216"
"R-HSA-5653890"	"Lactose synthesis"	"-0.049"	"0"	"0.049"	"0.216"
"R-HSA-211994"	"Sterols are 12-hydroxylated by CYP8B1"	"-0.049"	"0"	"0.049"	"0.225"
"R-HSA-2024101"	"CS/DS degradation"	"-0.05"	"0"	"0.05"	"0.223"
"R-HSA-5638303"	"Inhibition of Signaling by Overexpressed EGFR"	"-0.05"	"1"	"1.05"	"0.947"
"R-HSA-5638302"	"Signaling by Overexpressed Wild-Type EGFR in Cancer"	"-0.05"	"1"	"1.05"	"0.947"
"R-HSA-1299308"	"Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)"	"-0.05"	"0"	"0.05"	"0.223"
"R-HSA-1663150"	"The activation of arylsulfatases"	"-0.05"	"0"	"0.05"	"0.218"
"R-HSA-2555396"	"Mitotic Metaphase and Anaphase"	"-0.051"	"31"	"31.278"	"5.459"
"R-HSA-2033515"	"t(4;14) translocations of FGFR3"	"-0.051"	"0"	"0.051"	"0.229"
"R-HSA-1296053"	"Classical Kir channels"	"-0.052"	"0"	"0.052"	"0.227"
"R-HSA-1300644"	"Interaction With The Zona Pellucida"	"-0.053"	"0"	"0.053"	"0.237"
"R-HSA-203754"	"NOSIP mediated eNOS trafficking"	"-0.053"	"0"	"0.053"	"0.233"
"R-HSA-442660"	"Na+/Cl- dependent neurotransmitter transporters"	"-0.054"	"0"	"0.054"	"0.226"
"R-HSA-2023837"	"Signaling by FGFR2 amplification mutants"	"-0.054"	"0"	"0.054"	"0.226"
"R-HSA-8853333"	"Signaling by FGFR2 fusions"	"-0.054"	"0"	"0.054"	"0.226"
"R-HSA-174362"	"Transport and synthesis of PAPS"	"-0.054"	"0"	"0.054"	"0.231"
"R-HSA-351200"	"Interconversion of polyamines"	"-0.055"	"0"	"0.055"	"0.237"
"R-HSA-2408550"	"Metabolism of ingested H2SeO4 and H2SeO3 into H2Se"	"-0.055"	"0"	"0.055"	"0.232"
"R-HSA-2393930"	"Phosphate bond hydrolysis by NUDT proteins"	"-0.055"	"0"	"0.055"	"0.228"
"R-HSA-196783"	"Coenzyme A biosynthesis"	"-0.056"	"0"	"0.056"	"0.234"
"R-HSA-5657655"	"MGMT-mediated DNA damage reversal"	"-0.057"	"0"	"0.057"	"0.24"
"R-HSA-350562"	"Regulation of ornithine decarboxylase (ODC)"	"-0.057"	"0"	"0.057"	"0.232"
"R-HSA-5624958"	"ARL13B-mediated ciliary trafficking of INPP5E"	"-0.058"	"0"	"0.058"	"0.242"
"R-HSA-6803544"	"Ion influx/efflux at host-pathogen interface"	"-0.058"	"0"	"0.058"	"0.242"
"R-HSA-1855167"	"Synthesis of pyrophosphates in the cytosol"	"-0.059"	"0"	"0.059"	"0.24"
"R-HSA-1482922"	"Acyl chain remodelling of PI"	"-0.06"	"0"	"0.06"	"0.242"
"R-HSA-425381"	"Bicarbonate transporters"	"-0.06"	"0"	"0.06"	"0.246"
"R-HSA-2161517"	"Abacavir transmembrane transport"	"-0.061"	"0"	"0.061"	"0.244"
"R-HSA-5687128"	"MAPK6/MAPK4 signaling"	"-0.061"	"15"	"15.221"	"3.637"
"R-HSA-166020"	"Transfer of LPS from LBP carrier to CD14"	"-0.061"	"0"	"0.061"	"0.239"
"R-HSA-1482788"	"Acyl chain remodelling of PC"	"-0.062"	"0"	"0.062"	"0.245"
"R-HSA-196741"	"Cobalamin (Cbl, vitamin B12) transport and metabolism"	"-0.062"	"0"	"0.062"	"0.249"
"R-HSA-166662"	"Lectin pathway of complement activation"	"-0.062"	"0"	"0.062"	"0.241"
"R-HSA-2979096"	"NOTCH2 Activation and Transmission of Signal to the Nucleus"	"-0.062"	"8"	"8.163"	"2.624"
"R-HSA-425428"	"Amine compound SLC transporters"	"-0.063"	"0"	"0.063"	"0.243"
"R-HSA-2142770"	"Synthesis of 15-eicosatetraenoic acid derivatives"	"-0.063"	"0"	"0.063"	"0.251"
"R-HSA-70921"	"Histidine catabolism"	"-0.064"	"0"	"0.064"	"0.253"
"R-HSA-163282"	"Mitochondrial transcription initiation"	"-0.064"	"0"	"0.064"	"0.253"
"R-HSA-5660526"	"Response to metal ions"	"-0.064"	"0"	"0.064"	"0.249"
"R-HSA-69278"	"Cell Cycle, Mitotic"	"-0.065"	"104"	"104.647"	"9.887"
"R-HSA-964975"	"Vitamins B6 activation to pyridoxal phosphate"	"-0.065"	"0"	"0.065"	"0.259"
"R-HSA-420597"	"Nectin/Necl  trans heterodimerization"	"-0.066"	"0"	"0.066"	"0.268"
"R-HSA-8847453"	"Synthesis of PIPs in the nucleus"	"-0.067"	"0"	"0.067"	"0.254"
"R-HSA-1296346"	"Tandem pore domain potassium channels"	"-0.069"	"0"	"0.069"	"0.257"
"R-HSA-428559"	"Proton-coupled neutral amino acid transporters"	"-0.07"	"0"	"0.07"	"0.263"
"R-HSA-4411364"	"Binding of TCF/LEF:CTNNB1 to target gene promoters"	"-0.071"	"2"	"2.096"	"1.353"
"R-HSA-5221030"	"TET1,2,3 and TDG demethylate DNA"	"-0.072"	"0"	"0.072"	"0.27"
"R-HSA-75102"	"C6 deamination of adenosine"	"-0.075"	"0"	"0.075"	"0.267"
"R-HSA-77042"	"Formation of editosomes by ADAR proteins"	"-0.075"	"0"	"0.075"	"0.267"
"R-HSA-629594"	"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors"	"-0.075"	"0"	"0.075"	"0.285"
"R-HSA-75064"	"mRNA Editing: A to I Conversion"	"-0.075"	"0"	"0.075"	"0.267"
"R-HSA-8956320"	"Nucleobase biosynthesis"	"-0.075"	"2"	"2.104"	"1.385"
"R-HSA-1614517"	"Sulfide oxidation to sulfate"	"-0.075"	"0"	"0.075"	"0.264"
"R-HSA-193807"	"Synthesis of bile acids and bile salts via 27-hydroxycholesterol"	"-0.075"	"1"	"1.075"	"1"
"R-HSA-804914"	"Transport of fatty acids"	"-0.075"	"0"	"0.075"	"0.271"
"R-HSA-9020265"	"Biosynthesis of aspirin-triggered D-series resolvins"	"-0.076"	"0"	"0.076"	"0.276"
"R-HSA-9018676"	"Biosynthesis of D-series resolvins"	"-0.076"	"0"	"0.076"	"0.276"
"R-HSA-9023661"	"Biosynthesis of E-series 18(R)-resolvins"	"-0.076"	"0"	"0.076"	"0.276"
"R-HSA-9018896"	"Biosynthesis of E-series 18(S)-resolvins"	"-0.076"	"0"	"0.076"	"0.276"
"R-HSA-111452"	"Activation and oligomerization of BAK protein"	"-0.077"	"0"	"0.077"	"0.278"
"R-HSA-880009"	"Interconversion of 2-oxoglutarate and 2-hydroxyglutarate"	"-0.077"	"0"	"0.077"	"0.285"
"R-HSA-75944"	"Transcription from mitochondrial promoters"	"-0.077"	"0"	"0.077"	"0.281"
"R-HSA-1482839"	"Acyl chain remodelling of PE"	"-0.079"	"0"	"0.079"	"0.274"
"R-HSA-181431"	"Acetylcholine binding and downstream events"	"-0.08"	"0"	"0.08"	"0.299"
"R-HSA-629602"	"Activation of Nicotinic Acetylcholine Receptors"	"-0.08"	"0"	"0.08"	"0.299"
"R-HSA-8853383"	"Lysosomal oligosaccharide catabolism"	"-0.08"	"0"	"0.08"	"0.286"
"R-HSA-5576894"	"Phase 1 - inactivation of fast Na+ channels"	"-0.08"	"0"	"0.08"	"0.286"
"R-HSA-622327"	"Postsynaptic nicotinic acetylcholine receptors"	"-0.08"	"0"	"0.08"	"0.299"
"R-HSA-8949215"	"Mitochondrial calcium ion transport"	"-0.083"	"2"	"2.117"	"1.409"
"R-HSA-169131"	"Inhibition of PKR"	"-0.086"	"0"	"0.086"	"0.294"
"R-HSA-8851680"	"Butyrophilin (BTN) family interactions"	"-0.088"	"0"	"0.088"	"0.287"
"R-HSA-1482925"	"Acyl chain remodelling of PG"	"-0.09"	"0"	"0.09"	"0.307"
"R-HSA-75072"	"mRNA Editing"	"-0.09"	"0"	"0.09"	"0.297"
"R-HSA-77352"	"Beta oxidation of butanoyl-CoA to acetyl-CoA"	"-0.092"	"0"	"0.092"	"0.303"
"R-HSA-1475029"	"Reversible hydration of carbon dioxide"	"-0.092"	"0"	"0.092"	"0.303"
"R-HSA-1614635"	"Sulfur amino acid metabolism"	"-0.092"	"2"	"2.127"	"1.385"
"R-HSA-428643"	"Organic anion transporters"	"-0.094"	"0"	"0.094"	"0.302"
"R-HSA-1307965"	"betaKlotho-mediated ligand binding"	"-0.095"	"0"	"0.095"	"0.313"
"R-HSA-110331"	"Cleavage of the damaged purine"	"-0.098"	"0"	"0.098"	"0.307"
"R-HSA-73927"	"Depurination"	"-0.098"	"0"	"0.098"	"0.307"
"R-HSA-110330"	"Recognition and association of DNA glycosylase with site containing an affected purine"	"-0.098"	"0"	"0.098"	"0.307"
"R-HSA-9018679"	"Biosynthesis of EPA-derived SPMs"	"-0.099"	"0"	"0.099"	"0.312"
"R-HSA-2161541"	"Abacavir metabolism"	"-0.101"	"0"	"0.101"	"0.308"
"R-HSA-2142688"	"Synthesis of 5-eicosatetraenoic acids"	"-0.102"	"0"	"0.102"	"0.319"
"R-HSA-5545619"	"XAV939 inhibits tankyrase, stabilizing AXIN"	"-0.106"	"0"	"0.106"	"0.33"
"R-HSA-4791275"	"Signaling by WNT in cancer"	"-0.107"	"0"	"0.107"	"0.331"
"R-HSA-165160"	"PDE3B signalling"	"-0.108"	"0"	"0.108"	"0.32"
"R-HSA-109703"	"PKB-mediated events"	"-0.108"	"0"	"0.108"	"0.32"
"R-HSA-1839120"	"Signaling by FGFR1 amplification mutants"	"-0.108"	"0"	"0.108"	"0.323"
"R-HSA-549127"	"Organic cation transport"	"-0.109"	"0"	"0.109"	"0.321"
"R-HSA-5250968"	"Toxicity of botulinum toxin type A (BoNT/A)"	"-0.109"	"0"	"0.109"	"0.336"
"R-HSA-5250992"	"Toxicity of botulinum toxin type E (BoNT/E)"	"-0.109"	"0"	"0.109"	"0.336"
"R-HSA-549132"	"Organic cation/anion/zwitterion transport"	"-0.11"	"0"	"0.11"	"0.322"
"R-HSA-975577"	"N-Glycan antennae elongation"	"-0.112"	"0"	"0.112"	"0.337"
"R-HSA-8852405"	"Signaling by MST1"	"-0.114"	"0"	"0.114"	"0.339"
"R-HSA-9036866"	"Expression and Processing of Neurotrophins"	"-0.115"	"0"	"0.115"	"0.352"
"R-HSA-1187000"	"Fertilization"	"-0.115"	"0"	"0.115"	"0.343"
"R-HSA-8941237"	"Invadopodia formation"	"-0.115"	"0"	"0.115"	"0.34"
"R-HSA-167060"	"NGF processing"	"-0.115"	"0"	"0.115"	"0.352"
"R-HSA-3065679"	"SUMO is proteolytically processed"	"-0.117"	"4"	"4.217"	"1.858"
"R-HSA-8963889"	"Assembly of active LPL and LIPC lipase complexes"	"-0.119"	"0"	"0.119"	"0.348"
"R-HSA-6814848"	"Glycerophospholipid catabolism"	"-0.119"	"0"	"0.119"	"0.348"
"R-HSA-74752"	"Signaling by Insulin receptor"	"-0.12"	"11"	"11.38"	"3.169"
"R-HSA-5576886"	"Phase 4 - resting membrane potential"	"-0.121"	"0"	"0.121"	"0.344"
"R-HSA-162710"	"Synthesis of glycosylphosphatidylinositol (GPI)"	"-0.122"	"0"	"0.122"	"0.348"
"R-HSA-189483"	"Heme degradation"	"-0.123"	"0"	"0.123"	"0.343"
"R-HSA-6799990"	"Metal sequestration by antimicrobial proteins"	"-0.123"	"0"	"0.123"	"0.349"
"R-HSA-5601884"	"PIWI-interacting RNA (piRNA) biogenesis"	"-0.123"	"0"	"0.123"	"0.355"
"R-HSA-189085"	"Digestion of dietary carbohydrate"	"-0.125"	"0"	"0.125"	"0.349"
"R-HSA-5652227"	"Fructose biosynthesis"	"-0.127"	"0"	"0.127"	"0.339"
"R-HSA-197264"	"Nicotinamide salvaging"	"-0.127"	"0"	"0.127"	"0.376"
"R-HSA-1482801"	"Acyl chain remodelling of PS"	"-0.13"	"0"	"0.13"	"0.362"
"R-HSA-5661270"	"Catabolism of glucuronate to xylulose-5-phosphate"	"-0.131"	"0"	"0.131"	"0.355"
"R-HSA-181430"	"Norepinephrine Neurotransmitter Release Cycle"	"-0.131"	"1"	"1.14"	"1.072"
"R-HSA-5668541"	"TNFR2 non-canonical NF-kB pathway"	"-0.132"	"4"	"4.261"	"1.979"
"R-HSA-2046105"	"Linoleic acid (LA) metabolism"	"-0.136"	"0"	"0.136"	"0.371"
"R-HSA-3769402"	"Deactivation of the beta-catenin transactivating complex"	"-0.137"	"11"	"11.434"	"3.16"
"R-HSA-442380"	"Zinc influx into cells by the SLC39 gene family"	"-0.137"	"0"	"0.137"	"0.38"
"R-HSA-210455"	"Astrocytic Glutamate-Glutamine Uptake And Metabolism"	"-0.139"	"0"	"0.139"	"0.374"
"R-HSA-112313"	"Neurotransmitter uptake and metabolism In glial cells"	"-0.139"	"0"	"0.139"	"0.374"
"R-HSA-1247673"	"Erythrocytes take up oxygen and release carbon dioxide"	"-0.141"	"0"	"0.141"	"0.37"
"R-HSA-205017"	"NFG and proNGF binds to p75NTR"	"-0.141"	"0"	"0.141"	"0.376"
"R-HSA-2978092"	"Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate"	"-0.142"	"0"	"0.142"	"0.374"
"R-HSA-5668914"	"Diseases of metabolism"	"-0.142"	"0"	"0.142"	"0.374"
"R-HSA-977441"	"GABA A receptor activation"	"-0.142"	"0"	"0.142"	"0.369"
"R-HSA-389542"	"NADPH regeneration"	"-0.142"	"0"	"0.142"	"0.374"
"R-HSA-73930"	"Abasic sugar-phosphate removal via the single-nucleotide replacement pathway"	"-0.143"	"0"	"0.143"	"0.356"
"R-HSA-3065676"	"SUMO is conjugated to E1 (UBA2:SAE1)"	"-0.143"	"4"	"4.266"	"1.86"
"R-HSA-193144"	"Estrogen biosynthesis"	"-0.145"	"0"	"0.145"	"0.372"
"R-HSA-209968"	"Thyroxine biosynthesis"	"-0.147"	"0"	"0.147"	"0.389"
"R-HSA-389599"	"Alpha-oxidation of phytanate"	"-0.148"	"0"	"0.148"	"0.369"
"R-HSA-6793080"	"rRNA modification in the mitochondrion"	"-0.149"	"0"	"0.149"	"0.373"
"R-HSA-8868766"	"rRNA processing in the mitochondrion"	"-0.149"	"0"	"0.149"	"0.373"
"R-HSA-111458"	"Formation of apoptosome"	"-0.153"	"0"	"0.153"	"0.384"
"R-HSA-5362798"	"Release of Hh-Np from the secreting cell"	"-0.153"	"0"	"0.153"	"0.384"
"hsa00590"	"Arachidonic acid metabolism"	"-0.154"	"1"	"1.164"	"1.066"
"R-HSA-174403"	"Glutathione synthesis and recycling"	"-0.154"	"0"	"0.154"	"0.393"
"R-HSA-77288"	"mitochondrial fatty acid beta-oxidation of unsaturated fatty acids"	"-0.154"	"0"	"0.154"	"0.393"
"R-HSA-8935690"	"Digestion"	"-0.155"	"0"	"0.155"	"0.384"
"R-HSA-8951430"	"RUNX3 regulates WNT signaling"	"-0.155"	"2"	"2.22"	"1.423"
"R-HSA-433692"	"Proton-coupled monocarboxylate transport"	"-0.156"	"0"	"0.156"	"0.402"
"R-HSA-77285"	"Beta oxidation of myristoyl-CoA to lauroyl-CoA"	"-0.157"	"0"	"0.157"	"0.393"
"R-HSA-193681"	"Ceramide signalling"	"-0.157"	"0"	"0.157"	"0.401"
"R-HSA-8951911"	"RUNX3 regulates RUNX1-mediated transcription"	"-0.157"	"0"	"0.157"	"0.401"
"R-HSA-1280218"	"Adaptive Immune System"	"-0.159"	"70"	"71.18"	"7.426"
"R-HSA-209776"	"Amine-derived hormones"	"-0.159"	"0"	"0.159"	"0.405"
"R-HSA-8963743"	"Digestion and absorption"	"-0.159"	"0"	"0.159"	"0.387"
"R-HSA-419771"	"Opsins"	"-0.161"	"0"	"0.161"	"0.404"
"R-HSA-8939247"	"RUNX1 regulates transcription of genes involved in interleukin signaling"	"-0.161"	"0"	"0.161"	"0.397"
"R-HSA-2161522"	"Abacavir transport and metabolism"	"-0.162"	"0"	"0.162"	"0.4"
"R-HSA-74259"	"Purine catabolism"	"-0.162"	"0"	"0.162"	"0.385"
"R-HSA-446199"	"Synthesis of Dolichyl-phosphate"	"-0.162"	"0"	"0.162"	"0.405"
"R-HSA-112126"	"ALKBH3 mediated reversal of alkylation damage"	"-0.164"	"0"	"0.164"	"0.414"
"R-HSA-114294"	"Activation, translocation and oligomerization of BAX"	"-0.167"	"0"	"0.167"	"0.404"
"R-HSA-194306"	"Neurophilin interactions with VEGF and VEGFR"	"-0.167"	"0"	"0.167"	"0.391"
"R-HSA-1433617"	"Regulation of signaling by NODAL"	"-0.169"	"0"	"0.169"	"0.427"
"R-HSA-73943"	"Reversal of alkylation damage by DNA dioxygenases"	"-0.172"	"0"	"0.172"	"0.42"
"R-HSA-389887"	"Beta-oxidation of pristanoyl-CoA"	"-0.173"	"0"	"0.173"	"0.428"
"R-HSA-1483148"	"Synthesis of PG"	"-0.175"	"0"	"0.175"	"0.432"
"R-HSA-139853"	"Elevation of cytosolic Ca2+ levels"	"-0.183"	"0"	"0.183"	"0.414"
"R-HSA-5173214"	"O-glycosylation of TSR domain-containing proteins"	"-0.183"	"0"	"0.183"	"0.433"
"R-HSA-8851708"	"Signaling by FGFR2 IIIa TM"	"-0.183"	"0"	"0.183"	"0.424"
"R-HSA-8849472"	"PTK6 Down-Regulation"	"-0.185"	"0"	"0.185"	"0.416"
"R-HSA-181429"	"Serotonin Neurotransmitter Release Cycle"	"-0.188"	"1"	"1.207"	"1.102"
"R-HSA-71288"	"Creatine metabolism"	"-0.189"	"0"	"0.189"	"0.433"
"R-HSA-425471"	"Bile salt and organic anion SLC transporters"	"-0.191"	"0"	"0.191"	"0.446"
"R-HSA-210500"	"Glutamate Neurotransmitter Release Cycle"	"-0.191"	"1"	"1.21"	"1.099"
"R-HSA-8985801"	"Regulation of cortical dendrite branching"	"-0.191"	"0"	"0.191"	"0.432"
"R-HSA-195399"	"VEGF binds to VEGFR leading to receptor dimerization"	"-0.191"	"0"	"0.191"	"0.434"
"R-HSA-194313"	"VEGF ligand-receptor interactions"	"-0.191"	"0"	"0.191"	"0.434"
"R-HSA-844615"	"The AIM2 inflammasome"	"-0.194"	"0"	"0.194"	"0.45"
"R-HSA-1462054"	"Alpha-defensins"	"-0.195"	"0"	"0.195"	"0.449"
"R-HSA-8964011"	"HDL clearance"	"-0.195"	"0"	"0.195"	"0.444"
"R-HSA-947581"	"Molybdenum cofactor biosynthesis"	"-0.195"	"0"	"0.195"	"0.437"
"R-HSA-4085001"	"Sialic acid metabolism"	"-0.196"	"0"	"0.196"	"0.431"
"R-HSA-110329"	"Cleavage of the damaged pyrimidine "	"-0.197"	"0"	"0.197"	"0.422"
"R-HSA-73928"	"Depyrimidination"	"-0.197"	"0"	"0.197"	"0.422"
"R-HSA-110328"	"Recognition and association of DNA glycosylase with site containing an affected pyrimidine"	"-0.197"	"0"	"0.197"	"0.422"
"R-HSA-1236973"	"Cross-presentation of particulate exogenous antigens (phagosomes)"	"-0.198"	"0"	"0.198"	"0.437"
"R-HSA-264642"	"Acetylcholine Neurotransmitter Release Cycle"	"-0.199"	"1"	"1.219"	"1.101"
"R-HSA-173736"	"Alternative complement activation"	"-0.202"	"0"	"0.202"	"0.449"
"R-HSA-77108"	"Utilization of Ketone Bodies"	"-0.202"	"0"	"0.202"	"0.428"
"R-HSA-190374"	"FGFR1c and Klotho ligand binding and activation"	"-0.203"	"0"	"0.203"	"0.452"
"R-HSA-430116"	"GP1b-IX-V activation signalling"	"-0.203"	"2"	"2.293"	"1.44"
"R-HSA-428359"	"Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA"	"-0.204"	"0"	"0.204"	"0.452"
"R-HSA-165158"	"Activation of AKT2"	"-0.205"	"0"	"0.205"	"0.444"
"R-HSA-211916"	"Vitamins"	"-0.205"	"0"	"0.205"	"0.46"
"R-HSA-5632681"	"Ligand-receptor interactions"	"-0.207"	"0"	"0.207"	"0.454"
"R-HSA-6804114"	"TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"	"-0.211"	"5"	"5.475"	"2.255"
"R-HSA-8939245"	"RUNX1 regulates transcription of genes involved in BCR signaling"	"-0.212"	"0"	"0.212"	"0.453"
"R-HSA-1483248"	"Synthesis of PIPs at the ER membrane"	"-0.212"	"0"	"0.212"	"0.451"
"R-HSA-351906"	"Apoptotic cleavage of cell adhesion  proteins"	"-0.213"	"1"	"1.229"	"1.073"
"R-HSA-77305"	"Beta oxidation of palmitoyl-CoA to myristoyl-CoA"	"-0.213"	"0"	"0.213"	"0.447"
"R-HSA-193993"	"Mineralocorticoid biosynthesis"	"-0.218"	"0"	"0.218"	"0.461"
"R-HSA-190840"	"Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane"	"-0.219"	"0"	"0.219"	"0.442"
"R-HSA-199220"	"Vitamin B5 (pantothenate) metabolism"	"-0.219"	"0"	"0.219"	"0.462"
"R-HSA-6806942"	"MET Receptor Activation"	"-0.222"	"0"	"0.222"	"0.459"
"R-HSA-159740"	"Gamma-carboxylation of protein precursors"	"-0.223"	"0"	"0.223"	"0.471"
"R-HSA-1237112"	"Methionine salvage pathway"	"-0.223"	"0"	"0.223"	"0.462"
"R-HSA-198765"	"Signalling to ERK5"	"-0.224"	"0"	"0.224"	"0.469"
"R-HSA-1237044"	"Erythrocytes take up carbon dioxide and release oxygen"	"-0.226"	"0"	"0.226"	"0.462"
"R-HSA-1480926"	"O2/CO2 exchange in erythrocytes"	"-0.226"	"0"	"0.226"	"0.462"
"R-HSA-190872"	"Transport of connexons to the plasma membrane"	"-0.226"	"0"	"0.226"	"0.448"
"R-HSA-71262"	"Carnitine synthesis"	"-0.229"	"0"	"0.229"	"0.463"
"R-HSA-73942"	"DNA Damage Reversal"	"-0.229"	"0"	"0.229"	"0.495"
"R-HSA-2197563"	"NOTCH2 intracellular domain regulates transcription"	"-0.231"	"1"	"1.241"	"1.042"
"R-HSA-8941333"	"RUNX2 regulates genes involved in differentiation of myeloid cells"	"-0.232"	"0"	"0.232"	"0.478"
"R-HSA-190861"	"Gap junction assembly"	"-0.233"	"0"	"0.233"	"0.455"
"R-HSA-190704"	"Oligomerization of connexins into connexons"	"-0.233"	"0"	"0.233"	"0.455"
"R-HSA-190827"	"Transport of connexins along the secretory pathway"	"-0.233"	"0"	"0.233"	"0.455"
"R-HSA-2022923"	"Dermatan sulfate biosynthesis"	"-0.238"	"0"	"0.238"	"0.475"
"R-HSA-5676594"	"TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway"	"-0.239"	"1"	"1.262"	"1.098"
"R-HSA-5140745"	"WNT5A-dependent internalization of FZD2, FZD5 and ROR2"	"-0.239"	"0"	"0.239"	"0.476"
"R-HSA-3134963"	"DEx/H-box helicases activate type I IFN and inflammatory cytokines production "	"-0.24"	"3"	"3.407"	"1.695"
"R-HSA-159782"	"Removal of aminoterminal propeptides from gamma-carboxylated proteins"	"-0.24"	"0"	"0.24"	"0.472"
"R-HSA-69895"	"Transcriptional  activation of  cell cycle inhibitor p21 "	"-0.24"	"1"	"1.242"	"1.009"
"R-HSA-69560"	"Transcriptional activation of p53 responsive genes  "	"-0.24"	"1"	"1.242"	"1.009"
"R-HSA-388844"	"Receptor-type tyrosine-protein phosphatases"	"-0.241"	"0"	"0.241"	"0.485"
"R-HSA-69541"	"Stabilization of p53"	"-0.242"	"9"	"9.718"	"2.961"
"R-HSA-8956319"	"Nucleobase catabolism"	"-0.245"	"0"	"0.245"	"0.464"
"R-HSA-9033500"	"TYSND1 cleaves peroxisomal proteins"	"-0.246"	"0"	"0.246"	"0.5"
"R-HSA-77350"	"Beta oxidation of hexanoyl-CoA to butanoyl-CoA"	"-0.247"	"0"	"0.247"	"0.494"
"R-HSA-6804760"	"Regulation of TP53 Activity through Methylation"	"-0.247"	"10"	"10.769"	"3.115"
"R-HSA-8866906"	"TFAP2 (AP-2) family regulates transcription of other transcription factors"	"-0.247"	"0"	"0.247"	"0.492"
"R-HSA-77310"	"Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA"	"-0.248"	"0"	"0.248"	"0.495"
"R-HSA-71064"	"Lysine catabolism"	"-0.248"	"1"	"1.264"	"1.067"
"R-HSA-162791"	"Attachment of GPI anchor to uPAR"	"-0.251"	"0"	"0.251"	"0.506"
"R-HSA-5660668"	"CLEC7A/inflammasome pathway"	"-0.251"	"0"	"0.251"	"0.496"
"R-HSA-159854"	"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins"	"-0.253"	"0"	"0.253"	"0.495"
"R-HSA-193368"	"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"	"-0.253"	"1"	"1.279"	"1.102"
"R-HSA-844455"	"The NLRP1 inflammasome"	"-0.254"	"0"	"0.254"	"0.494"
"R-HSA-1296052"	"Ca2+ activated K+ channels"	"-0.255"	"0"	"0.255"	"0.48"
"R-HSA-196108"	"Pregnenolone biosynthesis"	"-0.256"	"0"	"0.256"	"0.484"
"R-HSA-8941284"	"RUNX2 regulates chondrocyte maturation"	"-0.259"	"0"	"0.259"	"0.52"
"R-HSA-3295583"	"TRP channels"	"-0.26"	"0"	"0.26"	"0.505"
"R-HSA-5607761"	"Dectin-1 mediated noncanonical NF-kB signaling"	"-0.264"	"2"	"2.394"	"1.493"
"R-HSA-5676590"	"NIK-->noncanonical NF-kB signaling"	"-0.264"	"2"	"2.394"	"1.493"
"R-HSA-8985947"	"Interleukin-9 signaling"	"-0.265"	"0"	"0.265"	"0.499"
"R-HSA-75109"	"Triglyceride biosynthesis"	"-0.265"	"0"	"0.265"	"0.53"
"R-HSA-975578"	"Reactions specific to the complex N-glycan synthesis pathway"	"-0.267"	"0"	"0.267"	"0.504"
"R-HSA-73843"	"5-Phosphoribose 1-diphosphate biosynthesis"	"-0.268"	"0"	"0.268"	"0.52"
"R-HSA-5223345"	"Miscellaneous transport and binding events"	"-0.271"	"0"	"0.271"	"0.498"
"R-HSA-352230"	"Amino acid transport across the plasma membrane"	"-0.273"	"0"	"0.273"	"0.518"
"R-HSA-73929"	"Base-Excision Repair, AP Site Formation"	"-0.275"	"0"	"0.275"	"0.502"
"R-HSA-209822"	"Glycoprotein hormones"	"-0.278"	"0"	"0.278"	"0.521"
"R-HSA-1268020"	"Mitochondrial protein import"	"-0.28"	"6"	"6.685"	"2.443"
"R-HSA-211728"	"Regulation of PAK-2p34 activity by PS-GAP/RHG10"	"-0.282"	"0"	"0.282"	"0.497"
"R-HSA-111457"	"Release of apoptotic factors from the mitochondria"	"-0.283"	"0"	"0.283"	"0.526"
"R-HSA-8935964"	"RUNX1 regulates expression of components of tight junctions"	"-0.286"	"0"	"0.286"	"0.526"
"R-HSA-2162123"	"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"	"-0.291"	"0"	"0.291"	"0.528"
"R-HSA-9027307"	"Biosynthesis of maresin-like SPMs"	"-0.292"	"0"	"0.292"	"0.534"
"R-HSA-390247"	"Beta-oxidation of very long chain fatty acids"	"-0.293"	"0"	"0.293"	"0.529"
"R-HSA-8853336"	"Signaling by plasma membrane FGFR1 fusions"	"-0.296"	"0"	"0.296"	"0.518"
"R-HSA-2514853"	"Condensation of Prometaphase Chromosomes"	"-0.298"	"3"	"3.561"	"1.88"
"R-HSA-112308"	"Presynaptic depolarization and calcium channel opening"	"-0.299"	"0"	"0.299"	"0.555"
"R-HSA-1606341"	"IRF3 mediated activation of type 1 IFN"	"-0.3"	"0"	"0.3"	"0.542"
"R-HSA-1482798"	"Acyl chain remodeling of CL"	"-0.301"	"0"	"0.301"	"0.543"
"R-HSA-9018682"	"Biosynthesis of maresins"	"-0.301"	"0"	"0.301"	"0.547"
"R-HSA-169911"	"Regulation of Apoptosis"	"-0.303"	"0"	"0.303"	"0.523"
"R-HSA-1483213"	"Synthesis of PE"	"-0.303"	"0"	"0.303"	"0.54"
"R-HSA-9013507"	"NOTCH3 Activation and Transmission of Signal to the Nucleus"	"-0.305"	"9"	"9.853"	"2.798"
"R-HSA-9020558"	"Interleukin-2 signaling"	"-0.306"	"1"	"1.354"	"1.155"
"R-HSA-6787450"	"tRNA modification in the mitochondrion"	"-0.308"	"0"	"0.308"	"0.556"
"R-HSA-190371"	"FGFR3b ligand binding and activation"	"-0.31"	"0"	"0.31"	"0.557"
"R-HSA-1810476"	"RIP-mediated NFkB activation via ZBP1"	"-0.312"	"4"	"4.628"	"2.013"
"R-HSA-212718"	"EGFR interacts with phospholipase C-gamma"	"-0.313"	"1"	"1.333"	"1.065"
"R-HSA-190377"	"FGFR2b ligand binding and activation"	"-0.316"	"0"	"0.316"	"0.555"
"R-HSA-166665"	"Terminal pathway of complement"	"-0.317"	"0"	"0.317"	"0.55"
"R-HSA-177539"	"Autointegration results in viral DNA circles"	"-0.318"	"0"	"0.318"	"0.569"
"R-HSA-175567"	"Integration of viral DNA into host genomic DNA"	"-0.318"	"0"	"0.318"	"0.569"
"R-HSA-211979"	"Eicosanoids"	"-0.32"	"0"	"0.32"	"0.573"
"R-HSA-173599"	"Formation of the active cofactor, UDP-glucuronate"	"-0.325"	"0"	"0.325"	"0.565"
"R-HSA-9026527"	"Activated NTRK2 signals through PLCG1"	"-0.326"	"0"	"0.326"	"0.54"
"R-HSA-2672351"	"Stimuli-sensing channels"	"-0.327"	"9"	"9.937"	"2.87"
"R-HSA-75108"	"Activation, myristolyation of BID and translocation to mitochondria"	"-0.329"	"0"	"0.329"	"0.556"
"WP179"	"Cell Cycle"	"-0.329"	"116"	"119.455"	"10.51"
"R-HSA-8951671"	"RUNX3 regulates YAP1-mediated transcription"	"-0.33"	"0"	"0.33"	"0.56"
"R-HSA-3772470"	"Negative regulation of TCF-dependent signaling by WNT ligand antagonists"	"-0.331"	"0"	"0.331"	"0.546"
"R-HSA-1234162"	"Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha"	"-0.331"	"0"	"0.331"	"0.558"
"R-HSA-190370"	"FGFR1b ligand binding and activation"	"-0.332"	"0"	"0.332"	"0.569"
"Glycosphingolipid metabolism"	"Glycosphingolipid metabolism"	"-0.332"	"0"	"0.332"	"0.571"
"R-HSA-977347"	"Serine biosynthesis"	"-0.332"	"0"	"0.332"	"0.59"
"R-HSA-2142789"	"Ubiquinol biosynthesis"	"-0.332"	"0"	"0.332"	"0.581"
"R-HSA-8939256"	"RUNX1 regulates transcription of genes involved in WNT signaling"	"-0.333"	"1"	"1.366"	"1.101"
"R-HSA-5649702"	"APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway"	"-0.337"	"0"	"0.337"	"0.581"
"R-HSA-8875513"	"MET interacts with TNS proteins"	"-0.337"	"0"	"0.337"	"0.578"
"R-HSA-3249367"	"STAT6-mediated induction of chemokines"	"-0.337"	"0"	"0.337"	"0.558"
"R-HSA-901032"	"ER Quality Control Compartment (ERQC)"	"-0.338"	"7"	"7.856"	"2.532"
"R-HSA-444473"	"Formyl peptide receptors bind formyl peptides and many other ligands"	"-0.338"	"3"	"3.581"	"1.718"
"R-HSA-5250971"	"Toxicity of botulinum toxin type C (BoNT/C)"	"-0.345"	"0"	"0.345"	"0.58"
"R-HSA-5676934"	"Protein repair"	"-0.347"	"0"	"0.347"	"0.577"
"R-HSA-2142691"	"Synthesis of Leukotrienes (LT) and Eoxins (EX)"	"-0.348"	"0"	"0.348"	"0.588"
"R-HSA-1461957"	"Beta defensins"	"-0.351"	"0"	"0.351"	"0.585"
"R-HSA-5423646"	"Aflatoxin activation and detoxification"	"-0.352"	"0"	"0.352"	"0.589"
"R-HSA-1362409"	"Mitochondrial iron-sulfur cluster biogenesis"	"-0.353"	"0"	"0.353"	"0.584"
"R-HSA-75205"	"Dissolution of Fibrin Clot"	"-0.354"	"0"	"0.354"	"0.589"
"R-HSA-936964"	"Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"	"-0.355"	"1"	"1.425"	"1.197"
"R-HSA-3000171"	"Non-integrin membrane-ECM interactions"	"-0.355"	"2"	"2.555"	"1.563"
"R-HSA-77348"	"Beta oxidation of octanoyl-CoA to hexanoyl-CoA"	"-0.359"	"0"	"0.359"	"0.594"
"R-HSA-164516"	"Minus-strand DNA synthesis"	"-0.36"	"0"	"0.36"	"0.589"
"R-HSA-164525"	"Plus-strand DNA synthesis"	"-0.36"	"0"	"0.36"	"0.589"
"R-HSA-162589"	"Reverse Transcription of HIV RNA"	"-0.36"	"0"	"0.36"	"0.589"
"R-HSA-162585"	"Uncoating of the HIV Virion"	"-0.36"	"0"	"0.36"	"0.589"
"R-HSA-380972"	"Energy dependent regulation of mTOR by LKB1-AMPK"	"-0.361"	"2"	"2.562"	"1.558"
"R-HSA-444209"	"Free fatty acid receptors"	"-0.361"	"0"	"0.361"	"0.582"
"R-HSA-110381"	"Resolution of AP sites via the single-nucleotide replacement pathway"	"-0.364"	"0"	"0.364"	"0.595"
"R-HSA-77111"	"Synthesis of Ketone Bodies"	"-0.364"	"0"	"0.364"	"0.585"
"R-HSA-2046106"	"alpha-linolenic acid (ALA) metabolism"	"-0.366"	"0"	"0.366"	"0.602"
"R-HSA-2046104"	"alpha-linolenic (omega3) and linoleic (omega6) acid metabolism"	"-0.366"	"0"	"0.366"	"0.602"
"R-HSA-1234158"	"Regulation of gene expression by Hypoxia-inducible Factor"	"-0.366"	"0"	"0.366"	"0.582"
"R-HSA-110357"	"Displacement of DNA glycosylase by APEX1"	"-0.367"	"0"	"0.367"	"0.584"
"R-HSA-933543"	"NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"	"-0.367"	"1"	"1.439"	"1.195"
"R-HSA-156711"	"Polo-like kinase mediated events"	"-0.368"	"2"	"2.573"	"1.556"
"R-HSA-192105"	"Synthesis of bile acids and bile salts"	"-0.371"	"1"	"1.427"	"1.152"
"R-HSA-8939242"	"RUNX1 regulates transcription of genes involved in differentiation of keratinocytes"	"-0.373"	"0"	"0.373"	"0.588"
"R-HSA-74182"	"Ketone body metabolism"	"-0.375"	"0"	"0.375"	"0.594"
"R-HSA-180585"	"Vif-mediated degradation of APOBEC3G"	"-0.376"	"7"	"7.957"	"2.545"
"R-HSA-975576"	"N-glycan antennae elongation in the medial/trans-Golgi"	"-0.379"	"0"	"0.379"	"0.611"
"R-HSA-418457"	"cGMP effects"	"-0.388"	"0"	"0.388"	"0.6"
"R-HSA-9008059"	"Interleukin-37 signaling"	"-0.39"	"0"	"0.39"	"0.585"
"WP1797"	"Circadian Clock"	"-0.391"	"5"	"5.925"	"2.365"
"R-HSA-211958"	"Miscellaneous substrates"	"-0.391"	"0"	"0.391"	"0.628"
"R-HSA-446107"	"Type I hemidesmosome assembly"	"-0.395"	"0"	"0.395"	"0.634"
"R-HSA-425374"	"Amino acid and oligopeptide SLC transporters"	"-0.396"	"0"	"0.396"	"0.629"
"R-HSA-69610"	"p53-Independent DNA Damage Response"	"-0.399"	"7"	"8.056"	"2.65"
"R-HSA-69613"	"p53-Independent G1/S DNA damage checkpoint"	"-0.399"	"7"	"8.056"	"2.65"
"R-HSA-69601"	"Ubiquitin Mediated Degradation of Phosphorylated Cdc25A"	"-0.399"	"7"	"8.056"	"2.65"
"R-HSA-211999"	"CYP2E1 reactions"	"-0.407"	"0"	"0.407"	"0.613"
"R-HSA-5635851"	"GLI proteins bind promoters of Hh responsive genes to promote transcription"	"-0.407"	"0"	"0.407"	"0.626"
"R-HSA-174113"	"SCF-beta-TrCP mediated degradation of Emi1"	"-0.409"	"8"	"9.168"	"2.856"
"R-HSA-194002"	"Glucocorticoid biosynthesis"	"-0.412"	"0"	"0.412"	"0.642"
"R-HSA-163754"	"Insulin effects increased synthesis of Xylulose-5-Phosphate"	"-0.412"	"0"	"0.412"	"0.625"
"R-HSA-8875791"	"MET activates STAT3"	"-0.417"	"0"	"0.417"	"0.649"
"R-HSA-109582"	"Hemostasis"	"-0.418"	"52"	"54.89"	"6.91"
"R-HSA-212676"	"Dopamine Neurotransmitter Release Cycle"	"-0.419"	"1"	"1.534"	"1.274"
"R-HSA-168316"	"Assembly of Viral Components at the Budding Site"	"-0.423"	"0"	"0.423"	"0.633"
"R-HSA-8985586"	"SLIT2:ROBO1 increases RHOA activity"	"-0.423"	"0"	"0.423"	"0.634"
"R-HSA-168268"	"Virus Assembly and Release"	"-0.423"	"0"	"0.423"	"0.633"
"R-HSA-429947"	"Deadenylation of mRNA"	"-0.425"	"4"	"4.892"	"2.097"
"R-HSA-5658623"	"FGFRL1 modulation of FGFR1 signaling"	"-0.425"	"0"	"0.425"	"0.653"
"R-HSA-8849474"	"PTK6 Activates STAT3"	"-0.427"	"0"	"0.427"	"0.649"
"R-HSA-9028731"	"Activated NTRK2 signals through FRS2 and FRS3"	"-0.428"	"0"	"0.428"	"0.621"
"R-HSA-1222556"	"ROS, RNS production in phagocytes"	"-0.431"	"4"	"4.928"	"2.153"
"R-HSA-352238"	"Breakdown of the nuclear lamina"	"-0.435"	"0"	"0.435"	"0.663"
"WP2718"	"Signaling by NOTCH2"	"-0.436"	"8"	"9.23"	"2.819"
"R-HSA-75158"	"TRAIL  signaling"	"-0.436"	"0"	"0.436"	"0.642"
"R-HSA-1606322"	"ZBP1(DAI) mediated induction of type I IFNs"	"-0.436"	"4"	"4.918"	"2.104"
"R-HSA-879518"	"Transport of organic anions"	"-0.439"	"0"	"0.439"	"0.661"
"R-HSA-416700"	"Other semaphorin interactions"	"-0.441"	"0"	"0.441"	"0.683"
"R-HSA-1592389"	"Activation of Matrix Metalloproteinases"	"-0.442"	"0"	"0.442"	"0.649"
"R-HSA-170660"	"Adenylate cyclase activating pathway"	"-0.445"	"0"	"0.445"	"0.669"
"R-HSA-180534"	"Vpu mediated degradation of CD4"	"-0.446"	"7"	"8.178"	"2.64"
"R-HSA-196807"	"Nicotinate metabolism"	"-0.452"	"0"	"0.452"	"0.687"
"R-HSA-211976"	"Endogenous sterols"	"-0.453"	"1"	"1.548"	"1.21"
"R-HSA-3065678"	"SUMO is transferred from E1 to E2 (UBE2I, UBC9)"	"-0.453"	"4"	"4.91"	"2.01"
"R-HSA-2993913"	"Clearance of Nuclear Envelope Membranes from Chromatin"	"-0.454"	"0"	"0.454"	"0.668"
"R-HSA-2022854"	"Keratan sulfate biosynthesis"	"-0.458"	"0"	"0.458"	"0.693"
"R-HSA-196791"	"Vitamin D (calciferol) metabolism"	"-0.458"	"2"	"2.701"	"1.532"
"R-HSA-2187338"	"Visual phototransduction"	"-0.459"	"4"	"5.007"	"2.195"
"R-HSA-74217"	"Purine salvage"	"-0.461"	"0"	"0.461"	"0.667"
"R-HSA-156584"	"Cytosolic sulfonation of small molecules"	"-0.463"	"0"	"0.463"	"0.679"
"R-HSA-5684264"	"MAP3K8 (TPL2)-dependent MAPK1/3 activation"	"-0.464"	"9"	"10.347"	"2.905"
"R-HSA-8854050"	"FBXL7 down-regulates AURKA during mitotic entry and in early mitosis"	"-0.467"	"8"	"9.331"	"2.852"
"R-HSA-75157"	"FasL/ CD95L signaling"	"-0.468"	"0"	"0.468"	"0.675"
"R-HSA-168315"	"Inhibition of Host mRNA Processing and RNA Silencing"	"-0.469"	"0"	"0.469"	"0.66"
"R-HSA-5357786"	"TNFR1-induced proapoptotic signaling"	"-0.472"	"1"	"1.58"	"1.23"
"R-HSA-5365859"	"RA biosynthesis pathway"	"-0.473"	"1"	"1.563"	"1.19"
"R-HSA-3000484"	"Scavenging by Class F Receptors"	"-0.474"	"2"	"2.7"	"1.476"
"R-HSA-111453"	"BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members"	"-0.477"	"0"	"0.477"	"0.665"
"R-HSA-389661"	"Glyoxylate metabolism and glycine degradation"	"-0.478"	"2"	"2.765"	"1.602"
"R-HSA-5576892"	"Phase 0 - rapid depolarisation"	"-0.481"	"1"	"1.568"	"1.182"
"R-HSA-1369062"	"ABC transporters in lipid homeostasis"	"-0.483"	"0"	"0.483"	"0.656"
"R-HSA-3215018"	"Processing and activation of SUMO"	"-0.483"	"4"	"4.98"	"2.028"
"R-HSA-6803211"	"TP53 Regulates Transcription of Death Receptors and Ligands"	"-0.486"	"1"	"1.557"	"1.145"
"R-HSA-392023"	"Adrenaline signalling through Alpha-2 adrenergic receptor"	"-0.488"	"0"	"0.488"	"0.697"
"R-HSA-373080"	"Class B/2 (Secretin family receptors)"	"-0.488"	"5"	"6.199"	"2.455"
"R-HSA-917729"	"Endosomal Sorting Complex Required For Transport (ESCRT)"	"-0.488"	"8"	"9.376"	"2.817"
"R-HSA-189451"	"Heme biosynthesis"	"-0.488"	"0"	"0.488"	"0.692"
"WP3579"	"Surfactant metabolism"	"-0.489"	"0"	"0.489"	"0.687"
"R-HSA-192905"	"vRNP Assembly"	"-0.49"	"1"	"1.546"	"1.115"
"R-HSA-176034"	"Interactions of Tat with host cellular proteins"	"-0.491"	"0"	"0.491"	"0.686"
"R-HSA-6788467"	"IL-6-type cytokine receptor ligand interactions"	"-0.493"	"0"	"0.493"	"0.674"
"R-HSA-1638074"	"Keratan sulfate/keratin metabolism"	"-0.494"	"0"	"0.494"	"0.723"
"R-HSA-349425"	"Autodegradation of the E3 ubiquitin ligase COP1"	"-0.498"	"7"	"8.328"	"2.669"
"R-HSA-8949275"	"RUNX3 Regulates Immune Response and Cell Migration"	"-0.498"	"0"	"0.498"	"0.693"
"R-HSA-376176"	"Signaling by ROBO receptors"	"-0.498"	"13"	"14.842"	"3.698"
"R-HSA-2408508"	"Metabolism of ingested SeMet, Sec, MeSec into H2Se"	"-0.499"	"1"	"1.577"	"1.156"
"R-HSA-211935"	"Fatty acids"	"-0.5"	"0"	"0.5"	"0.724"
"R-HSA-6803207"	"TP53 Regulates Transcription of Caspase Activators and Caspases"	"-0.501"	"1"	"1.583"	"1.165"
"R-HSA-3296197"	"Hydroxycarboxylic acid-binding receptors"	"-0.502"	"0"	"0.502"	"0.706"
"R-HSA-112409"	"RAF-independent MAPK1/3 activation"	"-0.503"	"2"	"2.839"	"1.667"
"R-HSA-2022870"	"Chondroitin sulfate biosynthesis"	"-0.506"	"0"	"0.506"	"0.728"
"R-HSA-5627083"	"RHO GTPases regulate CFTR trafficking"	"-0.506"	"0"	"0.506"	"0.697"
"R-HSA-420029"	"Tight junction interactions"	"-0.508"	"0"	"0.508"	"0.699"
"R-HSA-1170546"	"Prolactin receptor signaling"	"-0.512"	"2"	"2.835"	"1.631"
"R-HSA-209952"	"Peptide hormone biosynthesis"	"-0.513"	"0"	"0.513"	"0.697"
"R-HSA-1655829"	"Regulation of cholesterol biosynthesis by SREBP (SREBF)"	"-0.516"	"2"	"2.855"	"1.656"
"R-HSA-1251932"	"PLCG1 events in ERBB2 signaling"	"-0.517"	"1"	"1.612"	"1.184"
"R-HSA-8849175"	"Threonine catabolism"	"-0.517"	"0"	"0.517"	"0.69"
"R-HSA-114516"	"Disinhibition of SNARE formation"	"-0.518"	"0"	"0.518"	"0.7"
"R-HSA-3238698"	"WNT ligand biogenesis and trafficking"	"-0.519"	"0"	"0.519"	"0.703"
"R-HSA-2122948"	"Activated NOTCH1 Transmits Signal to the Nucleus"	"-0.52"	"8"	"9.497"	"2.881"
"R-HSA-417973"	"Adenosine P1 receptors"	"-0.52"	"0"	"0.52"	"0.696"
"WP698"	"Glucuronidation"	"-0.521"	"0"	"0.521"	"0.716"
"R-HSA-168274"	"Export of Viral Ribonucleoproteins from Nucleus"	"-0.526"	"7"	"8.453"	"2.76"
"R-HSA-6783984"	"Glycine degradation"	"-0.526"	"0"	"0.526"	"0.735"
"WP4063"	"Interleukin-10 signaling"	"-0.526"	"0"	"0.526"	"0.718"
"R-HSA-1980150"	"Signaling by NOTCH4"	"-0.526"	"0"	"0.526"	"0.708"
"R-HSA-8849468"	"PTK6 Regulates Proteins Involved in RNA Processing"	"-0.528"	"0"	"0.528"	"0.731"
"R-HSA-2033514"	"FGFR3 mutant receptor activation"	"-0.533"	"0"	"0.533"	"0.763"
"WP3394"	"NR1D1 (REV-ERBA) represses gene expression"	"-0.533"	"0"	"0.533"	"0.692"
"R-HSA-1839130"	"Signaling by activated point mutants of FGFR3"	"-0.533"	"0"	"0.533"	"0.763"
"R-HSA-390650"	"Histamine receptors"	"-0.535"	"0"	"0.535"	"0.715"
"R-HSA-5387390"	"Hh mutants abrogate ligand secretion"	"-0.536"	"7"	"8.413"	"2.634"
"R-HSA-5362768"	"Hh mutants that don,t undergo autocatalytic processing are degraded by ERAD"	"-0.536"	"7"	"8.413"	"2.634"
"R-HSA-68616"	"Assembly of the ORC complex at the origin of replication"	"-0.538"	"0"	"0.538"	"0.736"
"R-HSA-1614603"	"Cysteine formation from homocysteine"	"-0.538"	"0"	"0.538"	"0.711"
"R-HSA-194068"	"Bile acid and bile salt metabolism"	"-0.54"	"1"	"1.671"	"1.244"
"R-HSA-70370"	"Galactose catabolism"	"-0.542"	"0"	"0.542"	"0.716"
"R-HSA-1474244"	"Extracellular matrix organization"	"-0.545"	"8"	"9.635"	"2.997"
"R-HSA-68881"	"Mitotic Metaphase/Anaphase Transition"	"-0.545"	"0"	"0.545"	"0.719"
"R-HSA-1461973"	"Defensins"	"-0.546"	"0"	"0.546"	"0.746"
"R-HSA-190372"	"FGFR3c ligand binding and activation"	"-0.546"	"0"	"0.546"	"0.77"
"R-HSA-190239"	"FGFR3 ligand binding and activation"	"-0.546"	"0"	"0.546"	"0.77"
"R-HSA-9013957"	"TLR3-mediated TICAM1-dependent programmed cell death"	"-0.546"	"0"	"0.546"	"0.738"
"R-HSA-199920"	"CREB phosphorylation"	"-0.551"	"0"	"0.551"	"0.721"
"WP3558"	"Beta-catenin independent WNT signaling"	"-0.553"	"18"	"20.322"	"4.201"
"R-HSA-70614"	"Amino acid synthesis and interconversion (transamination)"	"-0.56"	"1"	"1.714"	"1.275"
"R-HSA-390918"	"Peroxisomal lipid metabolism"	"-0.562"	"0"	"0.562"	"0.755"
"R-HSA-1368108"	"BMAL1:CLOCK,NPAS2 activates circadian gene expression"	"-0.566"	"0"	"0.566"	"0.748"
"R-HSA-1679131"	"Trafficking and processing of endosomal TLR"	"-0.567"	"0"	"0.567"	"0.735"
"R-HSA-2168880"	"Scavenging of heme from plasma"	"-0.574"	"0"	"0.574"	"0.734"
"R-HSA-111448"	"Activation of NOXA and translocation to mitochondria"	"-0.575"	"1"	"1.688"	"1.198"
"R-HSA-5336415"	"Uptake and function of diphtheria toxin"	"-0.58"	"0"	"0.58"	"0.699"
"R-HSA-190322"	"FGFR4 ligand binding and activation"	"-0.581"	"0"	"0.581"	"0.787"
"R-HSA-428542"	"Regulation of commissural axon pathfinding by SLIT and ROBO"	"-0.581"	"0"	"0.581"	"0.746"
"R-HSA-190373"	"FGFR1c ligand binding and activation"	"-0.582"	"0"	"0.582"	"0.794"
"R-HSA-190375"	"FGFR2c ligand binding and activation"	"-0.582"	"0"	"0.582"	"0.795"
"R-HSA-1306955"	"GRB7 events in ERBB2 signaling"	"-0.582"	"0"	"0.582"	"0.769"
"R-HSA-1839122"	"Signaling by activated point mutants of FGFR1"	"-0.582"	"0"	"0.582"	"0.794"
"R-HSA-5658442"	"Regulation of RAS by GAPs"	"-0.587"	"8"	"9.656"	"2.821"
"R-HSA-211897"	"Cytochrome P450 - arranged by substrate type"	"-0.591"	"2"	"3.018"	"1.723"
"R-HSA-8847993"	"ERBB2 Activates PTK6 Signaling"	"-0.591"	"1"	"1.775"	"1.311"
"R-HSA-425397"	"Transport of vitamins, nucleosides, and related molecules"	"-0.591"	"0"	"0.591"	"0.77"
"R-HSA-9010553"	"Regulation of expression of SLITs and ROBOs"	"-0.592"	"6"	"7.469"	"2.483"
"R-HSA-8937144"	"Aryl hydrocarbon receptor signalling"	"-0.595"	"1"	"1.711"	"1.195"
"R-HSA-380095"	"Tachykinin receptors bind tachykinins"	"-0.598"	"0"	"0.598"	"0.741"
"R-HSA-539107"	"Activation of E2F1 target genes at G1/S"	"-0.6"	"2"	"2.986"	"1.644"
"R-HSA-69205"	"G1/S-Specific Transcription"	"-0.6"	"2"	"2.986"	"1.644"
"R-HSA-8849473"	"PTK6 Expression"	"-0.604"	"0"	"0.604"	"0.729"
"R-HSA-187037"	"Signaling by NTRK1 (TRKA)"	"-0.605"	"14"	"16.401"	"3.968"
"R-HSA-196854"	"Metabolism of vitamins and cofactors"	"-0.609"	"7"	"8.684"	"2.767"
"R-HSA-189445"	"Metabolism of porphyrins"	"-0.611"	"0"	"0.611"	"0.779"
"R-HSA-162588"	"Budding and maturation of HIV virion"	"-0.617"	"8"	"9.795"	"2.911"
"R-HSA-1234176"	"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha"	"-0.623"	"8"	"9.805"	"2.896"
"R-HSA-977068"	"Termination of O-glycan biosynthesis"	"-0.623"	"0"	"0.623"	"0.761"
"R-HSA-168253"	"Host Interactions with Influenza Factors"	"-0.627"	"2"	"3.041"	"1.66"
"R-HSA-9032845"	"Activated NTRK2 signals through CDK5"	"-0.633"	"0"	"0.633"	"0.731"
"R-HSA-209563"	"Axonal growth stimulation"	"-0.633"	"0"	"0.633"	"0.799"
"R-HSA-381753"	"Olfactory Signaling Pathway"	"-0.644"	"1"	"1.854"	"1.326"
"R-HSA-75153"	"Apoptotic execution phase"	"-0.645"	"5"	"6.623"	"2.518"
"R-HSA-392154"	"Nitric oxide stimulates guanylate cyclase"	"-0.645"	"0"	"0.645"	"0.79"
"R-HSA-400511"	"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)"	"-0.645"	"0"	"0.645"	"0.817"
"R-HSA-193775"	"Synthesis of bile acids and bile salts via 24-hydroxycholesterol"	"-0.647"	"0"	"0.647"	"0.796"
"R-HSA-446388"	"Regulation of cytoskeletal remodeling and cell spreading by IPP complex components"	"-0.648"	"0"	"0.648"	"0.8"
"R-HSA-176412"	"Phosphorylation of the APC/C"	"-0.649"	"2"	"3.158"	"1.784"
"R-HSA-5674499"	"Negative feedback regulation of MAPK pathway"	"-0.65"	"1"	"1.816"	"1.254"
"R-HSA-211163"	"AKT-mediated inactivation of FOXO1A"	"-0.651"	"0"	"0.651"	"0.826"
"WP3513"	"Regulation of beta-cell development"	"-0.651"	"0"	"0.651"	"0.826"
"R-HSA-210745"	"Regulation of gene expression in beta cells"	"-0.651"	"0"	"0.651"	"0.826"
"R-HSA-5358493"	"Synthesis of diphthamide-EEF2"	"-0.652"	"0"	"0.652"	"0.749"
"R-HSA-2262749"	"Cellular response to hypoxia"	"-0.656"	"8"	"9.9"	"2.897"
"R-HSA-114508"	"Effects of PIP2 hydrolysis"	"-0.656"	"0"	"0.656"	"0.784"
"WP2727"	"Regulation of Hypoxia-inducible Factor (HIF) by oxygen"	"-0.656"	"8"	"9.9"	"2.897"
"R-HSA-71737"	"Pyrophosphate hydrolysis"	"-0.661"	"0"	"0.661"	"0.766"
"R-HSA-198203"	"PI3K/AKT activation"	"-0.662"	"2"	"3.116"	"1.687"
"R-HSA-174490"	"Membrane binding and targetting of GAG proteins"	"-0.664"	"6"	"7.648"	"2.483"
"R-HSA-174495"	"Synthesis And Processing Of GAG, GAGPOL Polyproteins"	"-0.664"	"6"	"7.648"	"2.483"
"WP3436"	"Synthesis, secretion, and deacylation of Ghrelin"	"-0.666"	"0"	"0.666"	"0.813"
"R-HSA-4641257"	"Degradation of AXIN"	"-0.667"	"6"	"7.681"	"2.52"
"R-HSA-193634"	"Axonal growth inhibition (RHOA activation)"	"-0.668"	"0"	"0.668"	"0.811"
"R-HSA-69273"	"Cyclin A/B1/B2 associated events during G2/M transition"	"-0.668"	"6"	"7.749"	"2.617"
"R-HSA-3232118"	"SUMOylation of transcription factors"	"-0.668"	"6"	"7.731"	"2.59"
"R-HSA-174048"	"APC/C:Cdc20 mediated degradation of Cyclin B"	"-0.673"	"8"	"10.086"	"3.101"
"R-HSA-70350"	"Fructose catabolism"	"-0.675"	"0"	"0.675"	"0.79"
"R-HSA-2173782"	"Binding and Uptake of Ligands by Scavenger Receptors"	"-0.677"	"3"	"4.21"	"1.789"
"R-HSA-3656534"	"Loss of Function of TGFBR1 in Cancer"	"-0.677"	"0"	"0.677"	"0.789"
"R-HSA-3642278"	"Loss of Function of TGFBR2 in Cancer"	"-0.677"	"0"	"0.677"	"0.789"
"R-HSA-3301854"	"Nuclear Pore Complex (NPC) Disassembly"	"-0.677"	"5"	"6.722"	"2.543"
"R-HSA-3656532"	"TGFBR1 KD Mutants in Cancer"	"-0.677"	"0"	"0.677"	"0.789"
"R-HSA-3645790"	"TGFBR2 Kinase Domain Mutants in Cancer"	"-0.677"	"0"	"0.677"	"0.789"
"R-HSA-176409"	"APC/C:Cdc20 mediated degradation of mitotic proteins"	"-0.68"	"9"	"11.236"	"3.289"
"R-HSA-111995"	"phospho-PLA2 pathway"	"-0.683"	"0"	"0.683"	"0.756"
"R-HSA-180689"	"APOBEC3G mediated resistance to HIV-1 infection"	"-0.687"	"0"	"0.687"	"0.833"
"R-HSA-446343"	"Localization of the PINCH-ILK-PARVIN complex to focal adhesions"	"-0.687"	"0"	"0.687"	"0.805"
"R-HSA-901042"	"Calnexin/calreticulin cycle"	"-0.688"	"7"	"8.851"	"2.692"
"R-HSA-5357769"	"Caspase activation via extrinsic apoptotic signalling pathway"	"-0.69"	"1"	"1.962"	"1.394"
"R-HSA-111957"	"Cam-PDE 1 activation"	"-0.692"	"0"	"0.692"	"0.8"
"R-HSA-1362300"	"Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1"	"-0.694"	"2"	"3.19"	"1.714"
"R-HSA-937039"	"IRAK1 recruits IKK complex"	"-0.702"	"1"	"1.905"	"1.288"
"R-HSA-975144"	"IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation"	"-0.702"	"1"	"1.905"	"1.288"
"R-HSA-163680"	"AMPK inhibits chREBP transcriptional activation activity"	"-0.709"	"0"	"0.709"	"0.837"
"R-HSA-2033519"	"Activated point mutants of FGFR2"	"-0.71"	"0"	"0.71"	"0.88"
"R-HSA-5678895"	"Defective CFTR causes cystic fibrosis"	"-0.71"	"7"	"8.958"	"2.757"
"R-HSA-1839126"	"FGFR2 mutant receptor activation"	"-0.71"	"0"	"0.71"	"0.88"
"R-HSA-5619084"	"ABC transporter disorders"	"-0.712"	"7"	"8.96"	"2.754"
"R-HSA-1169091"	"Activation of NF-kappaB in B cells"	"-0.712"	"3"	"4.364"	"1.917"
"R-HSA-5619115"	"Disorders of transmembrane transporters"	"-0.712"	"7"	"8.96"	"2.754"
"R-HSA-5689877"	"Josephin domain DUBs"	"-0.712"	"7"	"8.937"	"2.72"
"R-HSA-68689"	"CDC6 association with the ORC:origin complex"	"-0.713"	"0"	"0.713"	"0.841"
"R-HSA-5358346"	"Hedgehog ligand biogenesis"	"-0.713"	"7"	"8.933"	"2.71"
"R-HSA-2562578"	"TRIF-mediated programmed cell death"	"-0.714"	"0"	"0.714"	"0.854"
"R-HSA-190241"	"FGFR2 ligand binding and activation"	"-0.715"	"0"	"0.715"	"0.881"
"WP3804"	"TP53 Regulates Transcription of Cell Cycle Genes"	"-0.716"	"8"	"10.201"	"3.073"
"R-HSA-187687"	"Signalling to ERKs"	"-0.717"	"5"	"6.76"	"2.454"
"R-HSA-190242"	"FGFR1 ligand binding and activation"	"-0.722"	"0"	"0.722"	"0.885"
"R-HSA-844456"	"The NLRP3 inflammasome"	"-0.722"	"1"	"1.951"	"1.318"
"R-HSA-70635"	"Urea cycle"	"-0.722"	"0"	"0.722"	"0.832"
"R-HSA-5368598"	"Negative regulation of TCF-dependent signaling by DVL-interacting proteins"	"-0.723"	"0"	"0.723"	"0.817"
"R-HSA-8866376"	"Reelin signalling pathway"	"-0.723"	"0"	"0.723"	"0.818"
"R-HSA-1169092"	"Activation of RAS in B cells"	"-0.724"	"0"	"0.724"	"0.845"
"R-HSA-390651"	"Dopamine receptors"	"-0.724"	"0"	"0.724"	"0.832"
"R-HSA-2465910"	"MASTL Facilitates Mitotic Progression"	"-0.726"	"2"	"3.228"	"1.692"
"R-HSA-6811555"	"PI5P Regulates TP53 Acetylation"	"-0.727"	"1"	"1.95"	"1.307"
"R-HSA-4641263"	"Regulation of FZD by ubiquitination"	"-0.728"	"6"	"7.846"	"2.535"
"R-HSA-8941332"	"RUNX2 regulates genes involved in cell migration"	"-0.728"	"0"	"0.728"	"0.884"
"R-HSA-391906"	"Leukotriene receptors"	"-0.73"	"0"	"0.73"	"0.816"
"WP3370"	"RORA activates gene expression"	"-0.732"	"0"	"0.732"	"0.829"
"R-HSA-425561"	"Sodium/Calcium exchangers"	"-0.734"	"0"	"0.734"	"0.833"
"R-HSA-193697"	"p75NTR regulates axonogenesis"	"-0.737"	"0"	"0.737"	"0.848"
"R-HSA-204174"	"Regulation of pyruvate dehydrogenase (PDH) complex"	"-0.738"	"1"	"2.044"	"1.415"
"R-HSA-8941855"	"RUNX3 regulates CDKN1A transcription"	"-0.74"	"1"	"1.934"	"1.261"
"R-HSA-174084"	"Autodegradation of Cdh1 by Cdh1:APC/C"	"-0.741"	"7"	"9.11"	"2.849"
"R-HSA-75815"	"Ubiquitin-dependent degradation of Cyclin D"	"-0.742"	"6"	"7.923"	"2.591"
"R-HSA-69229"	"Ubiquitin-dependent degradation of Cyclin D1"	"-0.742"	"6"	"7.923"	"2.591"
"R-HSA-211227"	"Activation of DNA fragmentation factor"	"-0.745"	"1"	"2.004"	"1.348"
"R-HSA-140342"	"Apoptosis induced DNA fragmentation"	"-0.745"	"1"	"2.004"	"1.348"
"R-HSA-193048"	"Androgen biosynthesis"	"-0.747"	"0"	"0.747"	"0.802"
"WP3313"	"Hedgehog ,on, state"	"-0.752"	"9"	"11.356"	"3.134"
"R-HSA-8876493"	"InlA-mediated entry of Listeria monocytogenes into host cells"	"-0.753"	"6"	"7.989"	"2.64"
"R-HSA-1296071"	"Potassium Channels"	"-0.756"	"2"	"3.3"	"1.719"
"R-HSA-69563"	"p53-Dependent G1 DNA Damage Response"	"-0.757"	"9"	"11.426"	"3.204"
"R-HSA-69580"	"p53-Dependent G1/S DNA damage checkpoint"	"-0.757"	"9"	"11.426"	"3.204"
"WP3798"	"Regulation of TP53 Activity through Association with Co-factors"	"-0.758"	"1"	"2.021"	"1.348"
"R-HSA-381771"	"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)"	"-0.758"	"0"	"0.758"	"0.887"
"R-HSA-933542"	"TRAF6 mediated NF-kB activation"	"-0.758"	"4"	"5.694"	"2.234"
"R-HSA-5663213"	"RHO GTPases Activate WASPs and WAVEs"	"-0.766"	"7"	"9.173"	"2.838"
"R-HSA-196849"	"Metabolism of water-soluble vitamins and cofactors"	"-0.769"	"2"	"3.318"	"1.713"
"R-HSA-419037"	"NCAM1 interactions"	"-0.773"	"0"	"0.773"	"0.901"
"R-HSA-110362"	"POLB-Dependent Long Patch Base Excision Repair"	"-0.776"	"0"	"0.776"	"0.873"
"R-HSA-1483166"	"Synthesis of PA"	"-0.78"	"0"	"0.78"	"0.875"
"R-HSA-419812"	"Calcitonin-like ligand receptors"	"-0.781"	"0"	"0.781"	"0.876"
"R-HSA-8849469"	"PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1"	"-0.784"	"6"	"8.012"	"2.566"
"R-HSA-1253288"	"Downregulation of ERBB4 signaling"	"-0.786"	"6"	"8.04"	"2.594"
"R-HSA-390648"	"Muscarinic acetylcholine receptors"	"-0.786"	"0"	"0.786"	"0.897"
"R-HSA-175474"	"Assembly Of The HIV Virion"	"-0.796"	"6"	"8.038"	"2.561"
"R-HSA-68827"	"CDT1 association with the CDC6:ORC:origin complex"	"-0.796"	"6"	"8.027"	"2.548"
"R-HSA-383280"	"Nuclear Receptor transcription pathway"	"-0.796"	"4"	"5.849"	"2.322"
"R-HSA-168333"	"NEP/NS2 Interacts with the Cellular Export Machinery"	"-0.798"	"5"	"7.01"	"2.519"
"R-HSA-189200"	"Cellular hexose transport"	"-0.799"	"0"	"0.799"	"0.883"
"R-HSA-5689896"	"Ovarian tumor domain proteases"	"-0.801"	"11"	"13.823"	"3.526"
"R-HSA-5652084"	"Fructose metabolism"	"-0.802"	"0"	"0.802"	"0.858"
"R-HSA-3134975"	"Regulation of innate immune responses to cytosolic DNA"	"-0.803"	"6"	"8.071"	"2.579"
"R-HSA-426496"	"Post-transcriptional silencing by small RNAs"	"-0.809"	"0"	"0.809"	"0.859"
"R-HSA-1855204"	"Synthesis of IP3 and IP4 in the cytosol"	"-0.81"	"1"	"2.131"	"1.396"
"R-HSA-176814"	"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"	"-0.812"	"9"	"11.747"	"3.383"
"R-HSA-139915"	"Activation of PUMA and translocation to mitochondria"	"-0.812"	"1"	"2.109"	"1.366"
"R-HSA-68952"	"DNA replication initiation"	"-0.813"	"0"	"0.813"	"0.888"
"R-HSA-391160"	"Signal regulatory protein family interactions"	"-0.813"	"1"	"2.142"	"1.405"
"R-HSA-174430"	"Telomere C-strand synthesis initiation"	"-0.813"	"0"	"0.813"	"0.888"
"R-HSA-200425"	"Import of palmitoyl-CoA into the mitochondrial matrix"	"-0.815"	"0"	"0.815"	"0.882"
"R-HSA-174184"	"Cdc20:Phospho-APC/C mediated degradation of Cyclin A"	"-0.816"	"8"	"10.607"	"3.195"
"R-HSA-5654227"	"Phospholipase C-mediated cascade; FGFR3"	"-0.816"	"0"	"0.816"	"0.907"
"R-HSA-918233"	"TRAF3-dependent IRF activation pathway"	"-0.816"	"1"	"2.149"	"1.408"
"R-HSA-8934903"	"Receptor Mediated Mitophagy"	"-0.817"	"2"	"3.432"	"1.753"
"R-HSA-2024096"	"HS-GAG degradation"	"-0.819"	"0"	"0.819"	"0.904"
"R-HSA-5666185"	"RHO GTPases Activate Rhotekin and Rhophilins"	"-0.82"	"0"	"0.82"	"0.894"
"R-HSA-418890"	"Role of second messengers in netrin-1 signaling"	"-0.82"	"0"	"0.82"	"0.879"
"R-HSA-191647"	"c-src mediated regulation of Cx43 function and closure of gap junctions"	"-0.822"	"0"	"0.822"	"0.857"
"R-HSA-5205685"	"Pink/Parkin Mediated Mitophagy"	"-0.822"	"7"	"9.313"	"2.814"
"R-HSA-191650"	"Regulation of gap junction activity"	"-0.822"	"0"	"0.822"	"0.857"
"R-HSA-174178"	"APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"	"-0.829"	"8"	"10.603"	"3.14"
"R-HSA-3899300"	"SUMOylation of transcription cofactors"	"-0.829"	"1"	"2.152"	"1.389"
"R-HSA-69615"	"G1/S DNA Damage Checkpoints"	"-0.83"	"9"	"11.688"	"3.24"
"R-HSA-8854691"	"Interleukin-20 family signaling"	"-0.832"	"0"	"0.832"	"0.926"
"WP2728"	"Incretin synthesis, secretion, and inactivation"	"-0.837"	"0"	"0.837"	"0.937"
"R-HSA-176408"	"Regulation of APC/C activators between G1/S and early anaphase"	"-0.843"	"11"	"14.1"	"3.676"
"R-HSA-6785631"	"ERBB2 Regulates Cell Motility"	"-0.849"	"1"	"2.239"	"1.459"
"R-HSA-9013508"	"NOTCH3 Intracellular Domain Regulates Transcription"	"-0.85"	"2"	"3.483"	"1.744"
"R-HSA-174143"	"APC/C-mediated degradation of cell cycle proteins"	"-0.853"	"12"	"15.255"	"3.815"
"R-HSA-453276"	"Regulation of mitotic cell cycle"	"-0.853"	"12"	"15.255"	"3.815"
"R-HSA-8939246"	"RUNX1 regulates transcription of genes involved in differentiation of myeloid cells"	"-0.853"	"0"	"0.853"	"0.87"
"R-HSA-6802952"	"Signaling by BRAF and RAF fusions"	"-0.861"	"6"	"8.271"	"2.637"
"R-HSA-1250342"	"PI3K events in ERBB4 signaling"	"-0.862"	"0"	"0.862"	"0.885"
"R-HSA-204626"	"Hypusine synthesis from eIF5A-lysine"	"-0.864"	"0"	"0.864"	"0.904"
"R-HSA-5654228"	"Phospholipase C-mediated cascade; FGFR4"	"-0.864"	"0"	"0.864"	"0.933"
"R-HSA-179419"	"APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint"	"-0.871"	"8"	"10.801"	"3.217"
"R-HSA-389397"	"Orexin and neuropeptides FF and QRFP bind to their respective receptors"	"-0.871"	"0"	"0.871"	"0.933"
"R-HSA-4641258"	"Degradation of DVL"	"-0.872"	"7"	"9.421"	"2.776"
"R-HSA-8866652"	"Synthesis of active ubiquitin: roles of E1 and E2 enzymes"	"-0.879"	"8"	"10.679"	"3.047"
"R-HSA-381033"	"ATF6 (ATF6-alpha) activates chaperones"	"-0.88"	"0"	"0.88"	"0.821"
"WP3354"	"C-type lectin receptors (CLRs)"	"-0.881"	"10"	"13.133"	"3.558"
"R-HSA-1566977"	"Fibronectin matrix formation"	"-0.882"	"0"	"0.882"	"0.916"
"R-HSA-8952158"	"RUNX3 regulates BCL2L11 (BIM) transcription"	"-0.882"	"0"	"0.882"	"0.912"
"R-HSA-442745"	"Activation of CaMK IV"	"-0.886"	"0"	"0.886"	"0.904"
"R-HSA-388479"	"Vasopressin-like receptors"	"-0.89"	"0"	"0.89"	"0.926"
"R-HSA-176407"	"Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase"	"-0.892"	"1"	"2.415"	"1.586"
"R-HSA-622312"	"Inflammasomes"	"-0.893"	"1"	"2.318"	"1.475"
"R-HSA-173107"	"Binding and entry of HIV virion"	"-0.905"	"0"	"0.905"	"0.914"
"R-HSA-1358803"	"Downregulation of ERBB2:ERBB3 signaling"	"-0.906"	"6"	"8.445"	"2.698"
"R-HSA-5626978"	"TNFR1-mediated ceramide production"	"-0.908"	"0"	"0.908"	"0.899"
"R-HSA-111367"	"SLBP independent Processing of Histone Pre-mRNAs"	"-0.91"	"1"	"2.423"	"1.564"
"R-HSA-448706"	"Interleukin-1 processing"	"-0.911"	"0"	"0.911"	"0.961"
"R-HSA-164940"	"Nef mediated downregulation of MHC class I complex cell surface expression"	"-0.911"	"0"	"0.911"	"0.928"
"R-HSA-77588"	"SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs"	"-0.913"	"1"	"2.434"	"1.571"
"R-HSA-2151201"	"Transcriptional activation of mitochondrial biogenesis"	"-0.914"	"1"	"2.339"	"1.465"
"R-HSA-166520"	"Signaling by NTRKs"	"-0.919"	"14"	"17.771"	"4.105"
"R-HSA-9032500"	"Activated NTRK2 signals through FYN"	"-0.924"	"0"	"0.924"	"0.913"
"R-HSA-532668"	"N-glycan trimming in the ER and Calnexin/Calreticulin cycle"	"-0.932"	"8"	"10.776"	"2.978"
"R-HSA-428543"	"Inactivation of CDC42 and RAC1"	"-0.939"	"0"	"0.939"	"0.922"
"WP2738"	"YAP1- and WWTR1 (TAZ)-stimulated gene expression"	"-0.94"	"0"	"0.94"	"0.928"
"R-HSA-204998"	"Cell death signalling via NRAGE, NRIF and NADE"	"-0.941"	"10"	"13.193"	"3.394"
"R-HSA-444257"	"RSK activation"	"-0.941"	"0"	"0.941"	"0.901"
"R-HSA-8931987"	"RUNX1 regulates estrogen receptor mediated transcription"	"-0.945"	"0"	"0.945"	"0.941"
"R-HSA-9012852"	"Signaling by NOTCH3"	"-0.945"	"10"	"13.109"	"3.291"
"WP4086"	"Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"	"-0.945"	"7"	"9.859"	"3.027"
"R-HSA-418346"	"Platelet homeostasis"	"-0.946"	"6"	"8.688"	"2.841"
"R-HSA-8941326"	"RUNX2 regulates bone development"	"-0.954"	"3"	"5.081"	"2.182"
"R-HSA-69109"	"Leading Strand Synthesis"	"-0.956"	"1"	"2.424"	"1.49"
"R-HSA-6802957"	"Oncogenic MAPK signaling"	"-0.956"	"6"	"8.571"	"2.69"
"R-HSA-69091"	"Polymerase switching"	"-0.956"	"1"	"2.424"	"1.49"
"R-HSA-174411"	"Polymerase switching on the C-strand of the telomere"	"-0.956"	"1"	"2.424"	"1.49"
"R-HSA-2428928"	"IRS-related events triggered by IGF1R"	"-0.965"	"3"	"5.107"	"2.184"
"R-HSA-6803204"	"TP53 Regulates Transcription of Genes Involved in Cytochrome C Release"	"-0.966"	"1"	"2.495"	"1.548"
"R-HSA-445989"	"TAK1 activates NFkB by phosphorylation and activation of IKKs complex"	"-0.968"	"4"	"6.208"	"2.282"
"R-HSA-5674400"	"Constitutive Signaling by AKT1 E17K in Cancer"	"-0.969"	"2"	"3.855"	"1.915"
"R-HSA-8866904"	"Negative regulation of activity of TFAP2 (AP-2) family transcription factors"	"-0.973"	"1"	"2.444"	"1.484"
"R-HSA-392851"	"Prostacyclin signalling through prostacyclin receptor"	"-0.975"	"1"	"2.529"	"1.568"
"R-HSA-9033241"	"Peroxisomal protein import"	"-0.977"	"7"	"9.803"	"2.87"
"R-HSA-9020591"	"Interleukin-12 signaling"	"-0.978"	"0"	"0.978"	"0.967"
"R-HSA-2129379"	"Molecules associated with elastic fibres"	"-0.982"	"0"	"0.982"	"0.972"
"R-HSA-5654219"	"Phospholipase C-mediated cascade: FGFR1"	"-0.985"	"0"	"1.005"	"1.02"
"R-HSA-141430"	"Inactivation of APC/C via direct inhibition of the APC/C complex"	"-0.987"	"1"	"2.635"	"1.656"
"R-HSA-141405"	"Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components"	"-0.987"	"1"	"2.635"	"1.656"
"R-HSA-9020933"	"Interleukin-23 signaling"	"-0.987"	"0"	"0.987"	"0.996"
"R-HSA-179409"	"APC-Cdc20 mediated degradation of Nek2A"	"-0.989"	"7"	"10.013"	"3.048"
"R-HSA-5654221"	"Phospholipase C-mediated cascade; FGFR2"	"-0.989"	"0"	"0.993"	"1.004"
"R-HSA-4608870"	"Asymmetric localization of PCP proteins"	"-0.99"	"6"	"8.659"	"2.686"
"R-HSA-1483206"	"Glycerophospholipid biosynthesis"	"-0.992"	"2"	"3.942"	"1.958"
"hsa00562"	"Inositol phosphate metabolism"	"-0.992"	"1"	"2.494"	"1.506"
"R-HSA-75892"	"Platelet Adhesion to exposed collagen"	"-0.992"	"0"	"0.992"	"0.959"
"WP1775"	"Cell Cycle Checkpoints"	"-0.994"	"51"	"58.404"	"7.445"
"R-HSA-5339562"	"Uptake and actions of bacterial toxins"	"-0.994"	"1"	"2.581"	"1.59"
"R-HSA-936440"	"Negative regulators of DDX58/IFIH1 signaling"	"-0.998"	"1"	"2.589"	"1.593"
"R-HSA-444821"	"Relaxin receptors"	"-1"	"0"	"1.015"	"1.015"
"R-HSA-416550"	"Sema4D mediated inhibition of cell attachment and migration"	"-1.002"	"0"	"1.002"	"0.954"
"R-HSA-111885"	"Opioid Signalling"	"-1.005"	"10"	"13.477"	"3.459"
"R-HSA-426486"	"Small interfering RNA (siRNA) biogenesis"	"-1.005"	"0"	"1.005"	"0.976"
"R-HSA-5682910"	"LGI-ADAM interactions"	"-1.007"	"0"	"1.007"	"0.96"
"R-HSA-2173788"	"Downregulation of TGF-beta receptor signaling"	"-1.009"	"10"	"13.374"	"3.344"
"R-HSA-109704"	"PI3K Cascade"	"-1.009"	"2"	"3.948"	"1.931"
"R-HSA-418217"	"G beta:gamma signalling through PLC beta"	"-1.01"	"1"	"2.574"	"1.558"
"R-HSA-3928662"	"EPHB-mediated forward signaling"	"-1.012"	"6"	"8.961"	"2.927"
"R-HSA-8941858"	"Regulation of RUNX3 expression and activity"	"-1.013"	"7"	"9.871"	"2.835"
"R-HSA-500657"	"Presynaptic function of Kainate receptors"	"-1.014"	"1"	"2.582"	"1.56"
"R-HSA-198323"	"AKT phosphorylates targets in the cytosol"	"-1.018"	"1"	"2.605"	"1.576"
"R-HSA-375281"	"Hormone ligand-binding receptors"	"-1.018"	"0"	"1.026"	"1.008"
"R-HSA-8948747"	"Regulation of PTEN localization"	"-1.018"	"6"	"8.749"	"2.699"
"R-HSA-3000157"	"Laminin interactions"	"-1.019"	"0"	"1.019"	"0.999"
"R-HSA-1296041"	"Activation of G protein gated Potassium channels"	"-1.02"	"1"	"2.547"	"1.517"
"R-HSA-1296059"	"G protein gated Potassium channels"	"-1.02"	"1"	"2.547"	"1.517"
"R-HSA-997272"	"Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"	"-1.02"	"1"	"2.547"	"1.517"
"R-HSA-434316"	"Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion"	"-1.022"	"0"	"1.022"	"0.946"
"R-HSA-400451"	"Free fatty acids regulate insulin secretion"	"-1.022"	"0"	"1.022"	"0.946"
"R-HSA-68884"	"Mitotic Telophase/Cytokinesis"	"-1.025"	"1"	"2.663"	"1.622"
"R-HSA-391908"	"Prostanoid ligand receptors"	"-1.026"	"0"	"1.102"	"1.074"
"R-HSA-1296065"	"Inwardly rectifying K+ channels"	"-1.027"	"1"	"2.563"	"1.521"
"R-HSA-9020702"	"Interleukin-1 signaling"	"-1.029"	"13"	"16.823"	"3.716"
"R-HSA-5362517"	"Signaling by Retinoic Acid"	"-1.029"	"2"	"3.961"	"1.906"
"R-HSA-1971475"	"A tetrasaccharide linker sequence is required for GAG synthesis"	"-1.032"	"0"	"1.059"	"1.026"
"R-HSA-3322077"	"Glycogen synthesis"	"-1.032"	"0"	"1.032"	"0.974"
"R-HSA-8957322"	"Metabolism of steroids"	"-1.037"	"6"	"9.049"	"2.939"
"R-HSA-6803157"	"Antimicrobial peptides"	"-1.038"	"0"	"1.045"	"1.007"
"R-HSA-173623"	"Classical antibody-mediated complement activation"	"-1.043"	"0"	"1.055"	"1.011"
"R-HSA-209943"	"Steroid hormones"	"-1.043"	"2"	"3.983"	"1.901"
"R-HSA-111932"	"CaMK IV-mediated phosphorylation of CREB"	"-1.046"	"0"	"1.063"	"1.016"
"R-HSA-442717"	"CREB phosphorylation through the activation of CaMKK"	"-1.054"	"0"	"1.075"	"1.02"
"R-HSA-1566948"	"Elastic fibre formation"	"-1.055"	"0"	"1.088"	"1.031"
"R-HSA-1630316"	"Glycosaminoglycan metabolism"	"-1.055"	"1"	"2.858"	"1.76"
"R-HSA-428890"	"Role of ABL in ROBO-SLIT signaling"	"-1.064"	"0"	"1.121"	"1.053"
"R-HSA-381042"	"PERK regulates gene expression"	"-1.065"	"0"	"1.065"	"0.943"
"R-HSA-164843"	"2-LTR circle formation"	"-1.071"	"0"	"1.132"	"1.057"
"R-HSA-166786"	"Creation of C4 and C2 activators"	"-1.071"	"0"	"1.117"	"1.043"
"WP4066"	"Interleukin-4 and 13 signaling"	"-1.072"	"0"	"1.152"	"1.074"
"R-HSA-8940973"	"RUNX2 regulates osteoblast differentiation"	"-1.072"	"2"	"4.081"	"1.942"
"hsa00620"	"Pyruvate metabolism"	"-1.073"	"1"	"2.813"	"1.689"
"R-HSA-2173791"	"TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"	"-1.077"	"6"	"8.951"	"2.74"
"R-HSA-5218900"	"CASP8 activity is inhibited"	"-1.082"	"0"	"1.116"	"1.031"
"R-HSA-69416"	"Dimerization of procaspase-8"	"-1.082"	"0"	"1.116"	"1.031"
"R-HSA-3371378"	"Regulation by c-FLIP"	"-1.082"	"0"	"1.116"	"1.031"
"R-HSA-5675482"	"Regulation of necroptotic cell death"	"-1.082"	"0"	"1.116"	"1.031"
"R-HSA-2428924"	"IGF1R signaling cascade"	"-1.083"	"3"	"5.43"	"2.244"
"R-HSA-6805567"	"Keratinization"	"-1.083"	"1"	"2.772"	"1.636"
"R-HSA-2404192"	"Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)"	"-1.083"	"3"	"5.43"	"2.244"
"R-HSA-9020956"	"Interleukin-27 signaling"	"-1.087"	"0"	"1.137"	"1.046"
"R-HSA-390471"	"Association of TriC/CCT with target proteins during biosynthesis"	"-1.097"	"6"	"9.143"	"2.866"
"R-HSA-5210891"	"Uptake and function of anthrax toxins"	"-1.1"	"0"	"1.146"	"1.042"
"R-HSA-205043"	"NRIF signals cell death from the nucleus"	"-1.106"	"6"	"9.037"	"2.745"
"R-HSA-196757"	"Metabolism of folate and pterines"	"-1.111"	"0"	"1.111"	"0.99"
"R-HSA-5357956"	"TNFR1-induced NFkappaB signaling pathway"	"-1.115"	"2"	"4.245"	"2.014"
"R-HSA-198693"	"AKT phosphorylates targets in the nucleus"	"-1.118"	"0"	"1.291"	"1.155"
"R-HSA-174154"	"APC/C:Cdc20 mediated degradation of Securin"	"-1.119"	"6"	"9.247"	"2.901"
"R-HSA-71336"	"Pentose phosphate pathway (hexose monophosphate shunt)"	"-1.12"	"0"	"1.289"	"1.151"
"R-HSA-71403"	"Citric acid cycle (TCA cycle)"	"-1.124"	"2"	"4.148"	"1.911"
"R-HSA-937042"	"IRAK2 mediated activation of TAK1 complex"	"-1.124"	"0"	"1.124"	"0.986"
"R-HSA-975163"	"IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation"	"-1.124"	"0"	"1.124"	"0.986"
"R-HSA-429958"	"mRNA decay by 3, to 5, exoribonuclease"	"-1.124"	"0"	"1.355"	"1.206"
"R-HSA-418990"	"Adherens junctions interactions"	"-1.125"	"0"	"1.273"	"1.131"
"R-HSA-446652"	"Interleukin-1 family signaling"	"-1.127"	"13"	"17.269"	"3.789"
"R-HSA-450321"	"JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1"	"-1.132"	"1"	"2.805"	"1.594"
"R-HSA-389357"	"CD28 dependent PI3K/Akt signaling"	"-1.133"	"1"	"2.829"	"1.614"
"R-HSA-110320"	"Translesion Synthesis by POLH"	"-1.134"	"8"	"11.647"	"3.217"
"R-HSA-442729"	"CREB phosphorylation through the activation of CaMKII"	"-1.135"	"1"	"2.861"	"1.639"
"R-HSA-446205"	"Synthesis of GDP-mannose"	"-1.138"	"0"	"1.166"	"1.024"
"R-HSA-168927"	"TICAM1, RIP1-mediated IKK complex recruitment "	"-1.142"	"7"	"10.43"	"3.004"
"R-HSA-210991"	"Basigin interactions"	"-1.144"	"0"	"1.252"	"1.094"
"R-HSA-450341"	"Activation of the AP-1 family of transcription factors"	"-1.148"	"2"	"4.16"	"1.881"
"R-HSA-5690714"	"CD22 mediated BCR regulation"	"-1.148"	"0"	"1.327"	"1.156"
"R-HSA-2022928"	"HS-GAG biosynthesis"	"-1.148"	"0"	"1.364"	"1.188"
"R-HSA-202040"	"G-protein activation"	"-1.149"	"2"	"4.235"	"1.945"
"R-HSA-9014325"	"TICAM1,TRAF6-dependent induction of TAK1 complex"	"-1.149"	"0"	"1.155"	"1.005"
"R-HSA-110312"	"Translesion synthesis by REV1"	"-1.15"	"7"	"10.534"	"3.073"
"R-HSA-69017"	"CDK-mediated phosphorylation and removal of Cdc6"	"-1.152"	"7"	"10.522"	"3.056"
"R-HSA-877312"	"Regulation of IFNG signaling"	"-1.153"	"1"	"2.831"	"1.588"
"R-HSA-165054"	"Rev-mediated nuclear export of HIV RNA"	"-1.154"	"5"	"8.102"	"2.687"
"R-HSA-5656121"	"Translesion synthesis by POLI"	"-1.158"	"7"	"10.564"	"3.077"
"R-HSA-5685939"	"HDR through MMEJ (alt-NHEJ)"	"-1.16"	"0"	"1.248"	"1.076"
"R-HSA-6802948"	"Signaling by high-kinase activity BRAF mutants"	"-1.16"	"4"	"6.789"	"2.405"
"R-HSA-3304349"	"Loss of Function of SMAD2/3 in Cancer"	"-1.167"	"0"	"1.279"	"1.096"
"R-HSA-3315487"	"SMAD2/3 MH2 Domain Mutants in Cancer"	"-1.167"	"0"	"1.279"	"1.096"
"R-HSA-3304356"	"SMAD2/3 Phosphorylation Motif Mutants in Cancer"	"-1.167"	"0"	"1.279"	"1.096"
"R-HSA-2485179"	"Activation of the phototransduction cascade"	"-1.168"	"0"	"1.283"	"1.098"
"R-HSA-5693548"	"Sensing of DNA Double Strand Breaks"	"-1.168"	"0"	"1.337"	"1.145"
"R-HSA-382556"	"ABC-family proteins mediated transport"	"-1.169"	"7"	"10.524"	"3.014"
"R-HSA-6794362"	"Protein-protein interactions at synapses"	"-1.169"	"2"	"4.559"	"2.19"
"R-HSA-179812"	"GRB2 events in EGFR signaling"	"-1.17"	"1"	"2.847"	"1.579"
"R-HSA-2586552"	"Signaling by Leptin"	"-1.17"	"0"	"1.356"	"1.159"
"R-HSA-196071"	"Metabolism of steroid hormones"	"-1.171"	"0"	"1.282"	"1.094"
"R-HSA-917937"	"Iron uptake and transport"	"-1.172"	"11"	"15.276"	"3.649"
"R-HSA-442982"	"Ras activation upon Ca2+ influx through NMDA receptor"	"-1.176"	"1"	"2.967"	"1.673"
"R-HSA-5655862"	"Translesion synthesis by POLK"	"-1.181"	"7"	"10.646"	"3.088"
"R-HSA-1793185"	"Chondroitin sulfate/dermatan sulfate metabolism"	"-1.182"	"0"	"1.455"	"1.231"
"R-HSA-390696"	"Adrenoceptors"	"-1.188"	"0"	"1.388"	"1.168"
"WP2773"	"Degradation of beta-catenin by the destruction complex"	"-1.192"	"12"	"16.561"	"3.827"
"R-HSA-937041"	"IKK complex recruitment mediated by RIP1"	"-1.195"	"7"	"10.641"	"3.046"
"R-HSA-2025928"	"Calcineurin activates NFAT"	"-1.196"	"0"	"1.344"	"1.124"
"R-HSA-140534"	"Ligand-dependent caspase activation"	"-1.196"	"0"	"1.371"	"1.147"
"R-HSA-376172"	"DSCAM interactions"	"-1.199"	"0"	"1.373"	"1.145"
"R-HSA-8874081"	"MET activates PTK2 signaling"	"-1.199"	"0"	"1.4"	"1.168"
"R-HSA-201688"	"WNT mediated activation of DVL"	"-1.199"	"1"	"2.991"	"1.661"
"R-HSA-1502540"	"Signaling by Activin"	"-1.203"	"0"	"1.29"	"1.072"
"R-HSA-399997"	"Acetylcholine regulates insulin secretion"	"-1.207"	"0"	"1.279"	"1.059"
"R-HSA-399955"	"SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion"	"-1.214"	"0"	"1.296"	"1.067"
"R-HSA-351202"	"Metabolism of polyamines"	"-1.215"	"0"	"1.395"	"1.148"
"R-HSA-5674135"	"MAP2K and MAPK activation"	"-1.217"	"4"	"6.947"	"2.421"
"R-HSA-73817"	"Purine ribonucleoside monophosphate biosynthesis"	"-1.218"	"0"	"1.391"	"1.142"
"R-HSA-912694"	"Regulation of IFNA signaling"	"-1.219"	"0"	"1.443"	"1.184"
"R-HSA-5205647"	"Mitophagy"	"-1.22"	"8"	"11.862"	"3.165"
"R-HSA-8941856"	"RUNX3 regulates NOTCH signaling"	"-1.22"	"1"	"2.949"	"1.597"
"R-HSA-5675221"	"Negative regulation of MAPK pathway"	"-1.223"	"10"	"14.191"	"3.427"
"R-HSA-203927"	"MicroRNA (miRNA) biogenesis"	"-1.225"	"0"	"1.427"	"1.165"
"R-HSA-2980766"	"Nuclear Envelope Breakdown"	"-1.225"	"5"	"8.591"	"2.932"
"R-HSA-170822"	"Regulation of Glucokinase by Glucokinase Regulatory Protein"	"-1.226"	"3"	"5.825"	"2.304"
"WP2797"	"Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)"	"-1.227"	"1"	"3.11"	"1.72"
"R-HSA-2179392"	"EGFR Transactivation by Gastrin"	"-1.231"	"1"	"3.022"	"1.642"
"R-HSA-450302"	"activated TAK1 mediates p38 MAPK activation"	"-1.237"	"1"	"3.034"	"1.645"
"R-HSA-69200"	"Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes"	"-1.238"	"0"	"1.434"	"1.158"
"R-HSA-1181150"	"Signaling by NODAL"	"-1.241"	"0"	"1.443"	"1.163"
"R-HSA-1362277"	"Transcription of E2F targets under negative control by DREAM complex"	"-1.247"	"1"	"3.192"	"1.758"
"R-HSA-428930"	"Thromboxane signalling through TP receptor"	"-1.25"	"1"	"3.129"	"1.703"
"R-HSA-3304351"	"Signaling by TGF-beta Receptor Complex in Cancer"	"-1.251"	"0"	"1.492"	"1.193"
"R-HSA-937072"	"TRAF6-mediated induction of TAK1 complex within TLR4 complex"	"-1.251"	"0"	"1.366"	"1.092"
"R-HSA-5607763"	"CLEC7A (Dectin-1) induces NFAT activation"	"-1.252"	"0"	"1.506"	"1.203"
"R-HSA-379726"	"Mitochondrial tRNA aminoacylation"	"-1.255"	"0"	"1.553"	"1.237"
"R-HSA-170670"	"Adenylate cyclase inhibitory pathway"	"-1.257"	"0"	"1.545"	"1.229"
"R-HSA-446353"	"Cell-extracellular matrix interactions"	"-1.257"	"0"	"1.577"	"1.254"
"R-HSA-997269"	"Inhibition of adenylate cyclase pathway"	"-1.257"	"0"	"1.545"	"1.229"
"R-HSA-6804757"	"Regulation of TP53 Degradation"	"-1.257"	"11"	"15.685"	"3.726"
"WP2786"	"Pre-NOTCH Expression and Processing"	"-1.258"	"4"	"7.1"	"2.465"
"R-HSA-975110"	"TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling"	"-1.258"	"0"	"1.409"	"1.12"
"WP3807"	"Regulation of TP53 Expression and Degradation"	"-1.26"	"11"	"15.7"	"3.73"
"R-HSA-75893"	"TNF signaling"	"-1.263"	"2"	"4.716"	"2.15"
"R-HSA-451308"	"Activation of Ca-permeable Kainate Receptor"	"-1.271"	"0"	"1.558"	"1.226"
"R-HSA-451306"	"Ionotropic activity of kainate receptors"	"-1.271"	"0"	"1.558"	"1.226"
"R-HSA-5621480"	"Dectin-2 family"	"-1.272"	"0"	"1.578"	"1.241"
"R-HSA-6802949"	"Signaling by RAS mutants"	"-1.277"	"4"	"7.164"	"2.478"
"R-HSA-164944"	"Nef and signal transduction"	"-1.278"	"0"	"1.54"	"1.205"
"R-HSA-8865999"	"MET activates PTPN11"	"-1.279"	"0"	"1.381"	"1.079"
"R-HSA-399956"	"CRMPs in Sema3A signaling"	"-1.281"	"0"	"1.448"	"1.131"
"R-HSA-3000178"	"ECM proteoglycans"	"-1.281"	"0"	"1.582"	"1.235"
"R-HSA-203765"	"eNOS activation and regulation"	"-1.283"	"1"	"3.226"	"1.735"
"R-HSA-202131"	"Metabolism of nitric oxide"	"-1.283"	"1"	"3.226"	"1.735"
"R-HSA-418885"	"DCC mediated attractive signaling"	"-1.285"	"1"	"3.2"	"1.712"
"R-HSA-8849470"	"PTK6 Regulates Cell Cycle"	"-1.287"	"0"	"1.478"	"1.148"
"R-HSA-209560"	"NF-kB is activated and signals survival"	"-1.289"	"6"	"9.592"	"2.786"
"R-HSA-70895"	"Branched-chain amino acid catabolism"	"-1.29"	"0"	"1.671"	"1.296"
"R-HSA-6804116"	"TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest"	"-1.29"	"1"	"3.121"	"1.645"
"R-HSA-1638091"	"Heparan sulfate/heparin (HS-GAG) metabolism"	"-1.292"	"0"	"1.728"	"1.337"
"R-HSA-8983432"	"Interleukin-15 signaling"	"-1.3"	"0"	"1.454"	"1.119"
"R-HSA-112411"	"MAPK1 (ERK2) activation"	"-1.301"	"0"	"1.516"	"1.165"
"R-HSA-180336"	"SHC1 events in EGFR signaling"	"-1.306"	"1"	"3.17"	"1.661"
"R-HSA-193670"	"p75NTR negatively regulates cell cycle via SC1"	"-1.307"	"0"	"1.548"	"1.185"
"R-HSA-2894862"	"Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"	"-1.308"	"11"	"15.939"	"3.775"
"R-HSA-2644606"	"Constitutive Signaling by NOTCH1 PEST Domain Mutants"	"-1.308"	"11"	"15.939"	"3.775"
"R-HSA-2029481"	"FCGR activation"	"-1.308"	"0"	"1.615"	"1.235"
"R-HSA-2894858"	"Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer"	"-1.308"	"11"	"15.939"	"3.775"
"R-HSA-2644603"	"Signaling by NOTCH1 in Cancer"	"-1.308"	"11"	"15.939"	"3.775"
"R-HSA-2644602"	"Signaling by NOTCH1 PEST Domain Mutants in Cancer"	"-1.308"	"11"	"15.939"	"3.775"
"R-HSA-8875360"	"InlB-mediated entry of Listeria monocytogenes into host cell"	"-1.309"	"6"	"9.775"	"2.884"
"R-HSA-2408517"	"SeMet incorporation into proteins"	"-1.309"	"0"	"1.588"	"1.213"
"R-HSA-8948700"	"Competing endogenous RNAs (ceRNAs) regulate PTEN translation"	"-1.314"	"0"	"1.581"	"1.203"
"R-HSA-8943723"	"Regulation of PTEN mRNA translation"	"-1.314"	"0"	"1.581"	"1.203"
"R-HSA-6802955"	"Paradoxical activation of RAF signaling by kinase inactive BRAF"	"-1.317"	"4"	"7.276"	"2.487"
"R-HSA-6802946"	"Signaling by moderate kinase activity BRAF mutants"	"-1.317"	"4"	"7.276"	"2.487"
"R-HSA-1059683"	"Interleukin-6 signaling"	"-1.318"	"0"	"1.692"	"1.284"
"R-HSA-8866907"	"Activation of the TFAP2 (AP-2) family of transcription factors"	"-1.324"	"0"	"1.649"	"1.246"
"R-HSA-72306"	"tRNA processing"	"-1.324"	"5"	"8.679"	"2.778"
"R-HSA-5673000"	"RAF activation"	"-1.325"	"3"	"6.111"	"2.348"
"R-HSA-400042"	"Adrenaline,noradrenaline inhibits insulin secretion"	"-1.326"	"1"	"3.267"	"1.71"
"R-HSA-417957"	"P2Y receptors"	"-1.326"	"0"	"1.863"	"1.405"
"WP3308"	"Oncogene Induced Senescence"	"-1.328"	"9"	"13.557"	"3.432"
"R-HSA-3134973"	"LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production"	"-1.339"	"0"	"1.627"	"1.215"
"R-HSA-2559584"	"Formation of Senescence-Associated Heterochromatin Foci (SAHF)"	"-1.34"	"1"	"3.318"	"1.73"
"R-HSA-112399"	"IRS-mediated signalling"	"-1.34"	"2"	"4.888"	"2.155"
"R-HSA-2151209"	"Activation of PPARGC1A (PGC-1alpha) by phosphorylation"	"-1.343"	"0"	"1.702"	"1.268"
"R-HSA-447115"	"Interleukin-12 family signaling"	"-1.343"	"0"	"1.706"	"1.27"
"R-HSA-8951936"	"RUNX3 regulates p14-ARF"	"-1.344"	"0"	"1.637"	"1.218"
"R-HSA-6783589"	"Interleukin-6 family signaling"	"-1.345"	"0"	"1.744"	"1.296"
"R-HSA-3928664"	"Ephrin signaling"	"-1.348"	"1"	"3.361"	"1.752"
"R-HSA-193648"	"NRAGE signals death through JNK"	"-1.349"	"1"	"3.356"	"1.747"
"R-HSA-909733"	"Interferon alpha/beta signaling"	"-1.354"	"1"	"3.485"	"1.835"
"R-HSA-2470946"	"Cohesin Loading onto Chromatin"	"-1.356"	"0"	"1.804"	"1.33"
"R-HSA-1963640"	"GRB2 events in ERBB2 signaling"	"-1.358"	"1"	"3.389"	"1.759"
"R-HSA-193692"	"Regulated proteolysis of p75NTR"	"-1.37"	"0"	"1.729"	"1.262"
"R-HSA-68867"	"Assembly of the pre-replicative complex"	"-1.373"	"6"	"9.996"	"2.911"
"R-HSA-418592"	"ADP signalling through P2Y purinoceptor 1"	"-1.375"	"1"	"3.456"	"1.786"
"R-HSA-1963642"	"PI3K events in ERBB2 signaling"	"-1.376"	"1"	"3.303"	"1.673"
"WP3382"	"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation"	"-1.381"	"0"	"1.77"	"1.282"
"R-HSA-193639"	"p75NTR signals via NF-kB"	"-1.382"	"6"	"9.885"	"2.81"
"R-HSA-195258"	"RHO GTPase Effectors"	"-1.383"	"50"	"60.381"	"7.508"
"R-HSA-421270"	"Cell-cell junction organization"	"-1.392"	"0"	"1.805"	"1.296"
"R-HSA-6807004"	"Negative regulation of MET activity"	"-1.392"	"6"	"10.098"	"2.944"
"R-HSA-390666"	"Serotonin receptors"	"-1.394"	"0"	"1.736"	"1.246"
"R-HSA-419408"	"Lysosphingolipid and LPA receptors"	"-1.399"	"0"	"1.885"	"1.347"
"R-HSA-162592"	"Integration of provirus"	"-1.4"	"0"	"1.97"	"1.408"
"R-HSA-512988"	"Interleukin-3, 5 and GM-CSF signaling"	"-1.401"	"4"	"7.725"	"2.658"
"R-HSA-72731"	"Recycling of eIF2:GDP"	"-1.404"	"0"	"1.806"	"1.286"
"R-HSA-5693554"	"Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)"	"-1.404"	"1"	"3.521"	"1.796"
"R-HSA-163841"	"Gamma carboxylation, hypusine formation and arylsulfatase activation"	"-1.405"	"0"	"1.825"	"1.298"
"R-HSA-5357905"	"Regulation of TNFR1 signaling"	"-1.407"	"1"	"3.66"	"1.89"
"R-HSA-202430"	"Translocation of ZAP-70 to Immunological synapse"	"-1.409"	"0"	"1.932"	"1.372"
"R-HSA-3270619"	"IRF3-mediated induction of type I IFN"	"-1.42"	"0"	"1.832"	"1.29"
"R-HSA-209543"	"p75NTR recruits signalling complexes"	"-1.423"	"0"	"1.803"	"1.267"
"R-HSA-70221"	"Glycogen breakdown (glycogenolysis)"	"-1.426"	"0"	"2.026"	"1.42"
"R-HSA-5696397"	"Gap-filling DNA repair synthesis and ligation in GG-NER"	"-1.429"	"7"	"11.59"	"3.212"
"R-HSA-5696399"	"Global Genome Nucleotide Excision Repair (GG-NER)"	"-1.43"	"20"	"27.077"	"4.948"
"R-HSA-5218859"	"Regulated Necrosis"	"-1.432"	"0"	"1.836"	"1.282"
"R-HSA-5213460"	"RIPK1-mediated regulated necrosis"	"-1.432"	"0"	"1.836"	"1.282"
"R-HSA-428540"	"Activation of RAC1"	"-1.434"	"0"	"1.935"	"1.349"
"R-HSA-167044"	"Signalling to RAS"	"-1.438"	"2"	"4.996"	"2.083"
"R-HSA-450604"	"KSRP (KHSRP) binds and destabilizes mRNA"	"-1.44"	"0"	"2.065"	"1.434"
"R-HSA-392170"	"ADP signalling through P2Y purinoceptor 12"	"-1.441"	"1"	"3.63"	"1.825"
"R-HSA-8851907"	"MET activates PI3K/AKT signaling"	"-1.446"	"0"	"1.695"	"1.172"
"R-HSA-391903"	"Eicosanoid ligand-binding receptors"	"-1.451"	"0"	"2.01"	"1.386"
"R-HSA-194840"	"Rho GTPase cycle"	"-1.454"	"4"	"8.07"	"2.799"
"R-HSA-418886"	"Netrin mediated repulsion signals"	"-1.455"	"0"	"1.915"	"1.316"
"R-HSA-180786"	"Extension of Telomeres"	"-1.458"	"3"	"6.574"	"2.452"
"R-HSA-5607764"	"CLEC7A (Dectin-1) signaling"	"-1.462"	"4"	"7.846"	"2.63"
"R-HSA-982772"	"Growth hormone receptor signaling"	"-1.462"	"0"	"2.081"	"1.424"
"R-HSA-171007"	"p38MAPK events"	"-1.466"	"0"	"1.964"	"1.34"
"R-HSA-202427"	"Phosphorylation of CD3 and TCR zeta chains"	"-1.468"	"0"	"2.129"	"1.45"
"R-HSA-68911"	"G2 Phase"	"-1.475"	"0"	"1.782"	"1.208"
"R-HSA-71406"	"Pyruvate metabolism and Citric Acid (TCA) cycle"	"-1.482"	"3"	"6.573"	"2.411"
"R-HSA-881907"	"Gastrin-CREB signalling pathway via PKC and MAPK"	"-1.485"	"2"	"5.101"	"2.089"
"R-HSA-112412"	"SOS-mediated signalling"	"-1.485"	"0"	"2.023"	"1.362"
"R-HSA-15869"	"Metabolism of nucleotides"	"-1.486"	"3"	"6.637"	"2.448"
"R-HSA-2173789"	"TGF-beta receptor signaling activates SMADs"	"-1.486"	"10"	"15.356"	"3.605"
"R-HSA-176974"	"Unwinding of DNA"	"-1.486"	"0"	"2.283"	"1.536"
"R-HSA-8939243"	"RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known"	"-1.487"	"3"	"6.793"	"2.551"
"R-HSA-110314"	"Recognition of DNA damage by PCNA-containing replication complex"	"-1.49"	"8"	"13.071"	"3.403"
"R-HSA-3928665"	"EPH-ephrin mediated repulsion of cells"	"-1.492"	"0"	"2.012"	"1.348"
"R-HSA-8953750"	"Transcriptional Regulation by E2F6"	"-1.493"	"4"	"8.149"	"2.779"
"WP3333"	"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"	"-1.494"	"0"	"2.052"	"1.374"
"R-HSA-8939902"	"Regulation of RUNX2 expression and activity"	"-1.494"	"7"	"11.815"	"3.223"
"R-HSA-379716"	"Cytosolic tRNA aminoacylation"	"-1.496"	"1"	"3.872"	"1.919"
"R-HSA-8876384"	"Listeria monocytogenes entry into host cells"	"-1.496"	"6"	"10.58"	"3.063"
"R-HSA-168928"	"DDX58/IFIH1-mediated induction of interferon-alpha/beta"	"-1.497"	"5"	"9.65"	"3.106"
"R-HSA-8875555"	"MET activates RAP1 and RAC1"	"-1.502"	"0"	"1.944"	"1.294"
"R-HSA-182971"	"EGFR downregulation"	"-1.503"	"7"	"11.778"	"3.179"
"R-HSA-1834941"	"STING mediated induction of host immune responses"	"-1.508"	"0"	"2.05"	"1.359"
"R-HSA-1168372"	"Downstream signaling events of B Cell Receptor (BCR)"	"-1.51"	"3"	"6.432"	"2.272"
"R-HSA-420092"	"Glucagon-type ligand receptors"	"-1.516"	"1"	"3.877"	"1.898"
"R-HSA-5685938"	"HDR through Single Strand Annealing (SSA)"	"-1.517"	"3"	"6.875"	"2.555"
"R-HSA-68875"	"Mitotic Prophase"	"-1.519"	"22"	"29.783"	"5.123"
"R-HSA-168254"	"Influenza Infection"	"-1.522"	"14"	"20.755"	"4.437"
"R-HSA-180292"	"GAB1 signalosome"	"-1.525"	"1"	"3.776"	"1.82"
"R-HSA-113510"	"E2F mediated regulation of DNA replication"	"-1.53"	"2"	"5.165"	"2.069"
"R-HSA-418038"	"Nucleotide-like (purinergic) receptors"	"-1.532"	"0"	"2.383"	"1.555"
"R-HSA-8869496"	"TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation"	"-1.537"	"0"	"2.137"	"1.391"
"R-HSA-1834949"	"Cytosolic sensors of pathogen-associated DNA "	"-1.539"	"10"	"15.611"	"3.645"
"R-HSA-201451"	"Signaling by BMP"	"-1.539"	"0"	"2.138"	"1.39"
"R-HSA-9026519"	"Activated NTRK2 signals through RAS"	"-1.542"	"0"	"2.163"	"1.402"
"R-HSA-69473"	"G2/M DNA damage checkpoint"	"-1.543"	"17"	"24.149"	"4.634"
"R-HSA-8863795"	"Downregulation of ERBB2 signaling"	"-1.547"	"7"	"11.902"	"3.169"
"R-HSA-187577"	"SCF(Skp2)-mediated degradation of p27/p21"	"-1.552"	"6"	"10.737"	"3.053"
"R-HSA-6783310"	"Fanconi Anemia Pathway"	"-1.554"	"6"	"10.741"	"3.05"
"R-HSA-177243"	"Interactions of Rev with host cellular proteins"	"-1.555"	"5"	"9.457"	"2.866"
"WP3331"	"Mitochondrial biogenesis"	"-1.557"	"1"	"3.968"	"1.906"
"R-HSA-210990"	"PECAM1 interactions"	"-1.56"	"0"	"2.462"	"1.578"
"R-HSA-1912408"	"Pre-NOTCH Transcription and Translation"	"-1.561"	"3"	"6.797"	"2.433"
"R-HSA-5693568"	"Resolution of D-loop Structures through Holliday Junction Intermediates"	"-1.561"	"1"	"4.015"	"1.931"
"R-HSA-1483191"	"Synthesis of PC"	"-1.564"	"0"	"2.326"	"1.487"
"R-HSA-202670"	"ERKs are inactivated"	"-1.566"	"1"	"3.823"	"1.803"
"R-HSA-991365"	"Activation of GABAB receptors"	"-1.571"	"1"	"4.092"	"1.969"
"R-HSA-977444"	"GABA B receptor activation"	"-1.571"	"1"	"4.092"	"1.969"
"R-HSA-1538133"	"G0 and Early G1"	"-1.581"	"2"	"5.741"	"2.366"
"R-HSA-168255"	"Influenza Life Cycle"	"-1.581"	"12"	"18.725"	"4.253"
"R-HSA-5693537"	"Resolution of D-Loop Structures"	"-1.581"	"1"	"4.062"	"1.937"
"R-HSA-389948"	"PD-1 signaling"	"-1.583"	"0"	"2.48"	"1.567"
"R-HSA-5656169"	"Termination of translesion DNA synthesis"	"-1.584"	"7"	"12.241"	"3.308"
"R-HSA-2428933"	"SHC-related events triggered by IGF1R"	"-1.587"	"0"	"2.247"	"1.416"
"R-HSA-451326"	"Activation of kainate receptors upon glutamate binding"	"-1.59"	"1"	"4.132"	"1.97"
"R-HSA-432142"	"Platelet sensitization by LDL"	"-1.592"	"1"	"4.061"	"1.923"
"R-HSA-2871837"	"FCERI mediated NF-kB activation"	"-1.593"	"1"	"3.927"	"1.837"
"R-HSA-194315"	"Signaling by Rho GTPases"	"-1.599"	"54"	"66.406"	"7.759"
"R-HSA-8849471"	"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases"	"-1.6"	"0"	"2.412"	"1.507"
"R-HSA-5627117"	"RHO GTPases Activate ROCKs"	"-1.601"	"1"	"4.02"	"1.886"
"R-HSA-110313"	"Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template"	"-1.608"	"8"	"13.623"	"3.498"
"R-HSA-445144"	"Signal transduction by L1"	"-1.612"	"2"	"5.712"	"2.303"
"R-HSA-1250347"	"SHC1 events in ERBB4 signaling"	"-1.614"	"0"	"2.383"	"1.477"
"R-HSA-8851805"	"MET activates RAS signaling"	"-1.615"	"0"	"2.418"	"1.497"
"R-HSA-1251985"	"Nuclear signaling by ERBB4"	"-1.618"	"0"	"2.521"	"1.558"
"R-HSA-2995383"	"Initiation of Nuclear Envelope Reformation"	"-1.619"	"0"	"2.44"	"1.507"
"R-HSA-2995410"	"Nuclear Envelope Reassembly"	"-1.619"	"0"	"2.44"	"1.507"
"R-HSA-977443"	"GABA receptor activation"	"-1.62"	"1"	"4.238"	"1.999"
"R-HSA-163767"	"PP2A-mediated dephosphorylation of key metabolic factors"	"-1.62"	"0"	"2.292"	"1.415"
"R-HSA-390450"	"Folding of actin by CCT/TriC"	"-1.625"	"2"	"5.483"	"2.144"
"R-HSA-2122947"	"NOTCH1 Intracellular Domain Regulates Transcription"	"-1.625"	"11"	"17.475"	"3.986"
"R-HSA-174437"	"Removal of the Flap Intermediate from the C-strand"	"-1.63"	"0"	"2.58"	"1.583"
"R-HSA-2173795"	"Downregulation of SMAD2/3:SMAD4 transcriptional activity"	"-1.632"	"6"	"10.917"	"3.012"
"R-HSA-69202"	"Cyclin E associated events during G1/S transition "	"-1.641"	"9"	"14.813"	"3.543"
"R-HSA-430039"	"mRNA decay by 5, to 3, exoribonuclease"	"-1.641"	"0"	"2.669"	"1.626"
"R-HSA-168276"	"NS1 Mediated Effects on Host Pathways"	"-1.641"	"0"	"2.397"	"1.461"
"R-HSA-4615885"	"SUMOylation of DNA replication proteins"	"-1.641"	"6"	"11.295"	"3.227"
"R-HSA-4086398"	"Ca2+ pathway"	"-1.644"	"3"	"7.215"	"2.565"
"R-HSA-69186"	"Lagging Strand Synthesis"	"-1.65"	"1"	"4.293"	"1.996"
"R-HSA-6784531"	"tRNA processing in the nucleus"	"-1.653"	"3"	"7.196"	"2.539"
"R-HSA-5654710"	"PI-3K cascade:FGFR3"	"-1.656"	"0"	"2.438"	"1.472"
"R-HSA-429914"	"Deadenylation-dependent mRNA decay"	"-1.659"	"4"	"8.916"	"2.964"
"R-HSA-5654720"	"PI-3K cascade:FGFR4"	"-1.662"	"0"	"2.486"	"1.496"
"R-HSA-5651801"	"PCNA-Dependent Long Patch Base Excision Repair"	"-1.663"	"1"	"4.325"	"1.999"
"R-HSA-174414"	"Processive synthesis on the C-strand of the telomere"	"-1.67"	"0"	"2.681"	"1.606"
"R-HSA-5654712"	"FRS-mediated FGFR4 signaling"	"-1.671"	"0"	"2.763"	"1.653"
"R-HSA-5654704"	"SHC-mediated cascade:FGFR3"	"-1.672"	"0"	"2.653"	"1.587"
"R-HSA-5654719"	"SHC-mediated cascade:FGFR4"	"-1.672"	"0"	"2.701"	"1.616"
"R-HSA-5654706"	"FRS-mediated FGFR3 signaling"	"-1.673"	"0"	"2.715"	"1.623"
"R-HSA-196299"	"Beta-catenin phosphorylation cascade"	"-1.677"	"1"	"4.455"	"2.06"
"R-HSA-5654689"	"PI-3K cascade:FGFR1"	"-1.677"	"0"	"2.627"	"1.567"
"R-HSA-5654695"	"PI-3K cascade:FGFR2"	"-1.681"	"0"	"2.615"	"1.556"
"R-HSA-8982491"	"Glycogen metabolism"	"-1.684"	"0"	"2.759"	"1.638"
"R-HSA-451927"	"Interleukin-2 family signaling"	"-1.687"	"1"	"4.408"	"2.02"
"R-HSA-77595"	"Processing of Intronless Pre-mRNAs"	"-1.692"	"1"	"4.419"	"2.021"
"R-HSA-2514859"	"Inactivation, recovery and regulation of the phototransduction cascade"	"-1.693"	"0"	"2.708"	"1.599"
"R-HSA-2514856"	"The phototransduction cascade"	"-1.693"	"0"	"2.711"	"1.601"
"R-HSA-5654688"	"SHC-mediated cascade:FGFR1"	"-1.698"	"0"	"2.842"	"1.674"
"R-HSA-162594"	"Early Phase of HIV Life Cycle"	"-1.699"	"0"	"2.725"	"1.604"
"WP4107"	"Transcriptional regulation by RUNX3"	"-1.699"	"11"	"17.729"	"3.961"
"R-HSA-5654693"	"FRS-mediated FGFR1 signaling"	"-1.702"	"0"	"2.904"	"1.706"
"R-HSA-8948751"	"Regulation of PTEN stability and activity"	"-1.709"	"6"	"11.358"	"3.136"
"R-HSA-203615"	"eNOS activation"	"-1.71"	"0"	"2.559"	"1.496"
"R-HSA-69656"	"Cyclin A:Cdk2-associated events at S phase entry"	"-1.712"	"7"	"12.762"	"3.366"
"R-HSA-372708"	"p130Cas linkage to MAPK signaling for integrins"	"-1.712"	"0"	"2.511"	"1.467"
"R-HSA-5625900"	"RHO GTPases activate CIT"	"-1.712"	"1"	"4.348"	"1.955"
"R-HSA-456926"	"Thrombin signalling through proteinase activated receptors (PARs)"	"-1.715"	"2"	"6.106"	"2.394"
"R-HSA-5654700"	"FRS-mediated FGFR2 signaling"	"-1.716"	"0"	"2.892"	"1.686"
"R-HSA-1295596"	"Spry regulation of FGF signaling"	"-1.724"	"6"	"11.109"	"2.964"
"R-HSA-8878166"	"Transcriptional regulation by RUNX2"	"-1.725"	"12"	"19.276"	"4.217"
"R-HSA-5654699"	"SHC-mediated cascade:FGFR2"	"-1.726"	"0"	"2.83"	"1.64"
"R-HSA-1474151"	"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation"	"-1.727"	"0"	"2.607"	"1.51"
"R-HSA-180910"	"Vpr-mediated nuclear import of PICs"	"-1.731"	"2"	"6.064"	"2.348"
"R-HSA-168138"	"Toll Like Receptor 9 (TLR9) Cascade"	"-1.733"	"16"	"23.917"	"4.568"
"R-HSA-442742"	"CREB phosphorylation through the activation of Ras"	"-1.741"	"1"	"4.477"	"1.997"
"R-HSA-69166"	"Removal of the Flap Intermediate"	"-1.752"	"0"	"2.973"	"1.697"
"R-HSA-8853334"	"Signaling by FGFR3 fusions in cancer"	"-1.754"	"0"	"2.611"	"1.489"
"R-HSA-194441"	"Metabolism of non-coding RNA"	"-1.757"	"4"	"9.259"	"2.993"
"R-HSA-1250196"	"SHC1 events in ERBB2 signaling"	"-1.757"	"1"	"4.519"	"2.003"
"R-HSA-191859"	"snRNP Assembly"	"-1.757"	"4"	"9.259"	"2.993"
"R-HSA-174417"	"Telomere C-strand (Lagging Strand) Synthesis"	"-1.763"	"1"	"4.713"	"2.105"
"R-HSA-5626467"	"RHO GTPases activate IQGAPs"	"-1.768"	"0"	"2.826"	"1.598"
"R-HSA-68949"	"Orc1 removal from chromatin"	"-1.772"	"7"	"12.9"	"3.33"
"R-HSA-69183"	"Processive synthesis on the lagging strand"	"-1.778"	"0"	"3.074"	"1.729"
"R-HSA-73893"	"DNA Damage Bypass"	"-1.782"	"9"	"15.538"	"3.668"
"R-HSA-198933"	"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"	"-1.783"	"1"	"4.686"	"2.067"
"WP2720"	"Signaling by NOTCH1"	"-1.787"	"12"	"19.497"	"4.195"
"R-HSA-110373"	"Resolution of AP sites via the multiple-nucleotide patch replacement pathway"	"-1.794"	"1"	"4.748"	"2.089"
"R-HSA-193704"	"p75 NTR receptor-mediated signalling"	"-1.796"	"10"	"16.8"	"3.787"
"R-HSA-606279"	"Deposition of new CENPA-containing nucleosomes at the centromere"	"-1.798"	"1"	"4.841"	"2.136"
"R-HSA-774815"	"Nucleosome assembly"	"-1.798"	"1"	"4.841"	"2.136"
"R-HSA-159227"	"Transport of the SLBP independent Mature mRNA"	"-1.804"	"3"	"7.827"	"2.676"
"R-HSA-159230"	"Transport of the SLBP Dependant Mature mRNA"	"-1.807"	"3"	"7.838"	"2.677"
"R-HSA-2173796"	"SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"	"-1.81"	"6"	"11.716"	"3.158"
"R-HSA-168638"	"NOD1/2 Signaling Pathway"	"-1.811"	"1"	"4.728"	"2.059"
"R-HSA-6799198"	"Complex I biogenesis"	"-1.814"	"0"	"3.418"	"1.884"
"R-HSA-2682334"	"EPH-Ephrin signaling"	"-1.818"	"7"	"13.355"	"3.496"
"WP2673"	"Interleukin-7 signaling"	"-1.822"	"0"	"2.952"	"1.621"
"R-HSA-8934593"	"Regulation of RUNX1 Expression and Activity"	"-1.822"	"0"	"3.144"	"1.726"
"R-HSA-379724"	"tRNA Aminoacylation"	"-1.823"	"1"	"4.876"	"2.126"
"R-HSA-3299685"	"Detoxification of Reactive Oxygen Species"	"-1.825"	"0"	"2.836"	"1.554"
"R-HSA-5655291"	"Signaling by FGFR4 in disease"	"-1.828"	"0"	"2.886"	"1.578"
"R-HSA-168271"	"Transport of Ribonucleoproteins into the Host Nucleus"	"-1.83"	"2"	"6.279"	"2.338"
"WP2751"	"Transcriptional regulation of white adipocyte differentiation"	"-1.832"	"2"	"6.602"	"2.512"
"R-HSA-5358606"	"Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)"	"-1.835"	"0"	"3.202"	"1.745"
"R-HSA-5693616"	"Presynaptic phase of homologous DNA pairing and strand exchange"	"-1.835"	"2"	"6.591"	"2.502"
"R-HSA-354194"	"GRB2:SOS provides linkage to MAPK signaling for Integrins "	"-1.842"	"0"	"3.155"	"1.713"
"R-HSA-373752"	"Netrin-1 signaling"	"-1.846"	"1"	"4.993"	"2.163"
"R-HSA-418597"	"G alpha (z) signalling events"	"-1.853"	"1"	"5.14"	"2.235"
"R-HSA-8978934"	"Metabolism of cofactors"	"-1.855"	"0"	"3.081"	"1.661"
"R-HSA-5358565"	"Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)"	"-1.858"	"0"	"3.248"	"1.749"
"R-HSA-392518"	"Signal amplification"	"-1.86"	"1"	"4.962"	"2.13"
"R-HSA-4420097"	"VEGFA-VEGFR2 Pathway"	"-1.86"	"8"	"14.982"	"3.754"
"R-HSA-933541"	"TRAF6 mediated IRF7 activation"	"-1.867"	"0"	"3.058"	"1.638"
"R-HSA-5218921"	"VEGFR2 mediated cell proliferation"	"-1.868"	"0"	"3.336"	"1.786"
"R-HSA-5654732"	"Negative regulation of FGFR3 signaling"	"-1.875"	"7"	"13.005"	"3.203"
"R-HSA-389359"	"CD28 dependent Vav1 pathway"	"-1.882"	"0"	"3.097"	"1.646"
"R-HSA-5693579"	"Homologous DNA Pairing and Strand Exchange"	"-1.885"	"2"	"6.827"	"2.56"
"R-HSA-194138"	"Signaling by VEGF"	"-1.885"	"8"	"15.094"	"3.764"
"R-HSA-5358508"	"Mismatch Repair"	"-1.889"	"0"	"3.353"	"1.775"
"R-HSA-399954"	"Sema3A PAK dependent Axon repulsion"	"-1.894"	"1"	"4.842"	"2.029"
"R-HSA-5654733"	"Negative regulation of FGFR4 signaling"	"-1.896"	"7"	"13.053"	"3.192"
"R-HSA-5654726"	"Negative regulation of FGFR1 signaling"	"-1.903"	"7"	"13.194"	"3.256"
"R-HSA-198753"	"ERK/MAPK targets"	"-1.904"	"1"	"4.872"	"2.034"
"R-HSA-416572"	"Sema4D induced cell migration and growth-cone collapse"	"-1.907"	"0"	"3.125"	"1.639"
"R-HSA-69481"	"G2/M Checkpoints"	"-1.908"	"19"	"28.581"	"5.021"
"R-HSA-6794361"	"Neurexins and neuroligins"	"-1.908"	"0"	"3.728"	"1.953"
"R-HSA-5654727"	"Negative regulation of FGFR2 signaling"	"-1.916"	"7"	"13.182"	"3.227"
"R-HSA-69052"	"Switching of origins to a post-replicative state"	"-1.921"	"8"	"14.94"	"3.613"
"R-HSA-5655332"	"Signaling by FGFR3 in disease"	"-1.922"	"0"	"3.376"	"1.757"
"R-HSA-8853338"	"Signaling by FGFR3 point mutants in cancer"	"-1.922"	"0"	"3.376"	"1.757"
"WP2821"	"Transcriptional regulation of pluripotent stem cells"	"-1.924"	"0"	"3.439"	"1.788"
"R-HSA-1839117"	"Signaling by cytosolic FGFR1 fusion mutants"	"-1.934"	"0"	"3.462"	"1.79"
"R-HSA-8875878"	"MET promotes cell motility"	"-1.939"	"0"	"3.233"	"1.668"
"R-HSA-198725"	"Nuclear Events (kinase and transcription factor activation)"	"-1.949"	"1"	"5.108"	"2.108"
"R-HSA-4641262"	"Disassembly of the destruction complex and recruitment of AXIN to the membrane"	"-1.952"	"1"	"5.375"	"2.242"
"R-HSA-3214841"	"PKMTs methylate histone lysines"	"-1.952"	"3"	"7.981"	"2.552"
"R-HSA-6804758"	"Regulation of TP53 Activity through Acetylation"	"-1.954"	"1"	"5.441"	"2.272"
"R-HSA-2029485"	"Role of phospholipids in phagocytosis"	"-1.954"	"0"	"3.635"	"1.86"
"R-HSA-446728"	"Cell junction organization"	"-1.958"	"0"	"3.777"	"1.929"
"R-HSA-5655253"	"Signaling by FGFR2 in disease"	"-1.959"	"0"	"3.553"	"1.813"
"R-HSA-3928663"	"EPHA-mediated growth cone collapse"	"-1.961"	"0"	"3.634"	"1.853"
"R-HSA-375170"	"CDO in myogenesis"	"-1.963"	"0"	"3.498"	"1.782"
"R-HSA-525793"	"Myogenesis"	"-1.963"	"0"	"3.498"	"1.782"
"R-HSA-210993"	"Tie2 Signaling"	"-1.965"	"0"	"3.464"	"1.763"
"R-HSA-912526"	"Interleukin receptor SHC signaling"	"-1.972"	"0"	"3.575"	"1.813"
"R-HSA-73884"	"Base Excision Repair"	"-1.973"	"1"	"5.289"	"2.174"
"R-HSA-73933"	"Resolution of Abasic Sites (AP sites)"	"-1.973"	"1"	"5.289"	"2.174"
"R-HSA-1433559"	"Regulation of KIT signaling"	"-1.976"	"0"	"3.598"	"1.821"
"R-HSA-73780"	"RNA Polymerase III Chain Elongation"	"-1.977"	"0"	"3.888"	"1.967"
"R-HSA-5696400"	"Dual Incision in GG-NER"	"-1.986"	"8"	"15.202"	"3.626"
"R-HSA-3214842"	"HDMs demethylate histones"	"-1.986"	"0"	"3.44"	"1.732"
"R-HSA-499943"	"Interconversion of nucleotide di- and triphosphates"	"-1.995"	"0"	"3.653"	"1.831"
"R-HSA-2029482"	"Regulation of actin dynamics for phagocytic cup formation"	"-2.005"	"8"	"15.369"	"3.675"
"R-HSA-73980"	"RNA Polymerase III Transcription Termination"	"-2.005"	"0"	"4.034"	"2.012"
"R-HSA-5368286"	"Mitochondrial translation initiation"	"-2.033"	"3"	"8.865"	"2.884"
"R-HSA-1169410"	"Antiviral mechanism by IFN-stimulated genes"	"-2.036"	"1"	"6.103"	"2.506"
"R-HSA-1169408"	"ISG15 antiviral mechanism"	"-2.036"	"1"	"6.103"	"2.506"
"R-HSA-168643"	"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways"	"-2.038"	"2"	"7.009"	"2.458"
"R-HSA-216083"	"Integrin cell surface interactions"	"-2.045"	"0"	"3.705"	"1.811"
"R-HSA-5689901"	"Metalloprotease DUBs"	"-2.047"	"8"	"15.743"	"3.783"
"R-HSA-5419276"	"Mitochondrial translation termination"	"-2.048"	"3"	"8.963"	"2.911"
"R-HSA-202433"	"Generation of second messenger molecules"	"-2.051"	"0"	"3.89"	"1.896"
"R-HSA-5627123"	"RHO GTPases activate PAKs"	"-2.057"	"1"	"5.5"	"2.188"
"R-HSA-162906"	"HIV Infection"	"-2.065"	"33"	"46.593"	"6.583"
"R-HSA-877300"	"Interferon gamma signaling"	"-2.069"	"2"	"7.261"	"2.543"
"SMP00040"	"Glycolysis"	"-2.074"	"10"	"18.188"	"3.948"
"R-HSA-912631"	"Regulation of signaling by CBL"	"-2.074"	"0"	"4.172"	"2.012"
"R-HSA-9006927"	"Signaling by Non-Receptor Tyrosine Kinases"	"-2.074"	"8"	"15.623"	"3.675"
"WP3826"	"Signaling by PTK6"	"-2.074"	"8"	"15.623"	"3.675"
"R-HSA-4570464"	"SUMOylation of RNA binding proteins"	"-2.074"	"5"	"11.759"	"3.26"
"R-HSA-5389840"	"Mitochondrial translation elongation"	"-2.078"	"3"	"9.11"	"2.941"
"R-HSA-975871"	"MyD88 cascade initiated on plasma membrane"	"-2.088"	"14"	"23.469"	"4.534"
"R-HSA-168142"	"Toll Like Receptor 10 (TLR10) Cascade"	"-2.088"	"14"	"23.469"	"4.534"
"R-HSA-168176"	"Toll Like Receptor 5 (TLR5) Cascade"	"-2.088"	"14"	"23.469"	"4.534"
"R-HSA-168898"	"Toll-Like Receptors Cascades"	"-2.099"	"18"	"28.85"	"5.168"
"R-HSA-400685"	"Sema4D in semaphorin signaling"	"-2.102"	"0"	"3.731"	"1.775"
"R-HSA-975138"	"TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation"	"-2.103"	"14"	"23.526"	"4.529"
"R-HSA-5654708"	"Downstream signaling of activated FGFR3"	"-2.107"	"0"	"4.029"	"1.912"
"R-HSA-5654716"	"Downstream signaling of activated FGFR4"	"-2.11"	"0"	"4.077"	"1.932"
"R-HSA-5620922"	"BBSome-mediated cargo-targeting to cilium"	"-2.111"	"0"	"3.883"	"1.839"
"R-HSA-5696395"	"Formation of Incision Complex in GG-NER"	"-2.111"	"11"	"19.745"	"4.142"
"R-HSA-5685942"	"HDR through Homologous Recombination (HRR)"	"-2.111"	"8"	"16.189"	"3.879"
"R-HSA-75067"	"Processing of Capped Intronless Pre-mRNA"	"-2.111"	"1"	"5.996"	"2.367"
"R-HSA-2172127"	"DAP12 interactions"	"-2.112"	"1"	"6.095"	"2.412"
"R-HSA-5654687"	"Downstream signaling of activated FGFR1"	"-2.112"	"0"	"4.24"	"2.008"
"R-HSA-70326"	"Glucose metabolism"	"-2.112"	"11"	"19.701"	"4.121"
"WP2781"	"Signaling by ERBB4"	"-2.113"	"7"	"14.402"	"3.504"
"R-HSA-113501"	"Inhibition of replication initiation of damaged DNA by RB1/E2F1"	"-2.115"	"0"	"3.709"	"1.754"
"R-HSA-448424"	"Interleukin-17 signaling"	"-2.117"	"11"	"19.796"	"4.155"
"R-HSA-450294"	"MAP kinase activation"	"-2.117"	"11"	"19.796"	"4.155"
"R-HSA-975155"	"MyD88 dependent cascade initiated on endosome"	"-2.12"	"14"	"23.628"	"4.541"
"R-HSA-168181"	"Toll Like Receptor 7/8 (TLR7/8) Cascade"	"-2.12"	"14"	"23.628"	"4.541"
"R-HSA-5654696"	"Downstream signaling of activated FGFR2"	"-2.145"	"0"	"4.206"	"1.961"
"R-HSA-5637810"	"Constitutive Signaling by EGFRvIII"	"-2.148"	"1"	"5.561"	"2.124"
"R-HSA-5637812"	"Signaling by EGFRvIII in Cancer"	"-2.148"	"1"	"5.561"	"2.124"
"R-HSA-5218920"	"VEGFR2 mediated vascular permeability"	"-2.149"	"1"	"5.793"	"2.23"
"R-HSA-2559586"	"DNA Damage/Telomere Stress Induced Senescence"	"-2.15"	"1"	"5.829"	"2.247"
"R-HSA-1839124"	"FGFR1 mutant receptor activation"	"-2.15"	"0"	"4.232"	"1.968"
"R-HSA-450282"	"MAPK targets/ Nuclear events mediated by MAP kinases"	"-2.157"	"2"	"7.373"	"2.491"
"R-HSA-157118"	"Signaling by NOTCH"	"-2.159"	"16"	"25.997"	"4.631"
"R-HSA-159231"	"Transport of Mature mRNA Derived from an Intronless Transcript"	"-2.159"	"3"	"9.244"	"2.892"
"R-HSA-167242"	"Abortive elongation of HIV-1 transcript in the absence of Tat"	"-2.161"	"2"	"8.014"	"2.783"
"R-HSA-8953897"	"Cellular responses to external stimuli"	"-2.163"	"72"	"91.278"	"8.914"
"R-HSA-159234"	"Transport of Mature mRNAs Derived from Intronless Transcripts"	"-2.163"	"3"	"9.255"	"2.892"
"R-HSA-9006115"	"Signaling by NTRK2 (TRKB)"	"-2.167"	"0"	"4.304"	"1.986"
"R-HSA-166058"	"MyD88:Mal cascade initiated on plasma membrane"	"-2.17"	"14"	"23.951"	"4.585"
"R-HSA-181438"	"Toll Like Receptor 2 (TLR2) Cascade"	"-2.17"	"14"	"23.951"	"4.585"
"R-HSA-168179"	"Toll Like Receptor TLR1:TLR2 Cascade"	"-2.17"	"14"	"23.951"	"4.585"
"R-HSA-168188"	"Toll Like Receptor TLR6:TLR2 Cascade"	"-2.17"	"14"	"23.951"	"4.585"
"R-HSA-2730905"	"Role of LAT2/NTAL/LAB on calcium mobilization"	"-2.181"	"0"	"4.167"	"1.91"
"R-HSA-73887"	"Death Receptor Signalling"	"-2.183"	"12"	"21.664"	"4.427"
"R-HSA-69002"	"DNA Replication Pre-Initiation"	"-2.184"	"6"	"13.552"	"3.458"
"R-HSA-68874"	"M/G1 Transition"	"-2.184"	"6"	"13.552"	"3.458"
"R-HSA-392451"	"G beta:gamma signalling through PI3Kgamma"	"-2.185"	"1"	"6.392"	"2.468"
"R-HSA-180746"	"Nuclear import of Rev protein"	"-2.185"	"2"	"7.654"	"2.587"
"R-HSA-5368287"	"Mitochondrial translation"	"-2.19"	"3"	"9.594"	"3.01"
"R-HSA-202424"	"Downstream TCR signaling"	"-2.211"	"1"	"6.428"	"2.455"
"R-HSA-168164"	"Toll Like Receptor 3 (TLR3) Cascade"	"-2.217"	"15"	"25.714"	"4.832"
"R-HSA-69190"	"DNA strand elongation"	"-2.221"	"1"	"6.576"	"2.51"
"R-HSA-8852135"	"Protein ubiquitination"	"-2.221"	"11"	"20.246"	"4.163"
"R-HSA-6811558"	"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"	"-2.224"	"6"	"14.007"	"3.601"
"R-HSA-397795"	"G-protein beta:gamma signalling"	"-2.236"	"1"	"6.651"	"2.528"
"R-HSA-8866654"	"E3 ubiquitin ligases ubiquitinate target proteins"	"-2.253"	"9"	"17.935"	"3.966"
"R-HSA-76061"	"RNA Polymerase III Transcription Initiation From Type 1 Promoter"	"-2.261"	"0"	"4.878"	"2.157"
"R-HSA-76066"	"RNA Polymerase III Transcription Initiation From Type 2 Promoter"	"-2.264"	"0"	"4.859"	"2.146"
"R-HSA-76071"	"RNA Polymerase III Transcription Initiation From Type 3 Promoter"	"-2.265"	"0"	"5.002"	"2.208"
"R-HSA-1236382"	"Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"	"-2.266"	"1"	"6.081"	"2.242"
"R-HSA-1643713"	"Signaling by EGFR in Cancer"	"-2.266"	"1"	"6.081"	"2.242"
"R-HSA-5637815"	"Signaling by Ligand-Responsive EGFR Variants in Cancer"	"-2.266"	"1"	"6.081"	"2.242"
"R-HSA-389356"	"CD28 co-stimulation"	"-2.28"	"1"	"6.347"	"2.345"
"R-HSA-177929"	"Signaling by EGFR"	"-2.282"	"7"	"15.255"	"3.617"
"R-HSA-375280"	"Amine ligand-binding receptors"	"-2.286"	"0"	"5.242"	"2.293"
"R-HSA-6781823"	"Formation of TC-NER Pre-Incision Complex"	"-2.292"	"11"	"21.232"	"4.464"
"R-HSA-166166"	"MyD88-independent TLR4 cascade "	"-2.297"	"15"	"26.167"	"4.861"
"R-HSA-937061"	"TRIF(TICAM1)-mediated TLR4 signaling "	"-2.297"	"15"	"26.167"	"4.861"
"R-HSA-983168"	"Antigen processing: Ubiquitination & Proteasome degradation"	"-2.312"	"21"	"33.126"	"5.244"
"R-HSA-199418"	"Negative regulation of the PI3K/AKT network"	"-2.316"	"6"	"14.552"	"3.693"
"R-HSA-5654741"	"Signaling by FGFR3"	"-2.324"	"7"	"15.317"	"3.579"
"R-HSA-611105"	"Respiratory electron transport"	"-2.327"	"0"	"5.62"	"2.415"
"R-HSA-354192"	"Integrin alphaIIb beta3 signaling"	"-2.332"	"0"	"4.881"	"2.093"
"R-HSA-9006921"	"Integrin signaling"	"-2.332"	"0"	"4.881"	"2.093"
"SMP00128"	"Gluconeogenesis"	"-2.333"	"1"	"6.646"	"2.42"
"R-HSA-163200"	"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins."	"-2.336"	"0"	"5.676"	"2.43"
"R-HSA-5654743"	"Signaling by FGFR4"	"-2.338"	"7"	"15.352"	"3.573"
"R-HSA-5625740"	"RHO GTPases activate PKNs"	"-2.342"	"13"	"23.754"	"4.592"
"R-HSA-389513"	"CTLA4 inhibitory signaling"	"-2.351"	"0"	"5.352"	"2.277"
"R-HSA-5654736"	"Signaling by FGFR1"	"-2.356"	"7"	"15.57"	"3.637"
"R-HSA-2029480"	"Fcgamma receptor (FCGR) dependent phagocytosis"	"-2.363"	"8"	"17.389"	"3.973"
"R-HSA-2173793"	"Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer"	"-2.366"	"6"	"14.272"	"3.497"
"R-HSA-176187"	"Activation of ATR in response to replication stress"	"-2.385"	"1"	"7.299"	"2.641"
"R-HSA-76046"	"RNA Polymerase III Transcription Initiation"	"-2.395"	"0"	"5.538"	"2.312"
"R-HSA-114604"	"GPVI-mediated activation cascade"	"-2.402"	"0"	"5.192"	"2.162"
"R-HSA-4551638"	"SUMOylation of chromatin organization proteins"	"-2.406"	"6"	"15.201"	"3.824"
"R-HSA-749476"	"RNA Polymerase III Abortive And Retractive Initiation"	"-2.428"	"0"	"5.684"	"2.341"
"R-HSA-74158"	"RNA Polymerase III Transcription"	"-2.428"	"0"	"5.684"	"2.341"
"R-HSA-2871809"	"FCERI mediated Ca+2 mobilization"	"-2.432"	"0"	"5.545"	"2.28"
"R-HSA-2871796"	"FCERI mediated MAPK activation"	"-2.434"	"2"	"8.991"	"2.872"
"R-HSA-8943724"	"Regulation of PTEN gene transcription"	"-2.447"	"5"	"13.517"	"3.48"
"R-HSA-983695"	"Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"	"-2.46"	"0"	"5.818"	"2.365"
"R-HSA-5655302"	"Signaling by FGFR1 in disease"	"-2.466"	"0"	"5.619"	"2.279"
"R-HSA-6803529"	"FGFR2 alternative splicing"	"-2.469"	"2"	"9.332"	"2.97"
"R-HSA-76009"	"Platelet Aggregation (Plug Formation)"	"-2.47"	"0"	"5.568"	"2.254"
"R-HSA-166016"	"Toll Like Receptor 4 (TLR4) Cascade"	"-2.475"	"15"	"27.572"	"5.079"
"R-HSA-2424491"	"DAP12 signaling"	"-2.48"	"0"	"5.629"	"2.27"
"R-HSA-3108214"	"SUMOylation of DNA damage response and repair proteins"	"-2.506"	"7"	"16.864"	"3.936"
"R-HSA-72086"	"mRNA Capping"	"-2.518"	"2"	"9.623"	"3.028"
"R-HSA-186763"	"Downstream signal transduction"	"-2.524"	"0"	"5.914"	"2.343"
"R-HSA-168325"	"Viral Messenger RNA Synthesis"	"-2.524"	"3"	"11.578"	"3.399"
"R-HSA-1226099"	"Signaling by FGFR in disease"	"-2.533"	"0"	"5.949"	"2.349"
"R-HSA-420499"	"Class C/3 (Metabotropic glutamate/pheromone receptors)"	"-2.536"	"0"	"6.187"	"2.439"
"R-HSA-6806834"	"Signaling by MET"	"-2.536"	"6"	"15.038"	"3.563"
"R-HSA-167238"	"Pausing and recovery of Tat-mediated HIV elongation"	"-2.544"	"1"	"8.519"	"2.956"
"R-HSA-167243"	"Tat-mediated HIV elongation arrest and recovery"	"-2.544"	"1"	"8.519"	"2.956"
"R-HSA-5663205"	"Infectious disease"	"-2.556"	"40"	"58.45"	"7.219"
"R-HSA-416482"	"G alpha (12/13) signalling events"	"-2.581"	"1"	"7.818"	"2.642"
"R-HSA-69239"	"Synthesis of DNA"	"-2.582"	"9"	"19.942"	"4.238"
"R-HSA-5696398"	"Nucleotide Excision Repair"	"-2.585"	"21"	"35.884"	"5.758"
"R-HSA-168273"	"Influenza Viral RNA Transcription and Replication"	"-2.596"	"4"	"13.124"	"3.515"
"R-HSA-167287"	"HIV elongation arrest and recovery"	"-2.597"	"1"	"8.779"	"2.995"
"R-HSA-167290"	"Pausing and recovery of HIV elongation"	"-2.597"	"1"	"8.779"	"2.995"
"R-HSA-113418"	"Formation of the Early Elongation Complex"	"-2.598"	"2"	"10.075"	"3.109"
"R-HSA-167158"	"Formation of the HIV-1 Early Elongation Complex"	"-2.598"	"2"	"10.075"	"3.109"
"WP466"	"DNA Replication"	"-2.63"	"9"	"20.207"	"4.262"
"R-HSA-170834"	"Signaling by TGF-beta Receptor Complex"	"-2.63"	"10"	"21.337"	"4.311"
"R-HSA-68962"	"Activation of the pre-replicative complex"	"-2.634"	"0"	"6.368"	"2.418"
"R-HSA-69231"	"Cyclin D associated events in G1"	"-2.638"	"7"	"16.824"	"3.725"
"R-HSA-69236"	"G1 Phase"	"-2.638"	"7"	"16.824"	"3.725"
"R-HSA-186797"	"Signaling by PDGF"	"-2.639"	"0"	"6.487"	"2.458"
"R-HSA-2219530"	"Constitutive Signaling by Aberrant PI3K in Cancer"	"-2.645"	"1"	"8.221"	"2.73"
"R-HSA-380108"	"Chemokine receptors bind chemokines"	"-2.647"	"0"	"6.959"	"2.629"
"R-HSA-5689603"	"UCH proteinases"	"-2.659"	"16"	"29.501"	"5.077"
"R-HSA-1227986"	"Signaling by ERBB2"	"-2.66"	"7"	"17.265"	"3.859"
"R-HSA-76002"	"Platelet activation, signaling and aggregation"	"-2.661"	"17"	"30.816"	"5.191"
"R-HSA-73772"	"RNA Polymerase I Promoter Escape"	"-2.665"	"0"	"6.525"	"2.449"
"R-HSA-77075"	"RNA Pol II CTD phosphorylation and interaction with CE"	"-2.668"	"1"	"8.766"	"2.91"
"R-HSA-167160"	"RNA Pol II CTD phosphorylation and interaction with CE during HIV infection"	"-2.668"	"1"	"8.766"	"2.91"
"R-HSA-73863"	"RNA Polymerase I Transcription Termination"	"-2.672"	"0"	"6.548"	"2.451"
"R-HSA-2219528"	"PI3K/AKT Signaling in Cancer"	"-2.733"	"3"	"12.076"	"3.321"
"R-HSA-449147"	"Signaling by Interleukins"	"-2.737"	"22"	"37.756"	"5.756"
"R-HSA-1428517"	"The citric acid (TCA) cycle and respiratory electron transport"	"-2.741"	"3"	"12.061"	"3.305"
"R-HSA-69206"	"G1/S Transition"	"-2.758"	"12"	"24.939"	"4.691"
"WP3827"	"RNA polymerase II transcribes snRNA genes"	"-2.76"	"4"	"13.963"	"3.61"
"R-HSA-167200"	"Formation of HIV-1 elongation complex containing HIV-1 Tat"	"-2.778"	"2"	"11.437"	"3.398"
"R-HSA-167169"	"HIV Transcription Elongation"	"-2.778"	"2"	"11.437"	"3.398"
"R-HSA-167246"	"Tat-mediated elongation of the HIV-1 transcript"	"-2.778"	"2"	"11.437"	"3.398"
"R-HSA-202403"	"TCR signaling"	"-2.802"	"1"	"8.791"	"2.78"
"R-HSA-6781827"	"Transcription-Coupled Nucleotide Excision Repair (TC-NER)"	"-2.804"	"12"	"26.055"	"5.012"
"R-HSA-167152"	"Formation of HIV elongation complex in the absence of HIV Tat"	"-2.827"	"2"	"11.697"	"3.43"
"R-HSA-9006936"	"Signaling by TGF-beta family members"	"-2.836"	"10"	"22.543"	"4.423"
"R-HSA-1433557"	"Signaling by SCF-KIT"	"-2.838"	"0"	"7.466"	"2.631"
"R-HSA-983705"	"Signaling by the B Cell Receptor (BCR)"	"-2.849"	"3"	"11.841"	"3.103"
"R-HSA-6790901"	"rRNA modification in the nucleus and cytosol"	"-2.903"	"2"	"11.452"	"3.256"
"R-HSA-8868773"	"rRNA processing in the nucleus and cytosol"	"-2.903"	"2"	"11.452"	"3.256"
"R-HSA-72312"	"rRNA processing"	"-2.929"	"2"	"11.601"	"3.278"
"R-HSA-202733"	"Cell surface interactions at the vascular wall"	"-2.953"	"1"	"10.317"	"3.155"
"R-HSA-8951664"	"Neddylation"	"-2.966"	"21"	"38.682"	"5.962"
"WP2772"	"S Phase"	"-2.983"	"11"	"25.031"	"4.704"
"R-HSA-5693565"	"Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"	"-3.004"	"10"	"24.062"	"4.681"
"R-HSA-373755"	"Semaphorin interactions"	"-3.006"	"1"	"9.486"	"2.823"
"R-HSA-3214858"	"RMTs methylate histone arginines"	"-3.011"	"3"	"12.828"	"3.264"
"R-HSA-913531"	"Interferon Signaling"	"-3.013"	"3"	"13.964"	"3.639"
"R-HSA-9006934"	"Signaling by Receptor Tyrosine Kinases"	"-3.015"	"42"	"64.335"	"7.408"
"R-HSA-5693606"	"DNA Double Strand Break Response"	"-3.019"	"10"	"24.265"	"4.726"
"R-HSA-112382"	"Formation of RNA Pol II elongation complex "	"-3.02"	"2"	"12.812"	"3.58"
"R-HSA-75955"	"RNA Polymerase II Transcription Elongation"	"-3.02"	"2"	"12.812"	"3.58"
"R-HSA-6814122"	"Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding"	"-3.03"	"1"	"9.864"	"2.926"
"R-HSA-6804756"	"Regulation of TP53 Activity through Phosphorylation"	"-3.054"	"12"	"27.415"	"5.048"
"R-HSA-167161"	"HIV Transcription Initiation"	"-3.137"	"3"	"14.066"	"3.527"
"R-HSA-167162"	"RNA Polymerase II HIV Promoter Escape"	"-3.137"	"3"	"14.066"	"3.527"
"R-HSA-75953"	"RNA Polymerase II Transcription Initiation"	"-3.137"	"3"	"14.066"	"3.527"
"R-HSA-76042"	"RNA Polymerase II Transcription Initiation And Promoter Clearance"	"-3.137"	"3"	"14.066"	"3.527"
"R-HSA-73779"	"RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"	"-3.137"	"3"	"14.066"	"3.527"
"R-HSA-6782210"	"Gap-filling DNA repair synthesis and ligation in TC-NER"	"-3.161"	"9"	"23.876"	"4.706"
"R-HSA-159236"	"Transport of Mature mRNA derived from an Intron-Containing Transcript"	"-3.169"	"3"	"15.148"	"3.833"
"R-HSA-6782135"	"Dual incision in TC-NER"	"-3.184"	"9"	"24.08"	"4.737"
"R-HSA-162599"	"Late Phase of HIV Life Cycle"	"-3.19"	"17"	"35.481"	"5.793"
"R-HSA-71387"	"Metabolism of carbohydrates"	"-3.193"	"12"	"27.683"	"4.912"
"WP4047"	"PTEN Regulation"	"-3.21"	"11"	"26.891"	"4.951"
"R-HSA-1799339"	"SRP-dependent cotranslational protein targeting to membrane"	"-3.21"	"12"	"30.018"	"5.613"
"R-HSA-418555"	"G alpha (s) signalling events"	"-3.211"	"2"	"13.397"	"3.549"
"R-HSA-3108232"	"SUMO E3 ligases SUMOylate target proteins"	"-3.234"	"9"	"24.738"	"4.867"
"R-HSA-2262752"	"Cellular responses to stress"	"-3.241"	"57"	"84.924"	"8.615"
"R-HSA-977225"	"Amyloid fiber formation"	"-3.251"	"9"	"23.838"	"4.564"
"R-HSA-2990846"	"SUMOylation"	"-3.264"	"9"	"24.928"	"4.88"
"R-HSA-72187"	"mRNA 3,-end processing"	"-3.275"	"1"	"12.383"	"3.476"
"R-HSA-156842"	"Eukaryotic Translation Elongation"	"-3.276"	"12"	"29.786"	"5.429"
"R-HSA-453279"	"Mitotic G1-G1/S phases"	"-3.279"	"13"	"29.754"	"5.11"
"WP3808"	"TP53 Regulates Transcription of DNA Repair Genes"	"-3.303"	"3"	"15.981"	"3.93"
"R-HSA-167172"	"Transcription of the HIV genome"	"-3.319"	"4"	"17.468"	"4.058"
"R-HSA-388841"	"Costimulation by the CD28 family"	"-3.341"	"1"	"11.683"	"3.198"
"R-HSA-73762"	"RNA Polymerase I Transcription Initiation"	"-3.363"	"0"	"10.357"	"3.079"
"R-HSA-5654738"	"Signaling by FGFR2"	"-3.368"	"9"	"24.764"	"4.68"
"R-HSA-9006925"	"Intracellular signaling by second messengers"	"-3.376"	"25"	"46.721"	"6.434"
"R-HSA-72165"	"mRNA Splicing - Minor Pathway"	"-3.38"	"2"	"15.404"	"3.966"
"R-HSA-73776"	"RNA Polymerase II Promoter Escape"	"-3.395"	"2"	"13.768"	"3.466"
"R-HSA-2454202"	"Fc epsilon receptor (FCERI) signaling"	"-3.411"	"3"	"15.167"	"3.567"
"R-HSA-190236"	"Signaling by FGFR"	"-3.435"	"9"	"25.127"	"4.695"
"R-HSA-72202"	"Transport of Mature Transcript to Cytoplasm"	"-3.45"	"3"	"17.02"	"4.064"
"R-HSA-162587"	"HIV Life Cycle"	"-3.456"	"17"	"37.846"	"6.032"
"R-HSA-1221632"	"Meiotic synapsis"	"-3.465"	"0"	"10.722"	"3.094"
"R-HSA-674695"	"RNA Polymerase II Pre-transcription Events"	"-3.471"	"4"	"18.507"	"4.179"
"R-HSA-109688"	"Cleavage of Growing Transcript in the Termination Region "	"-3.514"	"1"	"13.96"	"3.688"
"R-HSA-73856"	"RNA Polymerase II Transcription Termination"	"-3.514"	"1"	"13.96"	"3.688"
"R-HSA-3214847"	"HATs acetylate histones"	"-3.542"	"8"	"24.732"	"4.724"
"R-HSA-156902"	"Peptide chain elongation"	"-3.595"	"9"	"27.921"	"5.263"
"R-HSA-195721"	"Signaling by WNT"	"-3.601"	"30"	"54.171"	"6.713"
"R-HSA-72695"	"Formation of the ternary complex, and subsequently, the 43S complex"	"-3.605"	"2"	"15.269"	"3.681"
"R-HSA-5663202"	"Diseases of signal transduction"	"-3.613"	"21"	"43.809"	"6.313"
"R-HSA-975956"	"Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)"	"-3.635"	"10"	"29.148"	"5.268"
"R-HSA-5693607"	"Processing of DNA double-strand break ends"	"-3.727"	"10"	"28.59"	"4.988"
"R-HSA-5633007"	"Regulation of TP53 Activity"	"-3.757"	"15"	"37.254"	"5.923"
"R-HSA-72649"	"Translation initiation complex formation"	"-3.773"	"3"	"18.062"	"3.992"
"R-HSA-73728"	"RNA Polymerase I Promoter Opening"	"-3.776"	"1"	"15.173"	"3.754"
"R-HSA-72662"	"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"	"-3.797"	"3"	"18.211"	"4.006"
"R-HSA-2408557"	"Selenocysteine synthesis"	"-3.804"	"7"	"26.592"	"5.15"
"R-HSA-5693567"	"HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)"	"-3.832"	"12"	"32.23"	"5.28"
"R-HSA-1280215"	"Cytokine Signaling in Immune system"	"-3.838"	"26"	"52.167"	"6.817"
"WP3397"	"Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3"	"-3.84"	"1"	"15.249"	"3.711"
"R-HSA-8939236"	"RUNX1 regulates transcription of genes involved in differentiation of HSCs"	"-3.841"	"6"	"24.089"	"4.71"
"R-HSA-212300"	"PRC2 methylates histones and DNA"	"-3.849"	"2"	"17.55"	"4.04"
"R-HSA-171306"	"Packaging Of Telomere Ends"	"-3.866"	"0"	"14.076"	"3.641"
"R-HSA-5693571"	"Nonhomologous End-Joining (NHEJ)"	"-3.867"	"1"	"15.017"	"3.624"
"R-HSA-2299718"	"Condensation of Prophase Chromosomes"	"-3.871"	"2"	"17.575"	"4.024"
"R-HSA-72702"	"Ribosomal scanning and start codon recognition"	"-3.888"	"2"	"17.4"	"3.961"
"R-HSA-72764"	"Eukaryotic Translation Termination"	"-3.902"	"7"	"26.987"	"5.122"
"R-HSA-5693538"	"Homology Directed Repair"	"-3.957"	"12"	"32.977"	"5.301"
"R-HSA-912446"	"Meiotic recombination"	"-3.957"	"0"	"14.353"	"3.628"
"R-HSA-5693532"	"DNA Double-Strand Break Repair"	"-3.97"	"15"	"37.501"	"5.668"
"WP3391"	"Senescence-Associated Secretory Phenotype (SASP)"	"-3.971"	"9"	"30.069"	"5.305"
"R-HSA-1643685"	"Disease"	"-4.01"	"59"	"95.846"	"9.188"
"R-HSA-2408522"	"Selenoamino acid metabolism"	"-4.013"	"8"	"29.818"	"5.437"
"R-HSA-927802"	"Nonsense-Mediated Decay (NMD)"	"-4.016"	"10"	"31.981"	"5.473"
"R-HSA-975957"	"Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)"	"-4.016"	"10"	"31.981"	"5.473"
"R-HSA-5334118"	"DNA methylation"	"-4.018"	"0"	"14.76"	"3.674"
"R-HSA-72689"	"Formation of a pool of free 40S subunits"	"-4.021"	"8"	"29.266"	"5.289"
"R-HSA-3700989"	"Transcriptional Regulation by TP53"	"-4.021"	"37"	"68.909"	"7.936"
"WP3404"	"Oxidative Stress Induced Senescence"	"-4.039"	"12"	"35.228"	"5.751"
"R-HSA-427359"	"SIRT1 negatively regulates rRNA expression"	"-4.07"	"0"	"15.437"	"3.793"
"WP3339"	"TCF dependent signaling in response to WNT"	"-4.11"	"18"	"42.217"	"5.893"
"WP2653"	"PIP3 activates AKT signaling"	"-4.117"	"17"	"42.16"	"6.111"
"R-HSA-201722"	"Formation of the beta-catenin:TCF transactivating complex"	"-4.124"	"4"	"21.817"	"4.32"
"R-HSA-71291"	"Metabolism of amino acids and derivatives"	"-4.137"	"13"	"37.976"	"6.037"
"R-HSA-157579"	"Telomere Maintenance"	"-4.137"	"3"	"20.65"	"4.267"
"R-HSA-427389"	"ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression"	"-4.306"	"0"	"17.645"	"4.098"
"R-HSA-156827"	"L13a-mediated translational silencing of Ceruloplasmin expression"	"-4.325"	"9"	"32.9"	"5.526"
"WP4132"	"RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"	"-4.326"	"1"	"18.833"	"4.122"
"R-HSA-1500620"	"Meiosis"	"-4.356"	"0"	"17.182"	"3.945"
"R-HSA-1474165"	"Reproduction"	"-4.386"	"0"	"17.297"	"3.943"
"R-HSA-5689880"	"Ub-specific processing proteases"	"-4.41"	"20"	"49.178"	"6.616"
"R-HSA-72706"	"GTP hydrolysis and joining of the 60S ribosomal subunit"	"-4.437"	"8"	"32.495"	"5.52"
"R-HSA-416476"	"G alpha (q) signalling events"	"-4.441"	"7"	"29.97"	"5.172"
"R-HSA-3214815"	"HDACs deacetylate histones"	"-4.483"	"0"	"19.475"	"4.344"
"R-HSA-72737"	"Cap-dependent Translation Initiation"	"-4.493"	"9"	"34.395"	"5.652"
"R-HSA-72613"	"Eukaryotic Translation Initiation"	"-4.493"	"9"	"34.395"	"5.652"
"R-HSA-73886"	"Chromosome Maintenance"	"-4.498"	"3"	"23.877"	"4.641"
"R-HSA-5688426"	"Deubiquitination"	"-4.569"	"27"	"60.443"	"7.32"
"R-HSA-3247509"	"Chromatin modifying enzymes"	"-4.571"	"12"	"38.917"	"5.888"
"R-HSA-4839726"	"Chromatin organization"	"-4.571"	"12"	"38.917"	"5.888"
"R-HSA-375276"	"Peptide ligand-binding receptors"	"-4.593"	"4"	"28.187"	"5.266"
"R-HSA-72766"	"Translation"	"-4.601"	"23"	"57.086"	"7.408"
"R-HSA-5250924"	"B-WICH complex positively regulates rRNA expression"	"-4.605"	"2"	"22.976"	"4.555"
"R-HSA-5578749"	"Transcriptional regulation by small RNAs"	"-4.748"	"3"	"26.247"	"4.896"
"R-HSA-73894"	"DNA Repair"	"-4.763"	"27"	"62.338"	"7.419"
"R-HSA-1430728"	"Metabolism"	"-4.796"	"82"	"133.15"	"10.665"
"R-HSA-73777"	"RNA Polymerase I Chain Elongation"	"-4.818"	"0"	"20.971"	"4.352"
"WP4105"	"Transcriptional regulation by RUNX1"	"-4.84"	"11"	"39.955"	"5.983"
"R-HSA-211000"	"Gene Silencing by RNA"	"-4.866"	"3"	"27.2"	"4.973"
"R-HSA-9018519"	"Estrogen-dependent gene expression"	"-4.879"	"7"	"35.158"	"5.771"
"R-HSA-2559583"	"Cellular Senescence"	"-4.898"	"13"	"44.216"	"6.373"
"R-HSA-5250913"	"Positive epigenetic regulation of rRNA expression"	"-4.907"	"2"	"26.056"	"4.902"
"R-HSA-418594"	"G alpha (i) signalling events"	"-4.971"	"17"	"50.653"	"6.77"
"R-HSA-427413"	"NoRC negatively regulates rRNA expression"	"-5.022"	"0"	"23.453"	"4.67"
"R-HSA-73854"	"RNA Polymerase I Promoter Clearance"	"-5.027"	"1"	"25.43"	"4.86"
"R-HSA-5250941"	"Negative epigenetic regulation of rRNA expression"	"-5.03"	"0"	"23.917"	"4.755"
"R-HSA-73864"	"RNA Polymerase I Transcription"	"-5.037"	"1"	"25.557"	"4.876"
"R-HSA-212165"	"Epigenetic regulation of gene expression"	"-5.045"	"4"	"32.388"	"5.627"
"R-HSA-8939211"	"ESR-mediated signaling"	"-5.21"	"8"	"39.221"	"5.993"
"R-HSA-9006931"	"Signaling by Nuclear Receptors"	"-5.244"	"10"	"43.182"	"6.328"
"R-HSA-72163"	"mRNA Splicing - Major Pathway"	"-5.307"	"12"	"49.356"	"7.038"
"R-HSA-72172"	"mRNA Splicing"	"-5.364"	"12"	"49.756"	"7.039"
"R-HSA-72203"	"Processing of Capped Intron-Containing Pre-mRNA"	"-5.819"	"14"	"58.729"	"7.686"
"R-HSA-373076"	"Class A/1 (Rhodopsin-like receptors)"	"-6.149"	"4"	"43.796"	"6.471"
"R-HSA-500792"	"GPCR ligand binding"	"-6.61"	"9"	"56.182"	"7.138"
"R-HSA-372790"	"Signaling by GPCR"	"-6.94"	"25"	"83.472"	"8.425"
"R-HSA-162582"	"Signal Transduction"	"-6.95"	"172"	"270.608"	"14.188"
"R-HSA-8953854"	"Metabolism of RNA"	"-7.018"	"42"	"115.277"	"10.442"
"R-HSA-388396"	"GPCR downstream signalling"	"-7.321"	"21"	"82.518"	"8.403"
"R-HSA-212436"	"Generic Transcription Pathway"	"-7.76"	"65"	"159.3"	"12.153"
"R-HSA-73857"	"RNA Polymerase II Transcription"	"-8.559"	"68"	"177.993"	"12.851"
"R-HSA-74160"	"Gene expression (Transcription)"	"-9.049"	"72"	"192.957"	"13.367"
